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1.1 CHROMATOGRAPHY 
Chromatography is a technique for the separation of components by their 
difference in affinity for, or solubility in two different phases. One phase is stationary, 
usually in the form of tube of glass, plastic ro metal (the column) or a flat bed (planer) 
and the other phase (the mobile phase or eluent) is moving through the pore space of 
the stationary phase. Separation is accomplished by compounds spending different 
time on the stationary phase. Russian botanist Michael Tswett is known as the father 
of chromatography. His work was, originally presented in 1903 and then published in 
1906. Tswett described the separation of plant pigments by column liquid 
chromatography. The original article of Tswett is of significant historical interest and 
serves as a fitting introduction to a discussion of the concepts of chromatography. The 
English translated version of Tswett's original article is readily available [1]. 
There were some important developments during 1906 and 1952. In this 
period the techniques of planar chromatography were developed. Earlier the use of 
paper as a plane support was common, but when thin-layers of silica gel were 
introduced as an alternative in the late 1950's. The field of thin-layer chromatography 
(TLC) was developed and became so popular that it largely replaced the older 
technique. In 1940's the developments in the field of column chromatography 
accelerated. The widespread use and popularity of chromatography began with the 
article published by Martin and James on gas chromatography in 1952 [2]. This 
article reported use of a gas as a mobile phase in the separation of volatile fatty acids. 
Martin and Synge published their Nobel prize-winning article in which they 
introduced liquid-liquid (or partition) chromatography and plate theory [3]. Plate 
theory was further replaced by Craig, in 1950 [4], who published a paper entitled 
"Partition chromatography and countercurrent distribution". His countercurrent 
distribution apparatus gained some popularity but was soon replaced by liquid 
chromatography for most applications. In 1955 Glueckauf published an article entitled 
"The plate concept in column separations" which indicates the importance of plate 
theory to early chromatographic development. 
The rate theory, an alternative to plate theory came into prominence about the 
same time was published by the Dutch workers Van Deemter, Zuiderweg and 
Klinkenberg [5]. They described the chromatographic process in packed GC columns 
in terms of kinetics and elucidate the diffusion and mass transfer processes in gas-
liquid chromatography (GLC). Giddings published an article in 1963 entitled "LC 
with operating condition analogous to those of GC". This article setting off a 
revolution in LC that led to its achieving a level of efficiency comparable to that 
achieved in GC. These new conditions for operating LC columns required high 
pressure, so HPLC was used to describe high-pressure LC. The use of high pressure 
also produced expected high-performance separations, so HPLC is also denoted by 
high-performance liquid chromatography. The year 2003 was considered by many 
analytical chemists the mark of end of the first century of chromatography. The 
journal of chromatography chooses that year for the publication of its lOOO"' volume 
containing many useful reviews of recent chromatographic developments [6]. A 
simple classification of Chromatographic methods is summarized in (Table 1.1). 
Table 1.1: Classification of Chromatographic Methods 
Technique 
Gas Liquid Chromatography 
(GLC) 
Gas Solid Chromatography 
(GSC) 
Supercritical Fluid 
Chromatography (SFC) 
Liquid-Liquid Chromatography 
(LLC) 
Liquid Solid Chromatography 
(LSC) 
Thin-Layer Chromatography 
(TLC) 
Ion Exchange Chromatography 
(lEC) 
Size Exclusion 
Chromatography (SIC) 
Affinity Chromatography (AC) 
Bonded Phase Chromatography 
(BPC) 
Connguration 
Column 
Column 
Column 
Column 
Column 
Plane 
Column 
Column 
Column 
Column 
Stationary phase 
Liquid 
Solid (Adsorbent, 
Molecular sieve) 
Liquid or Solid 
Liquid 
Solid (Adsorbent) 
Liquid or 
Solid (Adsorbent) 
Solid (Ion exchange 
resin) 
Solid 
(Molecular sieve) 
Solid (Ligand) 
Solid (Bonded) 
Mobile phase 
Gas 
Gas 
Supercritical Fluid 
Liquid 
Liquid 
4 
Liquid 
Liquid 
Liquid 
Liquid 
Liquid 
Since the work presented in this thesis is mainly based on the use of thin layer 
chromatography as an analytical tool, it is necessary to mention the salient features of 
this technique. The following paragraphs are devoted to cover all-important aspects 
of the development and current state-of-art procedure of thin-layer chromatography. 
1.2 THIN-LAYER CHROMATOGRAPHY 
Thin-layer chromatography (TLC), a subdivision of liquid chromatography is 
carried out on a flat surface and hence it is sometimes referred to as planar 
chromatographic separation technique. In TLC, the mobile phase (a liquid) migrates 
through the stationary phase (thin layer of porous sorbent on a flat inert surface) by 
capillary action. This technique is simple, versatile and inexpensive for separating and 
identifying the components of complex mixtures of inorganic, organic and 
biochemical substances. 
The begirming of TLC can be ascribed to the report of Dutch biologist, 
Beyerink [7], who separated hydrochloric and sulfuric acids in the form of fine rings 
on thin layer of gelatin using a visualizing agent. Following the same method, 
Wijsman [8] identified the presence of two enzymes in malt diastase using a 
fluorescent method for detecting separated enzymes on thin layer. He used the 
bacteria obtained from sea water as fluorescent agent. However, the invention of TLC 
is usually credited to two Russian Scientists; N. A. Izmailov and M.S. Schraiher, who 
used binder free horizontal thin layers (2 mm thick) of alumina spread on glass plate 
to the analysis of pharmaceutical preparations which led to the publication of their 
classical paper [9] on ''A Spot Chromatographic Method of Analysis and its 
Application in Pharmacy'' in 1938. Since their method consists of depositing a drop 
of sample solution being investigated and the development by the application of 
several drops of solvent on flat surface of adsorbent before observing the separated 
zones, it was called ''Drop Chromatography or Spot Chromatography. They also 
pointed out the usefulness of this method for preliminary testing of sorbent properties 
before their utilization in the form of column. Though Izmailov is best known for his 
fundamental work on TLC, his main field of interest was electrochemistry for which 
he received the Mendeleiv Prize of the Academy of Science of USSR in 1961. 
In 1939, Brovm developed a useful technique called ''Circular Paper 
Chromatography" which involves the placing of filter paper between two glass plates 
and the application of sample and the developing solvent through a small hole of the 
upper plate. To obtain stronger adsorbent, he proposed the use of a thin layer of 
alumina between two sheets of paper. In 1940, Lapp and Erali used a loose layer of 
alumina spread on a glass slide that was supported on an inclined aluminum sheet. 
This sheet was cooled at its upper end and heated at the lower end. The sample was 
placed at the top of the adsorbent layer and gradually developed by solvent 
descending movement. The use of heat at the lower end of the layer increased the 
evaporation rate of the solvent so that increased development could take place [10]. It 
is interesting that, in 1949 two American Chemists, Meinhard and Hall [11] gave the 
concept of "Surface Chromatography" and described their work on the use of 
microscope slides coated with a mixture of alumina (an adsorbent) and celite (a 
binder) to separate Fe and Zn . Their work was probably the first application of 
TLC for the separation of inorganic ions. 
TLC is the most widely used chromatographic method because of the 
following reasons, (a) The availability of limited number of liquid chromatographs in 
research laboratories (b) simplicity of the techniques (c) possibility of simultaneous 
analysis of a large number of samples (d) low cost and (e) the ease of operation by a 
researcher with little experience. Numerous publications on TLC applications attest to 
the versatility and applicability of this technique in all branches of science. It has 
opened new fields of exploration and become an invaluable aid to separation 
scientists. 
TLC can be used for (a) qualitative analysis (to identity the presence or 
absence of a particular substance in a mixture (b) quantitative analysis (to determine 
precisely and accurately, the amount of a particular substance in a sample mixture) 
and (c) preparative analysis (to purify and isolate a particular substance for 
subsequent use). All three cases require the common procedures of sample 
application, chromatographic separation and sample component visualization. 
However, analytical TLC differs from preparative TLC as the sample solution/or 
amount is applied on thinner layers in the former case, whereas thicker TLC plates 
are used for preparative TLC. 
1.3 TLC PROCEDURE 
The TLC process is an off-line process in which all the procedural 
steps, depicted in (Fig. 1.1) are carried out independently. The basic TLC 
procedure involves the spotting of sample mixture (5-10 ^L) at about 2 cm above the 
lower edge of the TLC plate, drying the spot (usually at room temperature), 
development of plate with suitable mobile phase to a distance of 8-10 cm inside a 
cylindrical or rectangular closed chamber by ascending technique, withdrawing plate 
from the developing chamber, drying the layer at room temperature to remove the 
mobile phase, detection of spots on TLC plate using suitable detection reagent, 
measurement of Rp values of the resolved spots and the quantitative estimation of the 
analyte after extraction from the layer with suitable extractant. The differential 
migration of components results due to varying degrees of affinity of the components 
in a mixture for stationary and mobile phases. 
Sample Preparation 
Standard methods for sample preparation identification and separation of 
analyte present in a variety of samples such as plants, food, biological, geological and 
environmental samples have been reported. In general, solutions of the drugs are 
prepared by dissolving appropriate weights of powdered drug in methanol to give 
concentrations of 1 -5 mg/ml. 
TLC Plate Preparation or Coating Procedures 
The contemporary trend is of using commercially available pre-coated plates. 
The manual preparation of layers involves the coating of slurry of the adsorbent 
(silica gel, alumina and kieselguhr) on glass, aluminum or plastic sheet (20x20 or 
20x10cm) with the help of TLC applicator. The thickness of dried layer for analytical 
purposes is kept to 0.2-0.3 mm. A binder (starch, gypsum, dextrin or polyvinyl 
alcohol) is usually added to the layer material to provide better adhesion mechanical 
stability and durability. 
Sample preparation 
i 
Sample application 
I 
Plate development 
i 
Drying of TLC plate 
i 
Spot detection 
i 
Component removal (Optional) 
; 
Documentation 
Fig. 1.1: Scheme of Typical Thin-Layer Chromatographic Process 
Sample Application 
Sample application is one of the most important steps in the technology of 
TLC. Improperly applied samples result in poor chromatograms. Sample can be 
applied as spot or streak using micropipette, microsyringe, melting point capillaries 
etc. A number of automatic spotters of varying design are available for sample 
application. The nanoapplicator (Nanomat) is an example of micrometer controlled 
syringes which has a dynamic volume range of 50-230 nL. Another applicator 
(Linomat) allows sample application in narrow bands. The application of sample as 
streak or band provides more efficient separations. The sample should be completely 
dried before placing the plate in the developing chamber. Dilute solutions can be 
applied to the layer either with sorbent drying between successive applications or 
after bringing the sample solution to proper concentration. 
Development Modes 
The process of migration of mobile phase through the sorbent layer to effect 
separation of the sample substance is called development. Ascending development 
has been the most commonly used mode of development in TLC. Other development 
modes such as multiple, stepwise, circular two-dimensional and reversed-phase 
partition development have also been used to limited extent. The distance for the 
migration mobile phase has been kept to 10-12 cm for conventional TLC. While 
performing the development one should take care of the angle of the development and 
saturation of chamber apart from other factors. 
1.4 CHROMATOGRAPHIC SYSTEMS 
The stationary and mobile phases together comprise the chromatographic 
system. The proper selection of stationary and mobile phase conditions decides the 
degree to which effective separations of components in a mixture can be achieved. 
Stationary Phase (Layer Sorbent) 
Silica gel, an amorphous and porous sorbent has been the most preferred layer 
material followed by alumina and cellulose. Thin layers of silica gel G (gypsum 
binder) and silica gel S (starch binder) with or without, "fluorescent indicator" have 
been used more frequently. Silica gel is slightly acidic in nature. At the surface of 
silica gel the free valences of the oxygen are connected either with hydrogen (Si-O-H, 
silanol groups) or with another silicon atom (Si-O-Si, siloxane groups). The silanol 
groups represent adsorption active surface centers that are able to interact with solute 
molecules. On the other hand, alumina (aluminium oxide) is basic and is more 
reactive than silica gel. Adsorption is the separation mechanism in both silica gel and 
alumina. Cellulose, an organic material is used as a sorbent in TLC when it is 
convenient to perform a given paper chromatographic separation by TLC with 
decreased development time and increase in the sensitivity of detection. Mixed layers 
(impregnated and non-impregnated) have also been used by several workers for 
achieving enhanced resolution of components. Mixed layers are usually of medium 
activity as compared to the separated phases. The addition of kieselguhr in silica 
generally reduces the activity of silica, resulting in a new sorbent layer with altered 
activity that is capable of providing peculiar separations, not possible on separated 
phases. The mixed layers of upto three or four sorbents have been occasionally 
prepared and used for specific TLC applications. However, binary (or biphasic) 
sorbent layers have been more commonly used for routine analysis of organic as well 
as inorganic mixtures. 
Mobile Phase (Solvent System) 
In TLC, the separation of ions is usually governed by the physical interactions 
of the adsorbent and the coordinative properties of the mobile phase. The mixture of 
organic solvents containing some aqueous acid, base or a buffer is, in general well 
suited for the separation of ionic species whereas anhydrous organic solvents and 
water containing mobile phases have been found more useful for separating nonionic 
species. Mobile phase should be as simple as possible and prepared from the purest 
grade of solvent. The use of mixtures composed of more than four components of 
mobile phase should be avoided because of problems associated with reproducible 
preparations. In contrast to mobile phases of higher volatility, which are capable to 
evaporate quickly from the sorbent layer, better reproducibility is achieved with 
mobile phases of lower volatility. The mobile phases used as developers in TLC may 
be categorized into following groups. 
Inorganic Solvents 
Solutions of mineral acids, bases, salts and mixture of acids, bases and or 
their salts. 
Organic Solvents 
Acids, bases, hydrocarbons, alcohols, amines, ketones, aldehydes, 
organophosphates and their mixture in different proportions. 
Mixed Solvents 
Above mentioned organic solvents mixed with water, mineral, acids, 
inorganic bases or dimethyl sulphoxide and buffered salt solutions. 
Micellar Solvents 
Solutions of surfactants (SDS, CTAB or Triton X-100) have been recently used 
but to a lesser extent as mobile phase in TLC. 
The traditional mobile phase systems as mentioned above (a-c) have been 
widely used in TLC analysis of organic as well as inorganic substances. However, the 
use of surfactant - mediated mobile phase systems in TLC is of recent origin. 
Surfactant-Mediated TLC Systems 
Since the work presented in this dissertation is related to the use of surfactant -
mediated mobile phase systems, it is worthwhile to describe briefly the behavior of 
surfactants in aqueous medium. The following paragraphs are devoted to highlight the 
utility of surfactants as eluents in chromatography. 
Surfactant - mediated systems contain surfactant as one of the components of 
mobile phase. A surfactant in the aqueous mobile phase can be used in the following 
ways: 
(a) As monomer surfactants where the concentration of surfactant in aqueous 
mobile phase is restricted to well below the critical micelle concentration 
(CMC) of the surfactant. These mobile phases are most suited to separate ionic 
species by ion-pair chromatography (IPC). 
(b) As surfactant micelles where the surfactant concentration is kept well above its 
CMC value. In such cases, the mobile phase is composed of surfactant 
molecules in the form of monomers and aggregates (or micelles). These mobile 
phases are very useful for simultaneous separation of ionic and non-ionic 
compounds by micellar liquid chromatography (MLC). 
(c) As microemulsion where surfactant in the presence of water, an oil 
(hydrocarbon) and co-surfactant (i.e. medium chain length amine or alcohol) is 
used as transparent solution. 
Surfactants are long chain amphiphilic organic or organometallic molecules 
containing a highly polar (hydrophilic or lipophobic) or "ionic head group" attached 
to a non-polar (hydrophobic or lipophilic) hydrocarbon tail of varying chain lengths. 
The "head group" is either cationic (e.g. ammonium or pyridinium ion), anionic (e.g. 
hydroxy compounds) or zwitterionic (e.g. amine oxide, carboxylate or sulphonate 
betain) whereas the tail is hydrophobic and contain atleast 8 carbon atoms. Depending 
upon the nature of hydrophilic group, surfactant can be classified as anionic [R-X' 
M"^ ], cationic [R-N^(CH3)3X"], zwitterionic [R-(CH3)2 N^CHa X"] and nonionic [R 
(OCH2CH2)]m OH, where R is a long aliphatic hydrocarbon chain, M"^  is a metal ion, 
X' is a halogen, COO" or S04^' and m is an integer. A list of some common 
surfactants is provided in Table 1.2. 
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1.5 MICELLES 
Surfactant (or amphiphilic) molecules comprising of hydrophobic and hydrophilic 
moieties tend to exhibit a considerable degree of self-organization when dissolved in 
aqueous solutions. Above a certain concentration level, termed as critical micelle 
concentration (CMC), the surfactant molecules in solutions (water or organic solvents) 
aggregate to form micelles. The process of micelle formation is called "micellization". 
Micelles do not exist at all concentrations and temperatures. There is a very small 
concentration range below which aggregation to micelles is absent and above which 
association leads to micelle formation. This narrow concentration range during which 
micelle formation occurs is called the CMC. At low concentration i.e. below CMC and at 
temp above the CMC (e.g. kraft temperature), the surfactant is dispersed in the aqueous 
media at the molecular level as a monomer. The average number of monomer per micelle 
is called aggregation number (N). At 25°C and 1 atmospheric pressure, the CMC is 
typically less than 20m M, with each micelle consisting of 40-140 monomers. A 
conventional model of micelle is that proposed by Hartly (Fig. 1.2) which is very useful 
for visualization of a micelle. The various structures formed in aqueous solution on 
increasing the concentration of surfactant are illustrated in (Fig. 1.3). There are mainly 
two types of micelles. 
(a) Normal Micelles 
The molecular organization of surfactant molecules in aqueous solution results in 
the formation of normal micelles. Above CMC, the surfactant molecules are self 
aggregated in such a manner that the hydrophobic moieties (i.e. hydrocarbon tails) are 
oriented inward forming a non-polar core and hydrophilic (polar) head groups are 
outward keeping themselves in contact with the bulk aqueous phase. Normal aqueous 
micelles are generally formed from singly-chain surfactants and chain branching inhibits 
micellization. 
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Fig. 1.2: Hartley's model of a spherical micelle 
13 
^ 
- 0 i^ 
MONOMERS 
SURFACTANT 
CRYSTAL 
MICcLLE CyUNOfllCAL 
MiCELLE 
( RANDOMLY ORIENTED ) 
HEXAGONAL 
« PACKING OF CniNOEftS 
10-35 A WATER 
Tvmnjm 
LAMELLAR MICELLE 
MiCROEMULSION 
HEXAGONAL PACKING OF 
WATER CYLINDER 
Fig. 1.3: A schematic illustration for the formation of various 
structures in surfactant solutions upon increasing the 
concentration of surfactant 
14 
^a'^'i^• ^y^t 
(b) Reverse Micelles 
In contrast to the normal micelles which are formed in polar (i.e. aqueous media) 
solvents, reverse micelles are formed in non-polar solvents like hexane or chloroform and 
a trace of water where the polar head groups of the surfactant are directed towards the 
interior of the aggregate and the hydrocarbon chains are in contact with the non-polar 
solvent. Reverse micelles offer the same potential advantages for analysis as do normal 
micelles. An interesting aspect of reverse micelles is their capability to solubilize water in 
the interior of micelle structure. 
The use of micellar solutions as mobile phase in TLC was first suggested by 
Armstrong et al. [12, 13] who described the possible advantages of micellar mobile phase 
(MMP) systems over traditional pure and mixed solvent systems. Using aqueous SDS 
solutions in combination with polyamide and alumina thin layers they successfiilly 
separated pesticides and the pollutant decachlorobiphenyl by normal phase TLC. 
However, nucleosides could be separated by reversed phase TLC using a reversed 
micelle solution as mobile phase. Miceller TLC have found interesting applications in the 
separation of substituted benzoic acids, polynuclear aromatic hydrocarbons and vitamins 
[14]; phenols [15,16]; amino acids [17-19]; alkaloids [20]; dyes [15, 20-22]; aromatic 
amines [23]; drugs [24] and inorganics [25, 26]. The separation with MMP is based on 
selective dissolution of polar and non polar substances as a result of combined effect of 
electrostatic, hydrophobic and donor-acceptor interactions. 
From the above discussion it looks that micellar mobile phases have much to offer 
to physical, biochemical and analytical chemists. It is also perceived that TLC has more 
to offer to the study of micelles than MMP have to offer to chemical analysis performed 
by TLC. This aspect of micellar TLC will be a rewarding field for future research. 
1.6 VISUALIZATION 
Physical, chemical, enzymatic or biological detection methods are commonly 
used in TLC. A book by Jork et al. [27] is an excellent source of general information 
about physical and chemical methods of detection. Physical methods of detection involve 
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the use of spectroscopy (autoradiography), X-ray fluorescence and UV radiation etc. 
Among physical methods, visualization under UV-light is most common. The chemical 
detection methods involve the spraying of plates with a suitable reagent, which forms 
colored compounds with the separated species. Alternatively, the reagent can also be 
taken in the mobile phase or in the adsorbent. In some cases, the detection is completed 
by inspecting the TLC plate after spraying with a suitable detection reagent under UV-
light. Both selective and non-selective reagents may be used depending upon the 
requirement. However, reagents giving sufficiently sensitive color reactions with several 
species are generally preferred. The biological detection methods (bio-autography) are 
useful for specific detection of compounds with a certain physiological activity. An 
example is the detection of antibiotics on TLC plates using triphenyl-tetrazolium chloride 
and a microorganism that is sensitive to the antibiotic to be detected. Similarly, to detect 
antifungal compounds by TLC inhibition of fungal growth was assessed by the detection 
of dehydrogenase activity with thiazolyl blue. In addition to these techniques, enzyme 
inhibition, immunostaining and flame ionization detection methods have also been used. 
1.7 QUALITATIVE ANALYSIS 
(a) Identification 
In TLC the identification of separated compounds is primarily based on their 
mobility in a suitable solvent, which is described by the Rp value of each compound. 
Where 
Distance of solute motion from the origin 
RF = -
Distance of solvent motion from the origin 
The factors which influence the magnitude of Rp are nature of sorbent and mobile 
phases, layer thickness, activation temperature, sample volume, chamber saturation, 
relative humidity and mode of development technique. Another term R^ which is the 
logarithmic function of the Rp value [i.e. RM = log (1/Rp -1)] is more useful as it bears a 
linear relationship to some TLC parameters or structural element of the analyte. 
However, in case of continuous and multiple development, where the solvent front is not 
measured, the term Rx. 
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Distance moved by solute 
[Rx = —] is used 
Distance moved by standard 
RF value ranges from 0.0 for a zone not leaving the point of application to 0.999 
(==1.0) for zone migration with solvent front. Unlike Rp, Rx value can be greater than 1.0. 
(b) Separation 
When two or more analytes have differential migration with the same 
chromatographic system. They are mixed thoroughly, the mixture is spotted on the TLC 
plate and chromatographed. The separated components of mixture are detected and their 
RF values are recorded. Some of the basic requirements for a good separation arc (a) each 
spot should be compact (RL - RT < 0.3), (b) the difference in Rp values of two adjacent 
spots should be at least 0.1. 
(c) No complexation should occur between/among separable species and 
(d) Chromatography of individuals and the mixture should be performed under 
identical experimental conditions. 
1.8 QUANTITATIVE ANALYSIS 
The three main approaches related to quantitation TLC include visual estimation 
and spot-size measurement, zone elution and in-situ densitometry. 
Visual Estimation and Spot-Size Measurements 
This is the simplest method of semiquantitative analysis. TLC plates with a 
definite sample aliquot along side standards containing known weights of analyte are 
simultaneously developed. After detection, the weight of analyte in the sample is 
estimated by visual comparison of the size and intensity of the standards and sample 
zones. The visual comparison works well if the applied amounts of sample are kept close 
to the detection limit and the sample is accurately bracketed with standards. The accuracy 
and reproducibility of this method falls in the range of 10-30%. 
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To standardize the quantification methods in TLC, Mohammad and Fatima [28, 
29] Mohammad and Tiwari [30], Nanda and Devi [31] and Mlodzikowski [32] have 
established a linear relationship between the size of the spot and the amount of the 
analyte. 
Zone Elution 
The zone elution method involves (a) drying the layer (b) locating the separated 
analyte zones (c) scrapping the portion of layer containing the analyte (d) collecting the 
sorbent and (e) measurement against standards by an independent micro analytical 
method such as solution spectrometry, GC or voltammetry. Zone elution method is 
tedious and time consuming and is likely to be inaccurate; these errors are minimized if 
standards and samples are chromatographed. 
Scanning Densitometry 
In situ measurement of zones with a scanning densitometer is the preferred 
technique for quantitative TLC. Substances separated by TLC or HPTLC are quantified 
by in situ-measurement of absorbed visible or UV light or emitted fluorescence upon 
excitation with UV light. Modern optical densitometric scanners are linked with 
computer. Computer controlled densitometers may provide many functions such as 
automatic peak location and optimization, recording of spectra, multiwavelength 
scanning. With good quality HPTLC plates and regularly shaped and well resolved zones, 
basic single beam and single wavelength scanning with almost any commercial 
densitometer is capable of producing satisfactory quantitative results. A double beam 
densitometer equipped with a TLC scanner, an integrator and a micro computer has been 
used for simultaneous determination of light rare earths in monazite sand and the 
CAMAG turner fluorometric scanner was used for the estimation of cadmium ions. 
1.9 ADVANTAGES OF TLC 
TLC is the most versatile and flexible chromatographic method because of the 
following advantages: 
(a) It is rapid because pre-coated layers are available for use as received, without 
preparation. 
(b) The automated sample applications and developers allow high accuracy and 
precision in quantification. 
(c) There is a wide choice of layers, developers and detection methods. The wide 
choice of detection reagents leads to unsurpassed specificity. 
(d) Less pure samples can be successfully analyzed, as the layers are normally not 
reused. 
(e) Being an "offline" method, different steps of the procedure are carried out 
independently. 
(f) Possibility of simultaneous analysis of large number of samples. 
(g) Disposable nature of TLC plates. 
(h) Possibility of direct observation of colorful reactions on TLC plates. 
1.10 COMBINATION OF TLC WITH OTHER ANALYTICAL 
TECHNIQUES 
The careful combination of TLC with other analytical techniques is more 
useful to collect information regarding the analysis of a complex sample. 
Spectrophotometry, high-performance liquid chromatography (HPLC) and gas 
chromatography (GC) in conjugation with TLC are the three most widely used 
techniques. However, mass/GC, infrared and thermal analytical techniques in 
combination with TLC has also been used. One of the newest techniques used in 
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combination with TLC is photoaccuoustic spectrometry, whicii is capable to locate 
compounds in-situ on the plate. Issaq and Ban [33] combined TLC with flameless 
atomic absorption spectrometry (FAAS) to identify an inorganic compound in an impure 
organometallic complex and to determine the recovery and purity of organometallic 
samples. 
The examples cited above reveal, how the separation methods of TLC 
complement the analytical methods necessary for the absolute identification of a 
substance. TLC provides an excellent purification method for separating a substance of 
interest from other contaminants in the sample. Analytical techniques can then be applied 
to identify the separated substances. 
1.11 DRUGS 
Drugs are defined as those chemical substances used in the treatment, cure, 
prevention or diagnosis of diseases or used to otherwise enhance physical or mental, cure 
well being [34]. Medicines commonly used by the late 1920s included aspirin, codeine, 
and morphine for pain, digitalis, nitroglycerin and quinine for heart disorders, and insulin 
for diabetis. In 1930s antibiotics emerged, first as sulfa drugs, then penicillin's and other 
antibiotics. In the 1950s other drugs emerged including cortisteroids for inflammafion, 
rauwolfia alkaloids as tranqulizers and antihypertensive, antihistamines for nasal 
allergies, xanthines for asthma and typical antipsychotics for psychosis. In 2008 a 
thousands of approved drugs have been developed with the use of biotechnology. 
The idea that effect of drug in human body are mediated by specific interaction of 
the drug molecule with biological macromolecules (proteins or nucleic acids) led to 
scientists to the conclusion that individual chemicals are required for the biological 
activity of the drug. This made for the beginning of the modem era in pharmacology, as 
pure chemicals, instead of crude extracts, became the standard drugs. 
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1.12 CLASSIFICATION OF DRUGS 
Classification of drugs on the basis of effectors Pharmacotherapy [35]-
(1) Central Nervous System 
[a] Sedatives and A nxiolytics-
There drugs decreases activity, moderates scruitmut and calms the recipient 
eg.- Benrodiazepines, Non- benzodiazepines and Phenothiazines etc 
[b] Hypnotics -
These drugs produce drowsiness and facilitate the onset and maintenance of a 
state of sleep that resemble natural sleep. 
eg. - Barbiturates and Benzodiazepines 
[c] Antidepressants-
These drugs are given to patients with shattered confidence 
eg. - Tricyclic-Antidepressants, Tetracyclic Antidepressants, Monoamine oxidase 
Inhibitors, Selective Serotonin Reuptake Inhibitiors (SSRIs) and Related drugs. 
[d] Antipsychotics and Antimanics-
Antipsychotics are those drugs which inhibits Psychotic manifestations. 
eg. Phenothiazines, Butyrophenone, Diaberoxazepine and Diphenylbutypiperdine 
etc 
[e] Analgesic and Antipyretics-
Chemical substances used for relieving pain are called Analgesic while the 
chemical substances used to bring down the body temperature in high fever are 
called as Antipyretics. 
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(i) Non-opiod Analgesics: 
eg. - Salicylates, Paracetamol, Ketorolac etc 
(ii) Propionic acid derivatives: 
There are Propionic acid derivatives Analgesic drugs 
eg. - Ibuprofen, Ketoprofen and Naproxen etc 
(Hi) Opioid Analgesics: 
Drugs based on the extract obtained from Opium family are Opioid Analgesics 
eg.- Pentazozine, Dextropropoxyphene, Buprenorphine, Ethoheptarine etc 
(f) Antiemetics-
eg. -Dopamine Antagonists, Antihistamines and Anticholinergics etc. 
(g) Andconvulsants-
Drugs used to relieve Convulsive attacks 
eg - Barbiturates, Deoxyarbutrats, Hydantiocus, Iminostilbenes, Valproic acid 
and Suczinimides etc 
(2) Eye 
(a) Antibacterial: 
Drugs effective against Bacterial infections. 
eg.:- Sulphacetamide sodium, Gentamicin, Sisomicin, Chloramphenicol, 
Ciprofloxacin and Norfloxacin etc. 
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(b) Antifungal: 
Drugs effective against fungal infections 
eg. - Miconazol, Ketoconazol and Fluconazole etc. 
(c) Antiviral-
Drugs recommended for curing viral Infections: 
eg:- Acyclovir and Idoxuridine etc 
(d) Anti-inflammatory andAnti allergic Eye preparations: 
These are the drugs recommended for allergic symptoms of Eye. 
eg: Topical Steroids, Sodium Cromoglycate, Flurbiprofen sodium and Ketorolac 
etc. 
(e) Antiglaucoma Drugs (Motics. Sympathomimetics Beta blockers): 
eg:- Pilocarpine, Diplvefrine and Timolol etc. 
(f) Mydriatics and Cyclopegics (antimuscarinics): 
These are medicines which dilates the pupil of the Eye 
eg:- Atropine, Homatropine and Cyclepentolate etc. 
(g) Sympathomimetics: 
Drugs that mimic the effect of the Catecholamines, Epinepharine, Norepinephrine 
and Dopamine 
eg:- Phenylephrine 
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(3) Ear, Nose and Oropharynx 
(a) Aural preparations 
Pharmaceutical preparations for Ophthalmology, Ear, Nose and Throat (ENT) and 
Dentistry 
eg: Betasone N. 
(b) Nasal preparations: 
These drugs are aqueous solutions designed to be administered through the nasal 
passages in drops or sprays. 
eg: Ciclospray, Fluticasone etc. 
(4) Cardiovascular system 
(a) Antiarrhythmic drugs: 
There are the drugs used to suppress the fast rhythms of heart. 
(b) Antihypertensive during: 
There are the drugs used to help control of blood pressure in cases where blood 
pressure is too high 
eg:- Lisnopril, Catopril and Enalapril etc 
(c) Antianginals: 
Drugs prescribed for Angima pectoris (Ischaemic heart disease) 
(i) Organic nitrates: 
Eg: Isosorbidedinitrate, Glyceral trinitrate and erythrityl tetranitrate 
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(ii) Beta adreonergic Blockers: 
jMetoprolol, Atenolol and Propranolol etc. 
(Hi) Calcium channel blockers: 
eg: Dipyridamol and Verapamil etc. 
(1V) Antiplatelet drugs: 
eg: Dipyridamol and Aspirin etc. 
(d) Vasodilators: 
There are drugs which relaxes the smooth muscle in blood vessels, which causes 
the vessels to dilate. 
eg:- Vitamin K analogues (Menapthone), Botropase, Ethamsylate and 
Adrenochrome etc. 
(e) Anticoagulants, Thrombolytics and Antiplatelet Drugs: 
eg: Heparin, Warfarin, Urokinase and Aspirin etc. 
(5) Respiratory system-
fa) Respiratory Stimulants: 
It is a drug which acts to increase the action of the respiratory system. 
eg: Doxapram 
(b) Antitussives, Expatorants, Mucolytics and Decongenstants: 
These are the drugs used for giving relief from coughs caused by certain 
respiratory tract infections. 
eg: Actifed, Ascoril, Ambrol and Amsolozothine etc. 
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(c) Antiasthmatics: 
Drugs prescribed for Asthmatic problems, 
(i) Sympathomimetics - eg: Salbutamol and Salmetrol 
(ii) Xanthine derivatives - eg: Amenophylline and Theophylline 
(iii) Mastcell Stabilizsers - eg: Ketotifen and Sodium Cromoglycate 
(iv) Corticosteroids - eg: Beclomethasome and Budesonide 
(v) Antimascarinics - eg: Ipratropium bromide 
(vi) Leukotriene receptor Antagonists - eg: Zafirlukast 
(6) Gastro - Intestinal Tract 
(a) Anti ulcer and Antisecretory drugs: 
(i) H2 receptor Antagonist - eg: Cimetidine and Famotidine 
(ii) Proton pump Inhibitor - eg: Lansoprazole 
(iii) Prostalandin Analogues - eg: Misoprostal 
(b) Antacids: 
Antacids are medicines that neutralize stomach acid, 
(i) Systematic - eg: Sodium bicarbonate 
(ii) Non-Systemic - eg: Aluminum hydroxide and Magnesium trisilicate. 
(c) Antispasmodics and Drugs Modifying Intestinal Motility: 
(!) Antimuscarinics - eg: Propantheline bromide, Oxaphenomium and 
Isopropamide etc 
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(ii) Motility stimulants - eg: Cisapride and Metoclopramide. 
(d) Laxatives: 
These drugs act to increase the volume of stool by absorbing water 
(i) Bulk forming agent - eg: Ispaghula husk, 
(ii) Osmotic laxatives - eg: Magnesium and sodium salts, 
(iii) Faecal softeners - eg: Liquid paraffin's, 
(iv) Stimulant laxatives - eg: Bisaodyli, Senna 
(e) Antidiarrhoeals: 
(i) Adsorbents and Bulk forming drugs - eg: Pectin and Kaolin 
(ii) Antimotility drugs - eg: Codeine and Loperamide 
(iii) Ant secretory drugs - eg: Racecadotril 
(iv) Antimicrobial - eg: Metronidazol and Nalidixic acid 
(f) Enzymes, Carminatives and Hepatobiliary preparation: 
Enzymes are taken as appetite stimulants, Carminatives are agents that cause 
expulsion of gases from GIT and Hepatobiliary preparations are 
eg :- Diastase, Pancreatin, Tineture cardamom, Compound tincture gingu, 
Silymarin, L-Aspartate. 
(g) Colorectal preparations: 
There drugs are soothing preparations, containing Anti-septic Astringents or 
Vascoconstrictors. 
eg.: Proctosedyl, Rapilac 
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(7) Genito Urinary System-
(a) Urinary and- Infectives: 
Drugs recommended in Urinary infections, 
eg:- Nitrofuranton, Nalidixic acid. 
(b) Diuretics: 
These are the drugs which on administration increases the rate of urine 
formation inside the body 
(i) Thiazide and Related diuretics - eg: Chlorthalidone 
(11) Loop diuretics - eg: Frusemide 
(ill) Potassium sparing diuretics - eg: Amilorlde 
(iv) Carbonic anhydrase Inhibitor - eg: Acetazolamlde 
(v) Osmotic Diuretics - eg: Mannitol 
(c ) Urinary Analgesics and Antispasmodics: 
A drug prescribed to patients suffering from Urinary tract infections provides 
symptomatic pain relief 
eg.:- Phenazopyrldlne. 
(d) Locally acting drug on Urethra & Vagina: 
(i) Antl-lnfective drugs - eg: Clotrimazol, Miconazole 
(II) Local Analgesics - eg: Benzydamine 
(III) Preparations for Vaginal atrophy - eg: Dlenocstrol 
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(e) Drug acting on Uterus 
(i) Prostaglandins and Oxytocis- eg: Carboprost, Dinoprostone 
(ii) Mifepristone - eg: Mifegest 
(iii) Myometriai relaxants - eg: Ritodrine hydrochlovide 
(iv) Vasodilatars - eg: Isoxsuprine 
(f) Drugs for prostatic hyperteophy: 
(i) Alpha blockers - eg: Prarosin, Terarosin 
(ii) Antiandrogens - eg: Fincesteride, Allylestrenol 
(g) Drugs for Erectile Dysfunction: 
eg: Sildenafil citrate 
(h) Spermicidal and Nonhormonal Contraceptives: 
Spermicidal are that agent which kills the sperms. 
eg: Nonoxynol - 9 
(8) Skin-
(a) Emollients and Keratolytics: 
Emollients soothe and hydrate the skin. Application of emollients improves 
dryness of skin while Keratalytics softens the epidermal cells. 
eg: Glycerine, Salicyclic acid, Resorcinol and Benzoic acid. 
(b) Tropical Anti-infective: 
Use for the treatment of secondary bacterial infections of skin 
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eg: Chloroxylenol, Chlorhexidine and Cetrimide 
(c) Tropical Antifungals: 
These drugs are medicines applied to the skin to treat skin infections caused by a 
fungus. 
eg: Clotrimazole, Miconozole, tolnaftate etc. 
(d) Tropical Parasiticidals: 
These are agents which kills the dermal parasites causing skin infections, 
eg: Gammabenzene, Hexachloride, Benzyl benzoate etc. 
(e) Tropical Steroids: 
In dermatological practice Tropical steroids are used to teat various 
dermatological disorders. 
eg: Beclomethasone, Fluocinolone acetonide, Monetasone furoate etc 
(f) Antiseborrhoeics: 
Drugs which are effective for treatment of Seborrhoeic dermatitis. 
eg: Selenium sulphide, Selenium disulphide with Clotrimazole etc 
(9) Musculo - Skeletal Disorders 
(a) Non steroidal Anti inflammatory drugs (NSAIDs): 
These are heterogeneous group of compounds which inhibit biosynthesis and 
release of Prostaglandins. 
(i) Salicyclates - eg: Aspirin 
(ii) Propionic acid derivative - eg: Ibuprofen ,Ketoprofen 
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(iii) Fenamates - eg: Mefenamicacid 
(iv) Pyrazolones - eg: Oxyphenbutazone 
(v) Indole derivative - eg: Indomethacin 
(vi) Oxicam derivative - eg: Tenoxicam 
(b) Tropical Analgesics: 
Topical Analgesics are pain-relieving creams, lotions, rubs, gels, and sprays that 
applied on the skin over the affected joints. 
eg: Diclofenac, Piroxicam, Nimesuiide etc 
(c) Muscle relaxants: 
Drugs causes muscle relaxation by preferential blockade of Polysynaptic spinal 
reflexes. 
eg: Methacarbamol, Carisoprodol, Orphencedrine etc 
(d) Neuromuscular drugs: 
There are blocking drugs routinely used during administration of anaesthesia. 
(i) Non depolarizing muscle relaxants - eg: Atracurium 
(ii) Depolarizing neuromuscular blockers - eg: Succinylchotine 
(iii) Anticholinesterases - eg: Neostigmine 
(10) Infections and Infestations-
fa) Antibiotics and Antibacterial: 
There are drugs which kill or inhibit the growth of bacteria's. 
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(i) Pencillins: 
(a) Pencillinase sensitive - eg: Benzyl pencillin 
(b) Pencillinase resistant-eg: Cloxacillin 
(c) Broad spectrum - eg: Ampicillin, Amoxycillin 
(d) Antipseudomonal pencillins - eg: Carbencillin 
(ii) Cephalosporins: 
(a) 1st Generation - eg: Cephaliexin, Cefazolin 
(b) Ilnd Generation - eg: Cefuroxime, Cefaclor 
(c) Ilird Generation - eg: Cefatoxime, Cefixime 
(in) Fluroquinolones: 
There are effacious well tolerated bactericidal drugs, with broad sepctrum of 
antimicrobial activity 
eg: Nalidixic acid, Ciprofloxacin 
(IV) Aminoglycosids: 
These are effective in treatment of bacterial infections caused by Enterobactes, 
Serratia, Pseudomonas aeruginosa, and Klebsiella. 
eg:Gentamicin, Amikacin, Tobronycin etc. 
(V) Polymyxins: 
These are bactericidal drugs active against only gram -ve bacteria 
eg: Polymyxin B, Colistin sulphate etc 
32 
(vi) Macrolids: 
There are drugs act by binding to 50-S ribosomal submit of bacteria and inhibit 
protein synthesis. 
eg: Erythromycin, Roxithromycin, Azithromycin etc. 
(VII) Chloramphenicol: 
It is a broad spectrum Antibiotic 
eg: Chloromycetin, Enteromycetin etc 
(VIII) Tetracyclines: 
Tetracycline is a broad-spectrum polyketide Antibiotic produced by the 
Streptomyces genus of Actinobacteria indicated for use against many bacterial 
infections. 
eg: Doxycycline, Minocycline, Demeclocycline etc. 
(IX) Sulfonamides: 
Sulfur containing Antibacterial drugs. 
eg: Sulphamethoxarole, Sulphacetamide etc. 
(b) Antianaerofics: 
There are effective in infections due to Entamoeba histolytica, Giardialambia and 
Trichomoniasis 
eg: Metronidazole 
(c) Antitubercular drugs: 
Drugs effective against Mycobacterium tuberculi 
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eg: Isoniazid, Rifampicin, Ethambutol 
(d) Antileprosy drugs: 
Drugs prescribed during Leprosy symptoms, 
eg: Deprone, Clofazimine 
(e) Antifungal: 
Drugs having Antifungal activity 
(i) Polyene antifungals - eg: Amphotezicin 
(ii) Imidazole antifungals - eg: Miconazole 
(iii) Triarols antifungals - eg: Fluconaroll 
(f) Antiprotozoals: 
Drugs effective against Protozoal infections, 
eg: Dehydroemetine, Metrondarole etc. 
(g) Anthelmintics and Anti-infective drugs: 
(i) Ascaricides - eg: Mebendozol 
(ii) Drugs for Threadworms - eg: Piperazine 
(iii) Drugs for Tape worm infections - eg: Niclosamide 
(iv) Hydatid disease - eg: Albendazole 
(v) Schistosomicides - eg: Praziquantel 
(h) Antimalarial: 
Drugs active against Malarial infections. 
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eg: Chloroquene, Amodiaquine, Quinine sulphate etc. 
(I) Antiviral: 
Drugs effective against Viral infections, 
eg: Idoxeuridine, Rebavirin, Acyclovir etc 
(II) Endocrine system-
(a) Anabolic and Androgenic Steroid: 
Anabolic Steroids are effective protein anabolic agents but have low androgenic 
activity 
eg: Testorene, Mestozolone, Oxynutholone etc. 
(b) Corticosteroids: 
There are steroids synthesized in the adrenal cortex 
eg: Hydrocortisone, Prednisolone, Triamcinolaone etc 
(c) Oestrogens, Progestogens and Hormonal Contraceptives: 
There are belongs to group of medicines known as female sex hormones. 
eg: Oestraodiol, Progesterone, Centchroman, Hydroxyprogesterone, Caprocate 
etc. 
(d) Fertility agents, Trophic Harmones and Related drugs: 
These are drugs whose primary function is of regulating the production and 
secretion of other hormones in other Endocrine glands. 
eg: Antioestrogens, Gonadotrophins. 
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(e) Thyroid and Antithyroid drug: 
These are the drugs directed against the Thyroid gland, 
(i) Thyroid harmone - eg: Thyroxin 
(ii) Antihyroid harmone - eg: Carbimazole 
(f) Antidiabetics and Hyperglycemic: 
Drugs effective against Diabetes related problems 
(i) Oral hypoglycemics - eg: Chlorpropamide 
(ii) Insulins- eg: Isophane 
(iii) Hyper glycaemics - eg: Glucagon. 
(12) Nutritions 
(a) Vitamins: 
Organic compounds required by body as a nutrient in tiny amount 
(i) Waler soluble - eg: Vitamin B complex, Vitamin C 
(ii) Fat soluble - eg: Vitamin A, Vitamin D 
(b) Haematinics and Haematopoietics: 
These are drugs which increases the hemoglobin content of the blood, 
eg: Iron formulations, Iron (iii) Hydroxide, Polymaltose complex, Erythropoietin etc. 
(c) Tonics and Appetite stimulants: 
There are the Appetite promoter drugs 
eg: Cytoroheptadine, Ginseng etc. 
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(d) Mineral preparations: 
eg: Calcium, Zinc, Potassium etc. 
(e) Amino acids: 
There are drugs wiiich increase the body metabolic rate 
eg: L-Lucine, L-Isolucine, Phenylalanine etc. 
(f) Oral electrolytes: 
There are used to fulfill the lost of minerals and body fluids during dehydration, 
eg: Sodium chloride, Sodium citrate, Potassium citrate etc. 
(13) Metabolism-
Hypolipidoemic agents: 
There drugs are used of treatment of Hyperlipadaemia 
(i) Fibric acid derivative - eg: Clofibrate 
(ii) Statins - eg: Lovastatin 
(iii) Nicotinic acid - eg: Nicotinic acid 
(iv) Omega 3 Fatty acids - eg:Eicosepentaenoic acid 
(14) Neoplastic Disorders-
Anticancer drugs: 
(i) Alkylating drug - eg: Cycleophasphamide 
(ii) Cytotoxic Antibiotics - eg: Doxorubicin 
(iii) Vinca Alkaloids and Etoporide - eg: Vinblastive 
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(iv) Antimetabolites - eg: Methotrexcite 
(v) Tavares - eg: Paclitaxel 
(15) Allergy and Immunology-
(A) Antiallergics: 
These compounds are competitive blockers of Histamine at Hi receptors hence 
oppose effect of Histamine. 
eg: Astemizole, Cetrizine, Lozatadine etc 
(b) Vaccines and Immunoglobulin: 
There are agents used for both active and passive immunization. 
eg: Rubella, Tetanus antitoxin, Hepatitis B immune globulin. Gamma globulin 
etc. 
(C) Immunosuppressants: 
There are classes of drugs capable of inhibiting the body's immune system 
eg: Azathiopzine, Cyclosporine A, Mycophenolate . 
1.13 CLASSIFICATION OF HERBAL DRUGS 
For practical purposes, herbal drugs can be classified into four categories, based 
on their origin, evolution and the forms of current usage. While these are not always 
mutually exclusive, these categories have sufficient distinguishing features for a 
constructive examination of the ways in which safety, efficacy and quality can be 
determined and improved [36]. 
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Category 1: Indigenous herbal drugs: 
This category of herbal drugs is historically used in a local community or region 
and is very well known through long usage by the local population in terms of its 
composition, treatment and dosage. Detailed information on this category of traditional 
drug, which also includes folk drugs, may or may not be available. It can be used freely 
by the local community or in the local region. However, if the drug in this category enter 
the market or go beyond the local community or region in the country, they have to meet 
the requirements of safety and efficacy laid down in the national regulations for herbal 
medicines, eg: Turmeric and Black Pepper in India. 
Category 2: Herbal drugs in systems: 
Drugs in this category have been used for a long time and are documented with 
their special theories and concepts, and accepted by the countries. For example, 
Ayurveda, Unani and Siddha would fall into this category of traditional drug, eg: Triphia, 
Asvas etc. 
Category 3: Modified herbal drugs: 
These are herbal drugs as described above in categories 1 and 2, except that they 
have been modified in some way-cither shape, or form including dose, dosage form, 
mode of administration, herbal drug ingredients, methods of preparation and medical 
indications. They have to meet the national regulatory requirements of safety and efficacy 
of herbal drugs, eg: Natural Laxatives and Quinone. 
Category 4: Imported products with a herbal drug base: 
This category covers all imported herbal drug including raw materials and 
products. Imported herbal drugs must be registered and marketed in the countries of 
origin. The safety and efficacy data have to be submitted to the national authority of the 
importing country and need to meet the requirements of safety and efficacy of regulation 
of herbal drugs in the recipient country, eg: Gugglus and Opiads. 
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1.14 LITERATURE 
The work published on TLC studies of Herbal drugs, Analgesic and Antipyretics, 
and Antibiotics during the last 20 years are presented briefly in (Tables 1.3-1.5). 
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2.1 INTRODUCTION 
Thin layer chromatography (TLC) is the simplest and convenient analytical 
technique for identification and separation of several pharmaceutical products and 
permits separation by manipulation of mobile and stationary phases. As a result, 
numerous stationary and mobile phases have been developed for achieving improved 
chromatographic performance of drugs in terms of selectivity, resolution, rapidity and 
reproducibility [1-3] Paracetamol, ibuprofen, diclofenac sodium and aspirin are the most 
widely recommended co-administered analgesic and antipyretic drugs [4, 5] while 
vitamin C [ascorbic acid] works as a cofactor in numerous amidation and hydroxylation 
reactions of body. Analysis of paracetamol, diclofenac sodium, ibuprofen, aspirin and 
ascorbic acid by thin layer chromatography have been investigated by various researchers 
[6-8]. Reversed phase TLC offers distinct advantages such as organization of the 
hydrocarbon ligands on the silica surfaces, interaction of solvent into the bonded layers, 
and the activity of residual silanols on the solid support [9, 10]. The work undertaken in 
our laboratory has shown the tremendous analytical potential of reversed phase TLC 
during identification and separation of transition metal cations [11, 12]. Literature survey 
reveals that, not much information is available on reversed phase TLC for identification 
and mutual separation of co-administrated drugs (paracetamol, diclofenac sodium, 
ibuprofen, aspirin and ascorbic acid) using surfactant mediated mobile phases. The 
excellent capability of reversed phase TLC towards pharmaceuticals especially the 
surface active pharmaceutical molecules[13-15], it is considered worthwhile to study the 
selective identification and mutual separation of paracetamol, diclofenac sodium and 
ibuprofen, and paracetamol, aspirin and ascorbic acid on silica gel H layers, impregnated 
with different concentrations of tert-butyl phosphate, tert-butyl amine, paraffin and 
silicone oil, in the presence of surfactant mediated mobile phase systems. 
2.2 EXPERIMENTAL 
Apparatus 
A TLC applicator was used for coating silica gel on glass plates (18 x 3.5 cm). 
The chromatography was performed in the glass jars (24 x 6 cm). Iodine gas chamber 
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was used to locate the position of the spot of analyte 
Chemicals and Reagents 
Paraffin oil (CgHig), Tributyl phosphate [TBP] (C12H27O4P), Tributyl amine 
[TBA] (C4H11N), Silicone oil (C2H60Si), N-cetyi-N, N, N-trimethyl ammonium bromide 
(CTAB) and Iodine (CDH, Delhi, India). Silica gel H, Acetone, Formic acid and Glacial 
acetic acid (Merck, Mumbai, India). Methanol (MeOH), Ethyl acetate and Hexane 
(Qualigen Chemicals, Mumbai, India). Drugs [Fig. 2.1- 2.5] - Paracetamol (Paracip, 
Cipla, Mumbai, India). Diclofenac Sodium (Voveran, Emcure Pharma, Gujrat, India). 
Ibuprofen (Ibugesic, Cipla, Mumbai, India) Aspirin (Disprin, Reckitt benckiser, India). 
Ascorbic acid (Celin, G.S.K., Mumbai, India). Reagents used were of Analar grade. 
Test Solutions 
The Five tablets of each drug weighed and finely powdered. The drug powder 
(250 mg) was transferred into a 50 mL standard volumetric flask and then 25 mL 
methanol was added and the resulting mixture was sonicated for 40 mins. The solution 
was filtered through whatman filter paper (No. 41) and the residue obtained was washed 
again with methanol. The total filtrate was transferred in a 50 mL standard volumetric 
flask and made-up to the mark with methanol. This solution contains 5 mg/mL (w/v) of 
drug. 
Detection Reagents 
Iodine vapors were used for the detection of all the five drugs. Different colored 
spots were detected as follows: 
Paracetamol (black brown), ibuprofen (brown), ascorbic acid (yellow), diclofenac 
sodium (light brown) and aspirin (sunset yellow). 
Chromatography 
Stationary Phase: The following (Table 2.1) stationary phases were used for the 
chromatography 
16 
Mobile Phases: The solvent systems were used (Table 2.2) as mobile phases. 
Preparation ofTLC layers 
(a) Plain silica gel H Plates 
Silica gel H plates were prepared by mixing silica gel H with double distilled 
water in 1:3 ratio w/v. The resultant slurry was mechanically shaken for 10 min, after 
which it was applied to well clean glass plates with the help of TLC applicator to give a 
layer of approximately 0.25 mm thickness. The plates were dried at room temperature 
and then activated by heating at 100 ± 1°C for 1 hr. After activation, plates were stored in 
dessicator. 
(b) Impregnated silica gel H plates: 
Solutions of desired concentrations of impregnants, paraffin oil (1, 2, 5 and 8 %), 
tributyl phosphate (5, 10, 15 and 20 %), tributyl amine (5, 10, 15 and 20 %) and silicone 
oil (0.001, 0.01, 0.1 and 0.2 %) were prepared in petroleum ether. After that, plain silica 
gel H plates were dipped in above prepared solutions. The developed plates were then 
activated by heating at 60 ± 1°C for 1 hr. 
Chromatographic Procedure 
Thin layer chromatography was performed on unimpregnated and impregnated 
silica gel H layer plates. Test solution (l^L) were applied on ( 15 x 3 cm ) silica gel H 
impregnated and unimpreganted thin layer plates with the help of micropipettes at about 
2 cm above the lower edge of the plates. The solvent ascent was fixed to 10 cm in all 
cases for the determination of RF values of all individual drugs. Linear ascending 
development was carried out in a vapor equilibrated TLC twin trough chamber. The 
optimized chamber saturation time for the mobile phase was 15 min at room temperature 
(25 ± 1 °C). Subsequent to the development, TLC plates were dried at room temperature. 
The spots were then detected by using iodine vapors and all the drugs are 
visualized as colored spots. The Rp value (retardation factor) of drugs were determined 
by the 
17 
Following relation -
RF = 0.5 (RL + RT) 
Where RL - Rp of leading front. 
RT = RF of trailing front. 
Separation 
For separation, equal amount (5 mg/mL) of drugs (paracetamol, diclofenac 
sodium, and ibuprofen) and similarly the drugs (paracetamol, aspirin and ascorbic acid) 
were mixed to form two drug mixtures. The resulting solution (0.0ImL) of each drug 
mixture was chromatographed on silica gel H impregnated layers using solvent systems 
Ml and M3. 
2.3 RESULTS AND DISCUSSION 
(a) Chromatography on Surfactant modified solvent systems. 
The reported RF value of paracetamol, ibuprofen and diclofenac sodium are 0.50, 
0.78 and 0.36 respectively in the solvent system containing n hexane + ethyl acetate + 
acetic acid (7: 2.5: 0.5, v/v) [16-17]. The addition of 1% CTAB in MeOH to the above 
system (Mo) results in increase in mobility (Fig. 2.6) of ibuprofen (RF 0.81), whereas the 
mobility of paracetamol (RF 0.46) and diclofenac sodium (Rp 0.20) decreases. Similarly 
in the reported solvent system containing toluene + n-propanol + formic acid (5: 04: 01) 
the RF value of paracetamol, aspirin and ascorbic acid were 0.68, 0.30, and 0,05 
respectively [18]. The addition of 1% CTAB in MeOH in the above discussed solvent 
system (M2), results in increase of RF value of aspirin (RF 0.32) and ascorbic acid (RF 
0.14) (Fig. 2.7) whereas the Rp value of paracetamol (RF 0.62) decreases. This alteration 
in Rp value of these drugs in the presence of surfactant in solvent systems, may be due to 
variable hydrophobic or hydrophilic interactions with these drugs. 
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(b) Chromatography on silica gel H layers impregnated with different concentrations 
of Paraffin oil, TBP, TBA and Silicon oil as impregnanat. 
In order to find out the optimum concentration of paraffin oil, TBP, TBA and 
silicon oil as an impregnant. The drugs (paracetamol, diclofenac sodium,. aspirin, 
ibuprofen and ascorbic acid) were chromatographed on silica gel H layers (S2 - Sig) 
impregnated with different concentrations (1, 2, 5 and 8%) of paraffin oil, (2, 5, 10, 15 
and 20%) of TBP, (5, 10, 15 and 20%) of TBA and (0.001, 0.01, 0.1 and 0.2%) of silicon 
oil using Ml and M2 as mobile phases. From Table 2.3, it is clear that with the increase in 
concentration of paraffin oil, TBP and TBA, there occurs a considerable decrease in the 
RF value of all the five drugs as compared to RF value of these drugs on unimpreganted 
silica gel H layers. While in case of silicon oil as an impregnant, an increase in RF value 
of all the five drugs is observed as compared to Rp values obtained on unimpregnated 
layers. The decrease in RF value of all the five drugs on the silica gel H layers 
impregnated with Paraffin oil, TBP, TBA and silicon oil indicates the strong partitioning 
of drugs with these impregnants. The increase in RF value of all drugs on silica gel H 
layers impregnated with silicone oil indicates the weak partitioning of drugs with the 
impregnant (silicon oil). This weak portioning of drugs in silicone oil may be due to the 
presence of long and complex silicone oxygen (siloxane) molecule [19] as compared to 
the other impregnants. 
The higher concentrations of all the four impregnants shows several draw backs, 
such as prolonged development time, poor detection, difficulty in plate drying and poor 
adhesion of modified silica to glass surfaces. Therefore, the concentrations of 
impregnants, 2% paraffin oil, 10% TBP, 10% TBA and 0.01% silicon oil were found to 
be the best for the chromatography of all five drugs, due to following advantages-
(1) Detection clarity. 
(2) Formation of compact spots 
(3) Beneficial mobilities of drugs for mutual separation from their mixtures. 
19 
It is also observed that the drugs (aspirin and ascorbic acid), (diclofenac sodium 
and ibuprofen) are not detected in the solvent system Mi and M3 respectively 
The positive ARp value [ARp = Rp unimpregnated layer - Rp impregnated layer] 
of all the five drugs (paracetamol, diclofenac sodium, ibuprofen, aspirin and ascorbic 
acid) indicates the enhanced selectivity of silica gel H layers impregnated with paraffin 
oil [ARp = 0.06 (Pa), ARp = .08 (Ds), ARp = 0.11 (lb), ARp = 0.05 (As), ARp = 0.06 (Ac)] 
TBP [ARp = 0.02 (Pa), ARp = 0.13 (Ds), ARp = 0.17 (lb), ARp = 0.02 (As), ARp = 0.06 
(Ac)] and TBA [ARp = 0.05 (Pa), ARp = 0.06 (Ds), ARp = 0.18 (lb), ARp = 0.01 (As), ARp 
= 0.1 (Ac)] for these drugs. The negative ARP value [ARp = -0.04 (Pa), ARp = -0.08 (Ds), 
ARp = -0.12 (lb), ARF= 0.04 (As), ARp =0.03 (Ac)] obtained on silicone oil impregnated 
layers shows weak interaction and low selectivity for these drugs. This mobility trend on 
silica gel H layers impregnated with optimum concentrations of paraffin oil, TBP, TBA 
and silicon oil are utilized for the mutual separation of drugs from their mixture 
(paracetamol, ibuprofen and diclofenac sodium) and (paracetamol, aspirin and ascorbic 
acid) using solvent systems Mi and M3. The resolutions of mixtures of drugs are shown 
in (Fig. 2.8- 2.9). 
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Table 2.1: 
Symbol 
Si 
S2-S5 
Se-Sio 
S i i - Si4 
Sl5 - S18 
The following stationary phases were used for the chromatography 
Stationary Phase 
Unimpregnated silica gel H 
Silica gel H impregnated with 1,2, 5 and 8% paraffin oil respectively. 
Silica gel H impregnated with 2, 5, 10, 15 and 20% tributyl phosphate respectively. 
Silica gel H impregnated with 5, 10, 15 and 20% tributyl amine respectively. 
Silica gel H impregnated with 0.001,0.01,0.l and 0.2% silicone oil respectively. 
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Table 2.2: The following solvent systems were used as mobile phase 
Symbol 
Mo 
Ml 
M2 
M3 
Constituents" 
n hexane: ethyl acetate: acetic acid 
n hexane: 1% CTAB in MeOH: ethyl acetate: acetic acid 
toluene: nPrpanol: formic acid 
toulene: 1% CTAB in MeOH: nPrpanoI: formic acid 
Composition (v/v) 
7:2.5:0.5 
13:1:4:2 
5:4: 1.0 
14: 1:3:2 
a = Specific gravity of methanol (MeOH), hexane, ethylacetate, glacial acetic acid, 
formic acid and n propanol were 0.793, 0.65, 0.901,1.051,1.98, and 0.806g/cc 
respectively 
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Table 2.3: Rp value of drugs (paracetamol, diclofenac sodium, ibuprofen, aspirin 
and ascorbic acid) obtained on unimpragnated (Si) and impregnated (S2-S18) silica 
gel H layers developed with M 1 and M3 mobile phases 
Stationary 
phases 
s, 
S2 
S3 
S4 
S5 
S6 
S7 
Ss 
S9 
Sio 
Su 
S,2 
S,3 
Si4 
Sl5 
S16 
S,7 
Sig 
paracetamol 
M, 
0.46 
0.44 
0.39 
0.36 
0.31 
0.45 
0.40 
0.37 
0.33 
0.29 
0.42 
0.41 
0.40 
0.36 
0.43 
0.45 
0.49 
0.54 
M3 
0.62 
0.59 
0.56 
0.51 
0.44 
0.58 
0.53 
0.42 
0.40 
0.36 
0.60 
0.47 
0.42 
0.40 
0.59 
0.61 
0.64 
0.67 
Mobile ph 
diclofenac sodium 
M, 
0.20 
0.19 
0.12 
0.08 
0.05 
0.18 
0.12 
0.07 
0.04 
0.00 
0.21 
0.15 
0.12 
0.00 
0.21 
0.24 
0.28 
0.32 
M3 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ases 
aspirin 
Ml 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
M3 
0.32 
0.29 
0.27 
0.24 
0.19 
0.30 
0.27 
0.25 
0.19 
0.12 
0.34 
0.31 
0.30 
0.29 
0.34 
0.36 
0.36 
0.41 
ibuprofin 
Ml 
0.85 
0.82 
0.74 
0.69 
0.60 
0.83 
0.77 
0.68 
0.61 
0.57 
0.79 
0.67 
0.65 
0.62 
0.82 
0.84 
0.87 
0.90 
M3 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ascorbic acid 
M, 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
M3 
0.14 
O.U 
0.08 
0.07 
0.02 
0.13 
0.08 
0.08 
0.05 
0.00 
0.10 
0.04 
0.01 
0.00 
0.13 
0.15 
0.18 
0.20 
ND = Not detected 
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Fig. 2.1: Structure of paracetamol (CgHg NO2) 
Fig. 2.2: Structure of ibuprofen (CnHigOz) 
CO2NS 
Fig. 2.3: Structure of diclofenac sodium (CnHioCiaNNaOi) 
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CO^H 
Fig. 2.4: Structure of aspirin (C9H8O4) 
HO 
H 
O 
O 
HO OH 
Fig. 2.5: Structure of ascorbic acid (CeHgOe) 
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Paracetamol Ibuprofen 
Drugs 
Diclofenac sodium 
Fig. 2.6: Bar diagram showing Influence of surfactant in the solvent systems on the 
mobility of drugs 
Mo - n hexane: ethyl acetate: acetic acid, 7:2.5: 0.5, v/v 
M) - n hexane: 1% CTAB in MeOH: ethyl acetate: acetic acid, 13:1: 4: 2, v/v 
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Paracetamol Aspirin 
Drugs 
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Fig. 2.7: Bar diagram showing Influence of surfactant in the solvent systems on the 
mobility of drugs 
M2 - toluene: n-Prpanol: formic acid, 5: 4:1.0, v/v 
M3 - toluene: 1% CTAB in MeOH: n propanol: formic acid, 14:1:3: 2, v/v 
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Fig. 2.8: Chromatogram showing the resolution of a mixture of paracetamol (Pa), 
diclofenac sodium (Ds) and ibuprofen (lb) on unimpregnated (Si) and 
impregnated (S3, Sg.S^, and Sig) silica gel H layers using solvent system Mi 
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Fig. 2.9: Chroraatogram showing the resolution of a mixture of paracetamol (Pa), 
aspirin (As) and ascorbic acid (Ac) on unimpregnated (Si) and 
impregnated (S3, Ss.Su, and Sig) silica gel H layers using solvent system M3 
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3.1 INTRODUCTION 
Lisinopril, 1-[N- {(s)-I- carboxy- 3 phenyl propyl}-L-proIine dehydrate is a lysine 
analog of enalaprilat, the active metabolite of enalapril. It is long-acting, non-sulhydryl 
angiotensin- converting enzyme (ACE) inhibitor that is used for the treatment of 
hypertension and congestive heart failure in daily dosage 10-80 mg [1]. Pharmacological 
activity of lisinopril has been proved in various experimental and clinical studies [2, 3]. 
Owing to its importance and widespread use, efforts have been made towards the 
development of simple and reliable analytical methods. As per our literature survey, 
lisinopril in pharmaceutical formulations has been determined by various analytical 
methodologies like polaragraphy [4], potentiometry [5] and spectrophotometry [6],'but 
most of these analytical methods are not too suitable for the Identification of lisinopril 
from clinical samples because of the interferences caused by the amino acids and amino 
groups containing metabolites present in biological samples [7]. This report is an attempt 
in the direction of developing a simple and reliable method for on plate identification and 
quantification of lisinopril in pharmaceutical formulations as well as from human urine 
samples using silica gel H layers developed with a new mobile phase comprising of 
micellar solutions of N-cetyl-N, N, N- trimethylammonium bromide (CTAB). Micellar 
solutions have found numerous practical applications in many areas of separation science. 
Micellar liquid chromatography (MLC) has gained immense popularity and wider 
applicability due to operational simplicity, cost effectiveness, relatively non toxicity and 
enhanced separation efficiency, low aggressiveness [8-11]. Incorporation of aqueous 
micellar solutions as mobile phase was pioneered by Armstrong and Terrill [12] as they 
accentuated the importance of TLC where simultaneous separation of ionic or non-ionic 
species in a variety of matrices is required. A peculiarity of the micellar mobile phases 
(MMPs) is that they have no macroscopic analogues [13], as a result the typical 
separations can be easily achieved by using MMPs than aqueous organic mobile phases. 
Previously MMPs were successfully employed in TLC based critical separations of 
aromatic hydrocarbons [14], nucleotides [15] , vitamin Ki and K5 [16] , o-,m- and p-
aminophenol [17], amino acids [18], separation of penicillins [19]. 
132 
The human urine analysis for identification of selected drugs and their metabolites 
has emerged as an important investigation tool in forensic drug analysis [20]. Among all 
chromatographic methods available only thin layer chromatography (TLC) enables a 
simple fast and effective separation of the complex mixtures present in various biological 
samples [21] and is recommended as a approved testing for forensic drug analysis by 
federal Law [22]. TLC proved its applicability during successful separation of bio-active 
amines [23], carbohydrates [24], enzymes [25], porphyrins and their precursors [26], 
alkaloid and drugs [27] from urine samples. 
3.2 EXPERIJMENTAL 
Instrumentation and reagents 
A UV-VIS Spectrophotometer connected with P IV IBM computer, TLC 
applicator (Toshiwal India) and pH meter Elico India Ltd was used. Chemical required 
like silica Gel 'H', sodium dodecyl sulfate (SDS), N-cetyl-N, N, N-trimethylammonium 
bromide (CTAB) and t- octyl phenoxydacaethoxy ethanol (TX-lOO), methanol, ethanol, 
prpoanol and butanol, ninhydrin, isoamyl-alcohol, ethylene dichloride were purchased 
from Merck India, Iodine crystals, glacial acetic acid , dimethyl formamide (DMF) were 
obtained from CDH India, Lisinopril (Fig: 3.1) (pure & formulated) was from Lupin labs, 
Mandideep, M.P., India as a gift sample. 
General procedure 
Preparation of Test Solution 
Ten tablets equivalent to 100 mg of the lisinopril were powdered and transformed 
into a 50 mL standard flask and dissolved with 50 mL of methanol followed by stirring. 
The solution was filtered with Wattman no-41 and the filtrate was transferred again into a 
100 mL standard flask and diluted to volume with DMF. In case of pure lisinopril drug 
the 100 mg of powder was dissolved with 10 mL double distilled water and the final 
volume (100 mL) was made up with DMF. Standard lisinopril solutions (2mg/mL and 1-
100|ig mL) were prepared from above prepared stock solution by appropriate dilution 
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with DMF and water (9:1). 
Preparation ofninhydrin solution 
2% solution ofninhydrin was prepared in DMF. 
Extraction of Lisinopril from human urine samples 
Preparation of spiked drug urine samples -
A sample of Urine was taken from a healthy person. Take 100 mL of this urine 
sample and adjusted to pH 7-8 with 1 M NaOH solution. Add 100 mg of lisinopril drug 
powder to the urine sample. The resulting mixture was kept for shaking (20 minutes) at 
room temperature (15-20 °C) for achieving complete dissolution of drug in urine. 
Isolation of drug from spiked drug urine samples 
The 100 ml of spiked urine sample was filtered with whatman filter paper (No-41) 
and then the filtrate was mixed with 400 mL of ethylene dichloride containing 10% of 
isoamyl alcohol which was kept for shaking for 15 mins. After this the organic layer was 
separated and evaporated to obtain lisinopril drug as residue. The residue was diluted 
with 50 mL of DMF: double distilled water mixture (9:1). The chromatography of the 
extracted drug (lisinopril) was performed on silica gel H layers with solvent system Ms 
and the Rp value of spiked lisinopril is compared with Rp value of pure lisinopril drug. 
Detector: Iodine Vapors were used as a detector. 
Stationary Phase: Silica Gel 'H' layers were used as a stationary phase. 
Mobile phase: The solvent systems were used (Table 3.1) as mobile phases. 
Chromatography 
(a) Preparation of TLC plates 
The TLC plates were prepared by mixing silica gel H with double distilled water 
in 1:3 ratio by weight with constant shaking to obtain homogeneous slurry. The resultant 
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slurry was applied on the glass plates with the help of a manual applicator to give a 0.25 
mm-thick layer. The plates were dried at room temperature and then activated at 100 ± 2 
°C by heating in an electrically controlled oven for one hr. The activated plates were 
stored in a close chamber at room temperature until used. 
(b) Chromatographic procedure 
Test solutions (lOuL) were applied on (15 x 3 cm) silica gel H thin layer plates 
with the help of micropipette at about 2 cm above the lower edge of the plates. The 
solvent ascent was fixed to 10 cm in all cases for the determination of RF values of all 
individual drugs. Linear ascending development was carried out in a vapor equilibrated 
TLC twin trough chamber. The optimized chamber saturation time for the mobile phase 
was 15 min at room temperature (25 ± 1°C). Subsequent to the development, TLC plates 
were dried at room temperature. The plates were then detected by using iodine vapors 
and all the drugs are visualized as colored spots. The Rp values of drug were determined 
by the 
Following relation -
RF = 0.5 (RL + RT) 
Where RL = RF of leading front. 
RT = RF of trailing front. 
Interference 
For investigating the interference of various metabolites like sodium and 
potassium salts, urea and liquor ammonia, normally found in human urine on mobility of 
lisinopril. An aliquot (5 ^L) of lisinopril was spotted on silica gel HPTLC plate followed 
by spotting of 5|iL of the interfering species (Img/mL) on the same spot. The 
chromatography was performed with solvent system M5. The spots were detected and the 
RF values of drug were calculated and compared. 
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Quantitative determination oflisinopril 
The visible spectrophotometeric technique was applied for the quantitative 
determination of on plate identified iisinopril drug from formulated and human urine 
spiked samples. For this purpose 10 ^L oflisinopril solutions of different strength (10-
30^g) were spotted on TLC plates. After complete drying of the spots, the TLC plates 
were developed with solvent system M5. At the same time, a pilot plate was also 
developed to locate the position of Iisinopril spot. After such development the area was 
scarped from the plate. The scraped silica powder was then mixed with 2 mL of DMF for 
the extraction of Iisinopril from adsorbent. Then it was filtered with whatman filter paper 
no-41. In order to ensure complete extraction of drug the adsorbent was again washed 
with 3 mL of DMF: double distilled water mixture (9:1). All the filtrate was collected in a 
test tube, and then 1.5 mL of ninhydrin solution was added to it and kept for 90 min at 
room temperature for complete color development. The absorbance was measured at 595 
nm against reagent blank [22], A calibration curve was plotted between the absorbance 
Vs concentration of Iisinopril drug. The content of Iisinopril in the formulated and urine 
spiked samples was determined from the standard curve by six replicate readings under 
similar conditions by using the following relationship: 
Amount recovered - Amount loaded 
Relative Recovery (%)-100 x 100 
Amount loaded 
Amount loaded - Amount recovered 
Percentage Error = ^ 100 
Amount loaded 
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3.3 RESULTS AND DISCUSSION 
The mobility of lisinopril drug (pure and formulated) was examined on silica gel 
H layers using aqueous solutions of cationic (CTAB), anionic (SDS) and nonionic (TX-
100) surfactants. The experimental conditions were optimized on the mobility of 
lisinopril with various factors, such as type and concentration of surfactants used, nature 
and concentration of added alkanols in the micellar mobile phases, acidity or basicity of 
the medium, presence of urea and NaCl (electrolyte) in the surfactant- containing mobile 
phase and effect of various organic and inorganic metabolites normally found in urine 
samples. 
Effect of type and concentration of surf octants 
The chromatography of lisinopril was performed on silica gel H layers using 
different concentrations of cationic, anionic and nonionic surfactant-mediated mobile 
phase systems (M2- M19). The results of the effect of type and concentration of different 
classes of surfactants are presented in Table 3.2. The following conclusions are drawn 
from the Table 3.2. 
(1) In double distilled water (zero concentration of surfactant), the lisinopril remains at 
the point of application. 
(2) The mobility of lisinopril increases with the increase in concentration of CTAB in 
the solvent systems. 
(3) Reverse trend was observed in case of SDS as compared to CTAB, the mobility- of 
lisinopril decreases with the increase in concentration of SDS in solvent system. 
(4) The same trend was obtained in case of Triton X-100 as observed in case of CTAB 
containing solvent system. The mobility of lisinopril increases with the increase in 
concentration of Triton X-100 in the solvent system. 
It may be concluded from the present study that in case of both CTAB and Triton 
X-100, the micellar thin layer chromatography is involved. The surfactant in the solvent 
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system occurs in both the micellar and ionic forms. In this case concentration of 
surfactants in the mobile phase leads to an increase only in the concentration of micelles 
in MMPs and the concentration in the stationary phase remains nearly constant. This may 
result in decrease in retention of adsorbates. While in case of SDS, the ion-pair TLC 
situation is observed. The mobile phase in the system contains only ions of a surfactant. 
An increase in their concentration in the mobile phase increases the concentration of 
surfactant ions adsorbed on the stationary phase. As a result the retention of adsorbates 
increases [28]. 
Effect ofalkanols 
The different concentrations of alcohols (methanol, ethanol, n-propanol, or n-
butanol) of varying chain lengths were used with the 4% aqueous CTAB (M5) for the 
chromatography of lisinopril on silica gel H layer. The effect of nature of alcohols is 
presented in Table-3.2. From the results obtained, it is clear that with the increase in the 
concentration of alcohols the mobility decreases. At higher concentrations of different 
alcohols the visibility of lisinopril decreases and is not detected. The addition of alcohols 
in the micellar solvent systems may result in the less population of surfactants molecules 
on the adsorbent and this may provide some free silanol groups on the silica surface for 
the adsorption of lisinopril [29]. This may cause the increase in the retention of lisinopril 
on the silica surface and hence decreases the mobility. 
Effect of acidity and basicity of the solvent systems used 
TLC of lisinopril was performed with solvent systems M39- M42 prepared by using 
4% aqueous CTAB in borate phosphate buffers of different pH values (pH -2.3, 4.2, 5.7 
and 9.0). The results summarized in Table- 3.2, shows that at strongly acidic pH no spot 
was detected for lisinopril, while at pH (4.2 and 5.7) a decrease in the mobility of drug 
was observed with compact spots. At pH 9.0 a slight increase in mobility was observed 
for lisinopril drug with an elongated spot. 
Effect of electrolytes and non electrolytes addition in solvent systems 
It has been reported [30] that the microenvironment of micellar system is greatly 
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influenced by the presence of added organic substance or inorganic electrolytes. Thus the 
effect of addition of urea (organic non electrolyte) and NaCl (inorganic electrolyte) at 
two different concentration levels in the solvent system M5 (4% CTAB) on mobility of 
lisinopril were examined. The results presented in Table-3.2 and from the available data 
following trends are noticeable -
(1)A tailed spot was observed at lower concentration of urea but at higher 
concentration no spot was detected. 
(2) In case of NaCl mobility of lisinopril increases but at higher concentration spot 
compactness and intensity decreases. 
Identification of lisinopril in presence of impurities 
To widen the applicability of the developed TLC system (silica gel H layers with 
M5 solvent system) for identification and isolation of lisinopril from formulated drug and 
urine samples in presence of various metabolites normally found in urine are presented in 
Table 3.3. It is clear that potassium and sodium salts does not affect the mobility of the 
drug, but in case of liquor ammonia a long trailing spot was observed . In case of urea 
two spots were observed. 
Identification of lisinopril from human urine samples 
The proposed chromatographic method (silica gel H layers with 4% aqueous 
CTAB) successfully identified the lisinopril extracted from the human urine samples on 
the basis of RF value. The spots of the pure, formulated and the urine extracted lisinopril 
samples are shown in Fig. 3.2. Thus the proposed method is very sensitive for the 
identification of lisinopril from urine samples. 
TLC-Spectrophotometry of lisinopril 
The analytical parameters for the spectrophotometric determination of lisinopril 
by the proposed method are given in Table 3.4. Linear correlation was found between the 
absorbance and the concentration of lisinopril. Beers law was obeyed in a concentration 
range from 10-150 ngm/mL. The regression analysis of beer law data using the method 
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of least square was made to evaluate the slope (b), the intercept (a), correlation 
coefficient (r^), molar absorptivity and sandell sensitivity for each system. These values 
suggested that the proposed method is very sensitive for the determination of lisinopril. 
The accuracy and validity of the proposed method were ascertained by performing 
recovery studies. The recovery studies of pure, formulated and urine spiked lisinopril 
samples at different concentrations indicates that the recovery was good. The percentage 
recovery values ranged between 93.0 -100.2% with relative standard deviation of less 
than 3%. 
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Table 3.1: Solvent systems used 
Code 
Ml 
M2 
M3 
M4 
Ms 
Me 
M7 
Ms 
M9 
Mio 
Mn 
M12 
M,3 
Mu 
M,5 
M,6 
M,7 
Constituents 
Water 
0.5% aqueous CTAB 
1 % aqueous CTAB 
2% aqueous CTAB 
4% aqueous CTAB 
5% aqueous CTAB 
7% aqueous CTAB 
0.5% aqueous SDS 
1% aqueous SDS 
2% aqueous SDS 
4% aqueous SDS 
5% aqueous SDS 
7% aqueous SDS 
0.5% aqueous TX-100 
1% aqueous TX-100 
2% aqueous TX-100 
4% aqueous TX-100 
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Mi8 
Mi9 
M20 
M2, 
M22 
M23 
M24 
M25 
M26 
M27 
M28 
M29 
M30 
Ms, 
M32 
M33 
M34 
M35 
M36 
5% aqueous TX-100 
7% aqueous TX-100 
4% aqueous CTAB + Methanol (9:1) 
4% aqueous CTAB + Methanol (8 :2) 
4% aqueous CTAB + Methanol (7 : 3) 
4% aqueous CTAB + Methanol (6 : 4) 
4% aqueous CTAB + Methanol (5 : 5) 
4% aqueous CTAB + Methanol (4 : 6) 
4% aqueous CTAB + Ethanol (8 : 2) 
4% aqueous CTAB + Ethanol (5 : 5) 
4% aqueous CTAB + Ethanol (2 : 8) 
4% aqueous CTAB + Popanol (8 : 2) 
4% aqueous CTAB + Popanol (5 : 5) 
4% aqueous CTAB + Popanol (2 : 8) 
4% aqueous CTAB + Butanol (8 : 2) 
4% aqueous CTAB + Butanol (5 : 5) 
4% aqueous CTAB + Butanol (2 : 8) 
4% aqueous CTAB containing 1 g NaCl per 100 mL 
4% aqueous CTAB containing 5 g NaCl per 100 mL 
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M37 
Mjs 
M39 
M40 
M4, 
M42 
4 % aqueous CTAB containing 1 g Urea per 100 mL 
4 % aqueous CTAB containing 5 g Urea per 100 mL 
4% aqueous CTAB in buffer solution of pH 2.3 
4% aqueous CTAB in buffer solution of pH 4.2 
4% aqueous CTAB in buffer solution of pH 5.7 
4% aqueous CTAB in buffer solution of pH 9.1 
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Table 3.2: Rp values (mobility) of lisinopril on silica gel H layers with different (Mi-
M42) mobile phases 
Mobile Phases 
Ml 
M2 
M3 
M4 
M5 
M6 
My 
Ms 
M9 
Mio 
Mn 
M12 
M,3 
M,4 
M,5 
M,6 
RF Values 
Lisinopril (Pure) 
0.00 
0.20 
0.24 
0.27 
0.32 
0.35 
0.36 
0.28 
0.26 
0.24 
0.21 
0.20 
0.20 
0.24 
0.26 
0.29 
Lisinopril (Formulated) 
0.02 
0.18 
0.22 
0.29 
0.35 
0.36 
0.38 
0.29 
0.25 
0.23 
0.21 
0.19 
0.18 
0.22 
0.25 
0.30 
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M,7 
Mi8 
Mi9 
M20 
M21 
M22 
M23 
M24 
M25 
M26 
M27 
M28 
M29 
M30 
M3, 
M32 
M33 
M34 
M35 
0.33 
0.34 
0.34 
0.46 
0.42 
0.39 
0.36 
0.31 
ND 
0.49 
0.44 
ND 
0.50 
0.48 
ND 
0.49 
0.46 
ND 
0.36 
0.35 
0.35 
0.34 
0.44 
0.41 
0.37 
0.34 
0.30 
ND 
0.51 
0.43 
ND 
0.53 
0.49 
ND 
0.50 
0.48 
ND 
0.35 
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M36 
M37 
M38 
M39 
M40 
M4, 
M42 
0.38 
0.37(T) 
ND 
ND 
0.31 
0.29 
0.36 
0.38 
0.35(T) 
ND 
ND 
0.28 
0.25 
0.36 
T = Tailed spot 
ND = Not detected 
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Table 3.3: Effect of various organic and inorganic metabolites found in urine on 
mobility (Rp) of lisinopril Drug 
Impurity 
NaCI 
KCl 
Urea 
Liquor Ammonia 
RF Value 
0.34 
0.35 
0.33,0.68 
0.39 (T) 
T = Trailing 
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Table 3.4: Optical characteristics and statistical data for the regression equation of 
the proposed method 
S.No. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
Parameter 
^_max 
Beer's law limit (|ag/mL) 
Molar absorptivity (L mole-1 cm-1) 
Sandell's sensitivity ([ig/mL perO.OOl A) 
Regression equation (Y) 
Slope (m) 
Intercept (c) 
Correlation coefficient (r 
Relative Standard Deviation** (%) 
Limit of Detection (|ig/mL)*** 
Value 
595 nm 
10-150 
4.083x10^ 
1.2x10-' 
Y = mx + C 
6.28x10'^ 
2.8x10-^ 
0.9778 
0.883 
5.587 
Where X is the concentration of analyte (|ig/mL) and Y is absorbance unit. 
**Calculated from six determinations 
***Calculated as per ICH guidelines 
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Table 3,5: Spectrophotometric determination of lisinopril from pure formulated and 
urine spiked samples 
Drug samples (fig/ml) 
Amount taken 
10 
12 
14 
16 
18 
20 
22 
24 
26 
Found 
(^g/ml) 
9.3 
11.2 
13.2 
15.5 
17.3 
19.4 
21.6 
23.7 
25.6 
Relative Recovery 
(%) 
93.0 
93.3 
94.2 
96.8 
96.1 
97.0 
98.1 
98.7 
98.6 
Relative Error 
(%) 
-6.9 
-6.6 
-5.7 
-3.1 
-3.8 
-3.0 
-1.8 
-1.2 
-1.15 
R.S.D 
2.8 
2.0 . 
2.2 
2.6 
1.9 
1.7 
2.9 
1.5 
1.6 
Formulated drug 
50 
100 
50.3 
100.2 
100.6 
100.2 
+0.59 
+0.20 
1.3 
0.9 
Urine sample 
20 18.8 94.0 -5.9 2.3 
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HO2C H H 
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Fig. 3.1: Structure of lisinopril drug 
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Fig. 3.2: Chromatogram showing identification of lisinopril in pure and formulated 
as well as spiked urine samples on silica gel H layers developed with mobile 
phase Ms 
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4.1 INTRODUCTION 
Jatiphaladya is a powdered herbal formulation of 6000 year old Indian ayurvedic 
system of medicine. Therapeutically Jatiphaladya is beneficial in many human intestinal 
disorders like tastelessness (aruci), Diarrhea (Atisara), Malabsorption syndrome (Graha), 
Dysentery (Pravahika), Cough (Kasa) and Rhinitis (Vatsa!e-ma-Pratisyaya). The main 
constituents of Jatiphaladya formulation are Cannabis sativa (Bhang), Myhstica fragrans 
(Jatiphala), Piper longum (Pippali) and Embleia ribes (Vidanga) [1]. Cannabis sativa 
(Bhang) is a major constituent of the Jatiphaladya formulation (20 % wt/vol). It is a 
commonly grown herb of high medicinal importance [2]. Myristica fragrans (Jatiphala) 
commonly known as nutmeg, is a popular herbal plant used in traditional Ayurvedic, 
Chinese and Thai medicine as aphrodisiac, antimicrobial, antipyretic, abortifacient and 
stomachic [3]. This plant is pharmacologically studied for various activities like chemo 
protective, antioxidant, aphrodisiac, antimicrobial, hepatoprotective, and anti-
inflammatory [4]. Piper longum (Pippali) is a widely available species of the genus piper. 
Because of high therapeutic values, pipali has been used as antibacterial, anti-
inflammatory and as a local anesthetic [5]. Embleia ribes (Vidanga) is a climbing herb 
found in Sri-lanka, India and Singapore. Therapeutically Embeleia inhibited pregnancy, 
possessed anti-estrogenic and weak progestational activity, shows analgesic, anti-
inflammatory, antibacterial, antitumor and free radical scavenging activities [6, 7]. As 
per our literature survey there is no analytical study available for Jatiphaladya 
formulation, But Previously Cannabis was analysed by various analytical methods 
including immunoassays (EMIT, Elisa fluorescence polarization, radioimmunoassay) [8], 
Gas Chromatography- Mass spectrometry [9], High performance liquid chromatography-
Mass spectrometry [10] and TLC [II]. However in case oi Myristica fragrans (Jatiphal), 
Piper longum (Pippali) and Embleia ribes (Vidanga) a very few analytical studies are 
available using GC or HPLC [12-14]. Most of these techniques involves costly 
instruments and require highly purified standard reference samples [15]. Thin Layer 
Chromatography is a suitable method to screen simultaneously numerous samples 
extracted directly from plants. It has become a modem technique with the 
commercialization of numerous adsorbents and solvent systems [16]. 
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Micellar liquid cliromatography involving the use of surfactant ions above their critical 
micellar concentration (CMC) as mobile phase for controlling the retention of a solute 
has been the focus of numerous studies [17-19]. The use of surfactants (cationic, anionic, 
and nonionic) in TLC has expanded its potentiality by providing efficient separations of 
peptides [20], vitamins [21], steroids [22] etc. Surfactant-modified TLC provides 
enhanced selectivity as a result of difference in the degree of binding of separated 
mixture components with mobile and stationary phases [23]. The selective solubilization 
of mixture components with micelles is caused by complex electrostatic, hydrophobic, 
donor-acceptor and polarization interactions. Micelles are capable by differentially 
solubilizing and binding a variety of solutes leading to their potential usefulness for 
achieving several new separations including the resolution of optical isomers [24]. The 
present communication is probably the first report on the use surfactant in TLC 
analysis of an herbal formulation (Jatiphaladya). 
4.2 EXPERIMENTAL 
Apparatus 
A TLC applicator (Tyshiwal, India) was used for coating silica gel on 20cmx 3cm 
glass plate. A glass sprayer and iodine gas chamber was used to locate the position of 
spot of analyte. A pH meter (Elico, India) and a reflux assembly of Borosil India were 
also used. 
Chemicals and Reagents 
Silica Gel 'G', sodium dodecyl sulfate (SDS), N-cetyl-N, N, N-
trimethylammonium bromide (CTAB), t- octyl phenoxydacaethoxy ethanol (TX-lOO), 
methanol, propanol, butanol and buffer capsules for pH 2.4, 4.0 and 9.2 (on dilution with 
100 mL distilled water) were obtained from Merck Reagents, Mumbai, India. Sulfuric 
acid, iodine, vanillin and ethanol were from CDH India, Jatiphaldaya formulation was 
from Baidyanath Pharmaceutical Ltd India. 
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Parent API herbs, Cannabis sativa (Bhanga), Myristica fragrans (Jatiphala), Piper 
longum (Pippali) and Embleia ribes (Vidanga) were obtained from Ashyuwani herbal 
Pharmaceuticals, U.P., India. 
Chromatography 
Mobile phases: The following solvent systems (Table-1) were used for the 
chromatography. 
Stationary phase: Silica gel G was used as a stationary phase. 
Detection reagent 
(a) Iodine vapors 
(b) 1% solution of vanillin in methanolic sulfuric acid. 
(c) Sulfuric-acid anisaldehyde solution. 
Extraction of Drug 
A powdered sample of herb was dried at 65°C for 17 hours. A weighed amount 
of material (5 gm herb powder) was added to 20 ml of ethanol: water (8:2) solution and 
allowed to stand at room temperature for four hr. After that solution was refluxed on 
water bath for 30 min, cooled and then filtered through a small funnel plugged with 
cotton wool and Watman filter paper (41). The solid residue obtained was again washed 
with 10 ml of Ethanol: water (4:1) solution. After that all filtrates and washings were 
collected and solvent was evaporated. The final residue obtained after drying was further 
dissolved in 10 ml of toluene containing 0.5mg/mL of drug as standard [25]. 
Preparation of TLC plates 
The TLC plates were prepared by mixing silica gel G with double distilled water 
in 1:3 ratios by weight with constant shaking to obtain homogeneous slurry. The resultant 
slurry was applied on the glass plates with the help of a manual TLC applicator to give a 
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0.25 mm-thick layer. The plates were dried at room temperature and then activated at 100 
± 2°C by heating in an electrically controlled oven for one hr. The activated plates were 
stored in a close chamber at room temperature until used. 
Chromatographic procedure 
Test solutions (lO^L) were applied on (15 x 3 cm) silica gel G thin layer plates 
with the help of micropipette at about 2 cm above the lower edge of the plates. The 
solvent ascent was fixed to 10 cm in all cases for the determination of Rp values of all 
individual drugs. Linear ascending development was carried out in a vapor equilibrated 
TLC twin trough chamber. The optimized chamber saturation time for the mobile phase 
was 15 min at room temperature (25 ± 1°C). Subsequent to the development, TLC plates 
were dried at room temperature. The spot were then detected and compared by using 
iodine vapors, vanillin sulfuric acid and sulfuric acid aniseldhyde solution as 
chromogenic reagents and all the drugs are visualized as colored spots. For comparing 
spot intensity, 10 L aliquot (0.5 mg/mL) were loaded on silica gel TLC plate and 
chromatography was performed with different mobile phases (M1-M42) and then spots 
were visualized using a common detector. The identified spots were visually compared 
for spot intensity. The Rp values of drug were determined by the 
following relation -
RF = 0.5(RL + RT) 
Where RL = Rp of leading front. 
RT = Rp of trailing front. 
Separation 
For the separation, equal amount of solution of drugs to be separated were mixed 
and 10 L of the resultant mixture was loaded on the TLC plates. The plates were 
developed with solvent system (M12) and the spots were detected and the Rp values of the 
separated drugs were determined. For separation of active constituents from Jatiphaladya 
formulation drug was extracted from the formulation andlO L of this extract was loaded 
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on TLC plates and chromatography was performed. 
Ejfect of different modifiers in solvent system 
To study the effect of change in microenvironment of solvent systems due to 
presence of alkanols, pH buffers, electrolytes (NaCl) and non electrolyte (urea) on the 
identification and mobility of all the four herbal drugs, different alcohols (methanol, 
ethanol, propanol and butanol) and 5% aqueous SDS solution prepared in 1% and 5% 
aqueous solution of NaCl and urea were used as solvent systems. After that the 
chromatography was performed on silica gel layers with these solvent systems (M20- M42) 
and RF values are calculated and compared 
Interference 
For investigating the interference of various organic and inorganic metabolites 
like sodium and potassium salts, urea, liquor ammonia, nitrate and glucose as an sample 
impurity, on the identification and mobility of herbal drugs (Bhanga, Jataiphala, Pippali 
and Vidanga), an aliquot (10 |iL) of all herbal drugs were spotted separately on silica gel 
TLC plate followed by spotting of 10|iL of the interfering species (Img/mL) on the same 
spot. The chromatography was performed with solvent system M12. The spots were 
detected and the Rp values of drugs were calculated and compared. 
Detection limits with different detectors 
The detection limits of jatiphala, bhanga, pippali and vidanga were determined by 
spotting different amounts of all the four compounds on silica gel stationary phase, 
developed with solvent system (M12) and the spots were detected with various detectors 
such as -
(a) Iodine vapors 
(b) 1% solution of vanillin in methanolic sulfuric acid 
(c) Sulfuric acid anisaldhyde. 
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The method was repeated with successive lowering of the amount of drugs. The 
lowest amount that could be detected was taken as the limit of detection for each detector. 
4.3 RESULTS AND DISCUSSION 
The four main constituents (Bhanga, Jatiphala, Pippali and Vidanga) of an 
aurvedic herbal formulation Jatiphaladya have been separated by using micellar thin layer 
chromatatography. These four constituents of Jatiphaladya were first extracted from their 
natural sources using aqueous organic solvent and then chromtographed on silica gel 
layers with various surfactant mediated solvent systems (M2- M19). The surfactants used 
in this study differ mainly on the basis of the charge present on their hydrophilic groups. 
The results of the present study are reported in Table 2. In addition to the effect of nature 
of charge of various surfactants, the additive effect of various organic and inorganic 
modifiers, electrolytes and non-electrolytes, as well as the pH of the solvent system were 
utilized to examine the chromatographic behavior of these herbal drugs. 
The following conclusions are drawn from the results reported in Table 2 for the 
effect of nature of different surfactants on the chromatography of these herbal drugs. 
(1) In double distilled water (zero concentration of surfactants), Jatiphala was not 
detected while the other compounds appeared as tailed spots with different 
mobility. 
(2) In case of CTAB and TX-lOO, the mobility of Bhanga, Vidanga and Jatiphala 
decreases with the increase in concentration of surfactant in the solvent system 
while in case of Pippali mobility increases with the increase in concentration of 
TX-lOO in solvent system and decreases in case of CTAB. 
(3) The SDS containing solvent systems have shown appreciable increase in the 
mobility of all the four herbal drugs with the increase in the concentration of 
surfactant in the solvent system. 
It may be concluded from the results that in case of CTAB and TX-lOO, all the 
four drugs (Jatiphala, Pippali, Vidanga and Bhanga) are expelled or excluded from the 
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micelle due to some sort of repulsion. This repulsion causes the increase in the retention 
of these compounds with the stationary phase with the increase in concentration of 
surfactants in the solvent system. While in case of SDS all the four drugs associate or 
bind with the micelle. This association with drugs causes a decrease in the retention of all 
the four drugs with stationary phase. This may also be concluded that these drugs behave 
as binding solutes for the SDS and the antibinding solutes for both CTAB and TX-100. 
From the chromatographic point of view, solvent system (M12) was found to be best 
solvent system for the resolution of all the four herbal drugs due to higher ARp values 
[(RF Bhanga - Rp vidanga) and (Rp jatiphaia" Rp Pippaii)] which was 0.31 and 0.15 respectively in 
solvent system M12 as compared to M20 (ARF values, 0.28 and 0.13 respectively) and 
also all the four drugs studied produced compact spots with high color intensity in 5% 
aqueous SDS containing solvent system (M12). Therefore, solvent system M12 is selected 
for the further study. 
The mobility (RF) of all the four drugs is greatly affected by the presence of 
alcohols in the miceller solvent system. The addition of alcohols in the micellar solvent 
systems may result in the less population of surfactants molecules on the adsorbent and 
this may provide some free silanol groups on the silica surface for the adsorption of 
analyte [27] and also the addition of short-chain alcohols to the micellar mobile phase 
increases the polarity of solvent system and reduces the thickness of the film of surfactant 
molecules covering the stationary phase which results in increase of mobility of drugs. It 
is also reported that the addition of short-chain alcohols at lower concentrations also 
affects the micelle formation [28, 29]. From all the alcohols used butanol containing 
solvent system (M32) provides highly compact spots for all the four drugs. This may be 
due to decrease in the polarity of the solvent system which in turn improves the 
efficiency and this could be related to improvement brought about by wetting the 
stationary phase with organic modifier. The actual polarity decreases in the order 
methanol>ethanol>propanol>butanol and hence efficiency follows the reverse trend as 
butanol<propanol<ethanol < methanol. 
To widen the applicability of developed thin layer chromatographic method in the 
field of herbal drugs all the four constituents was identified and separated from ayurvedic 
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formulation Jatiphaladya. Simultaneous use of other sensitive analytical methods such as 
HPLC and GC-MS may further provide the evidence about accuracy of our developed 
TLC system and data for estimation of biochemical structural composition of these 
herbals for future research. All the four important herbal drugs were identified and 
separated from an ayurvedic herbal formulation Jatiphaladya. The identification and 
resolution of Cannabis sativa (Bhanga), Embleia ribes (Vidanga), Myristica fragrans 
(Jatiphala) and Piper longum (Pippali) from Jatiphaladya ayurvedic formulation on silica 
gel layers with solvent system M]2 is shown in Fig. 1. The characterization and 
comparative studies of these identified and separated herbals with their standards may be 
more informative and useful for the proposed chromatographic system during future 
analytical studies of these herbals drugs. 
Effect ofAlkanols 
The results of the additive effects of various organic modifiers such as alcohols in 
the micellar mobile phase M12 on the mobility of all the four drugs studied are presented 
in Table 2. It is clear from the results that the presence of traces of alcohols in solvent 
system increases the mobility of all the four drugs but further increase in concentration of 
various alcohols viz. methanol, ethanol, propanol and butanol in the micellar mobile 
phase (M12) decreases the mobility of all the four drugs. 
Effect of electrolyte and non electrolyte 
It has been reported [26] that the microenvironment of micellar system is greatly 
influenced by the presence of added organic substance or inorganic electrolytes. Thus the 
effect of addition of urea (organic non electrolyte) and NaCl (inorganic electrolyte) at 
two different concentration levels in the solvent system M12 (5% SDS) on mobility of all 
the four herbal drugs were examined. The results presented in Table 2 shows following 
noticable trend -
(3) In urea containing solvent systems (M37- M38) both Bhanga and Vidanga are not 
detected while in case of Pippali and Jatiphala the mobility decreases. 
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(4) In case of NaCl containing solvent systems (M35-M36), all the three drugs (Jatiphala, 
Pippali and Bhanga) produced tailed spots except Vidanga. 
Effect of pH 
The results showing effect of pH (2.3, 4.2, 5.7 and 9.0) of the solvent systems 
(M39-M42) on the mobility of all the four herbal drugs are presented in Table 2. It is clear 
from the results that in strongly acidic pH none of the drugs except Vidanga was detected 
on TLC plates. In the pH range 4.2-5.7 no significant change in mobility was observed 
for all drugs. At pH 9.1 Bhanga could not be detected. 
Limits of detection 
The lowest possible amount of all the drugs detected using various detection 
reagents on silica gel surfaces with solvent system M12 are presented in Table 3. The 
results obtained indicate that vanillin sulfuric acid is most suitable for sensitive and 
efficient detection of drugs under study. 
Interference studies 
It is clear from Table 4 that the presence of various organic and inorganic 
metabolites like sodium and potassium salts, urea, liquor ammonia, nitrate and glucose in 
the herbal drug sample as impurities influences the mobility of all the four herbal drugs. 
In case of NaCl, KCl and glucose as an interfering species all the three drugs produced 
tailed spots except Pippali which was not detected in glucose. Only Bhanga was detected 
when N03" was used as an interfering species. No spot was detected for Bhanga and 
Vidanga in presence of ammonia. In case urea as an interfering species Bhanga and 
Pippali were not detected. 
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Table 4.1: Solvent Systems 
Code 
Ml 
M2 
M3 
M4 
Ms 
M6 
M7 
Mg 
M9 
Mio 
Mu 
M,2 
M,3 
M,4 
M,5 
M,6 
M,7 
M18 
Mi9 
M20 
Constituents 
Water 
0.5% aqueous CTAB 
1% aqueous CTAB 
2% aqueous CTAB 
4% aqueous CTAB 
5% aqueous CTAB 
7% aqueous CTAB 
0.5% aqueous SDS 
1% aqueous SDS 
2% aqueous SDS 
4% aqueous SDS 
5 % aqueous SDS 
7% aqueous SDS 
0.5%) aqueous TX-100 
I % aqueous TX-100 
2% aqueous TX-100 
4% aqueous TX-100 
5% aqueous TX-100 
7% aqueous TX-100 
5% aqueous SDS + Methanol (9 :1) 
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M21 
M22 
M23 
M24 
M25 
M26 
M27 
M2g 
M29 
M30 
M3, 
M32 
M33 
M34 
M35 
M36 
M37 
M38 
M39 
M40 
M4, 
M42 
5% aqueous SDS + Methanol (8 : 2) 
5% aqueous SDS + Methanol (7 : 3) 
5% aqueous SDS + Methanol (6 : 4) 
5% aqueous SDS + Methanol (5 : 5) 
5% aqueous SDS + Methanol (4 : 6) 
5% aqueous SDS + Ethanol (8 : 2) 
5% aqueous SDS + Ethanol (5 : 5) 
5% aqueous SDS + Ethanol (2 : 8) 
5% aqueous SDS + Propanol (8 : 2) 
5% aqueous SDS + Propanol (5 : 5) 
5% aqueous SDS + Propanol (2 : 8) 
5% aqueous SDS + Butanol (8 : 2) 
5% aqueous SDS + Butanol (5 : 5) 
5% aqueous SDS + Butanol (2 : 8) 
5 % aqueous SDS containing 1 g NaCl per 100 mL 
5 % aqueous SDS containing 5 g NaCl per 100 mL 
5% aqueous SDS containing 1 g Urea per 100 mL 
5% aqueous SDS containing 5 g Urea per 100 mL 
5% aqueous SDS in buffer solution of pH 2.3 
5% aqueous SDS in buffer solution of pH 4.2 
5% aqueous SDS in buffer solution of pH 5.7 
5% aqueous SDS in buffer solution of pH 9.1 
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Table 4.2: Rp values (mobility) of Cannabis sativa (Bhanga), Embleia rites 
(Vidanga), Myristica fragrans (Jathiphala) and Piper longum (Pippali) on silica gel 
'G' Layers with different (M)-M42) mobile phases 
Mobile 
Phases 
Ml 
M2 
M3 
M4 
M5 
M6 
M7 
Ms 
M9 
Mio 
Mu 
M)2 
Mi3 
M,4 
M,5 
M,6 
M,7 
M18 
Mi9 
M20 
M2r 
M22 
M23 
M24 
M25 
Cannabis sativa 
(Bhanga) 
0.72 (T) 
0.70 
0.67 
0.64 
0.62 
0.60 
0.60 
0.86 
0.88 
0.91 
0.93 
0.95 
0.97 
0.90 
0.88 
0.87 
0.85 
0.83(T) 
0.83(T) 
0.98 
0.98 
0.95 
0.91 
N.D 
N.D 
Embleia ribes 
(Vidanga) 
0.60 (T) 
0.64 
0.61 
0.57 
0.48 
0.50 
0.51 
0.56 
0.58 
0.59 
0.61 
0.64 
0.65 
0.69 
0.67 
0.66 
0.63 
0.61 
0.60 
0.70 
0.71 
0.69 
0.67 
0.64 
0.64 
Myristica fragrans 
(Jatiphala) 
ND 
0.22 
0.18 
0.15 
0.13 
O.ll(T) 
0.10(T) 
0.32 
0.35 
0.39 
0.39 
0.41 
0.43 
0.61 
0.59 
0.55 
0.52 
0.50 
0.50 
0.49 
0.49 
0.47 
0.45 
0.42 
0.40 
Piper longum 
(Pippali) 
0.14 (T) 
0.20 
0.18 
0.15 
0.12 
0.10(T) 
0.10(T) 
0.20 
0.22 
0.23 
0.25 
0.26 
0.27 
0.00 
0.00 
0.14 
0.17 
0.18 
0.19 
0.36 
0.30 
0.29 
0.27 
0.25 
0.26 
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M26 
M27 
Mas 
M29 
M30 
M3, 
M32 
M33 
M34 
M35 
M36 
M37 
M38 
M39 
M40 
M4, 
M42 
0.94 
0.90 
N.D 
0.93 
0.90 
0.89 
0.91 
0.89 
N.D 
0.92(T) 
0.90(T) 
N.D. 
N.D. 
N.D. 
0.93 
0.91 
N.D. 
— . 
0.68 
0.66 
0.62 
0.67 
0.66 
N.D 
0.65 
0.63(T) 
0.63(T) 
0.71 
0.69 
N.D. 
N.D. 
0.61(T) 
0.60 
0.58 
0.65 
0.47 
0.47 
0.44 
0.45 
0.43 
0.40 
0.45 
0.42 
0.43 
0.42(T) 
0.39(T) 
0.37 
0.39 
N.D 
0.40 
0.37 
0.44 
0.30 
0.28 
0.25 
0.27 
0.24 
0.21 
0.24 
0.20 
0.20(T) 
0.23(T) 
0.27(T) 
0.21 
0.23 
N.D 
0.24 
0.25 
0.26 
N.D = Not detected 
T = Trailing 
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Table 4.3: Limit of Detection (jJg/mL) achieved using different detection reagents on 
silica gel 'G' layers with solvent system M12 
Herbal Drug 
Embleia ribes 
Myristica fragrans 
Piper longum 
Cannabis sativa 
Detection reagents 
Iodine 
0.20 Mg/mL (light 
brown) 
0.40 Hg/mL (brown) 
0.70 Mg/mL (brown) 
0.90 pg/mL (black 
brown) 
Vanillin sulfuric 
acid 
0.50 pg/mL (bluish 
grey) 
0.20 Mg/mL (light 
pink) 
0.30 Mg/mL (light 
yellow) 
0.40 Mg/mL (violet) 
Sulfuric acid 
anisaldehyde 
0.90 Mg/mL (blue) 
0.70 Mg/mL 
(orange) 
1.0 Mg/mL (green) 
0.80 Mg/mL (black) 
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Table 4.4: Effect of various organic and inorganic impurities (interference) on the 
identification and mobility (Rp) of Cannabis sativa, Embleia ribes, Myristica fragrans 
and Vipper longum on silica gel 'G' layers developed with solvent system Mn 
Impurity 
NaCl 
KCl 
Urea 
Ammonia 
NO3" 
Glucose 
Cannabis sativa 
0.91 (T) 
0.86 
ND 
ND 
0.97 
0.94 (T) 
Embleia ribes 
0.58 (T) 
0.55 (T) 
0.71 
N.D. 
ND 
0.38 (T) 
Myristica fragrana 
0.44 (T) 
0.43 (T) 
0.41 
0.00 
ND 
0.47 (T) 
Pipper longum 
0.32 (T) 
0.30 (T) 
ND 
0.13 (T) 
ND 
ND 
ND = Not detected 
T = Trailing 
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5.1 INTRODUCTION 
Diclofenac sodium (DS) is sodium-[(2, 6- dicholorophenyl) aminoj-phenyl 
acetate. It is sodium salt of an aryl acetic acid derivative [1, 2]. It possesses analgesic 
anti-inflammatory and antipyretic activity. It inhibits prostaglandin synthesis by 
interfering with the action of prostaglandin synthetase (Cyclooxygenase) [2]. While 
Paracetamol (Para-acetyl amino phenol) is a widely used analgesic and antipyretic 
medication. It is the active metabolite of phenacetin, but unlike phenacetin, paracetamol 
has not been shown to be carcinogenic. Paracetamol reduces the production of 
prostaglandins (pro-inflammatory chemicals [3]. The separation of drugs by thin layer 
chromatography (TLC) is generally governed by the physical interaction of the adsorbent 
and the coordinative properties of the mobile phase. As a general practice, the 
compositions of mobile phases are usually altered to achieve the desired separation on a 
particular adsorbent [4-7]. An extensive survey of literature reveals that the single and 
multicomponent mobile phases belonging to the following main groups have been used 
for TLC analysis of drugs. 
(1) Organic solvents containing alcohols (methanol, ethanol, propanol or butanol), 
chloroform, acetone and acetonitrile as one of the components [5,6]. 
(2) Aqueous organic solvents containing chloroform, alcohol, ethyl acetate and 
pyridine as one of the components [8, 9]. 
(3) Mixed aqueous organic acidic or alkaline solvents containing ammonia, 
hydrochloric acid and acetic acid as one of the components [8, 9]. 
In most cases, three or four components mixture of solvents in various 
proportions have been used as mobile phase. These systems have one major drawback of 
compositional nonuniformity during the development of thin layer chromatographic 
plates due to differences in evapouration tendencies of each component. Thus, the need 
of a simple mobile phase system for the analysis of pharmaceutical products is always 
felt by the chromatographers. The systematic studies in our laboratory on TLC analysis of 
heavy metals [10, 11], amines [12], anions [13], and amino acids [14] showed that toxic 
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organic solvents can be easily replaced by aqueous surfactant mediated systems. Keeping 
this in mind we decided to develop a simple mobile phase system containing surfactant as 
one of the component for identification, separation of coexisting paracetamol and 
diclofenac sodium on silica gel H layers. 
Surfactant modified mobile phases have received considerable attention in 
liquid chromatography since first report by Armstrong and Fendler in 1977 [15] who 
exploited the advantageous features of micellar system in chromatography. The use of 
surfactant ions as mobile phase components below their critical micelle concentration 
(CMC), in ion-pair chromatography (IPC) or above their CMC in micellar liquid 
chromatography (MLC) has been the focus of numerous studies [16,17]. This report is an 
attempt in the direction of developing a simple and reliable method for on plate 
identification and separation of paracetamol and diclofenac sodium using silica gel H 
layers developed with a new mobile phase comprising of 0.0001% - 1.0% aqueous N-
cetyl-N, N, N- trimethylammonium bromide (CTAB), sodium dodecyl sulphate (SDS) or 
t- octyl phenoxydecaethoxy ethanol (TX-lOO) in combination of methanol and glacial 
acetic acid in 5:4:1 v/v/v ratio. Paracetamol and diclofenac sodium have been previously 
separated by TLC on silica coated glass plates using several mixed aqueous organic 
mobile phases involving mainly methanol, water and acetic acid [18-20]. Silica gel 
stationary phase have been successfully utilized for identification of second series of 
drugs [21], densitometric determination of certain antidiabetic drugs [22] and detection of 
tuberculosis drugs [23] in dosage form. 
Urine is most often preferred testing substance for drug analysis because of ease 
of collection, presence of high concentrations of drugs and metabolites in it, and their 
presence in urine for up to two or three days after consumption. In case of forensic drug 
analysis TLC enables the simple, fast, cheap and effective extraction, identification and 
separations of the complex mixtures of drugs and other metabolites from human urine 
samples [24, 25]. Therefore TLC is considered as one of the best known and thoroughly 
tested methods of the analysis of substances such as biologically active amines [26], 
Carbohydrates [27] Enzymes [28], Porphyrins and their precursors [29], alkaloids [30], 
Banned drugs [30] from human urine samples. 
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As far as we are aware, TLC with surfactant modified mobile phases has not 
been used for identification and mutual separation of paracetamol and diclofenac sodium. 
This study thus bears practical as well as theoretical importance. 
5.2 EXPERIMENATL 
Apparatus 
A TLC applicator, pH meter (Elico model L 1 0 T), Electronic heating dry box 
(T S I India). 
Reagents 
Silica gel H, iodine crystals, N-cetyl-N, N, N-trimethylammonium bromide 
(CTAB), sodium dodecyl sulfate (SDS) and t- octyl phenoxydacaethoxy ethanol (TX-
100) were purchased from CDH, Delhi, India. Methanol, isoamyl alcohol, ethylene-
dichloride, ethanol, propanol, butanol and glacial acetic acid were from Qualigen 
Chemicals, Mumbai, India. Buffer capsules for pH 2.4, 4.0 and 9.2 (on dilution with 100 
mL distilled water) were obtained from Merck Reagents, Mumbai, India. Drug 
paracetamol (Paracip) of Cipla Labs, India and diclofenac sodium (voveran) of Emcure 
Pharma, India were used. All reagents were of Analar grade. 
Detection 
Iodine vapors were used for detection of all drugs. 
Ch romatography 
Preparation of Test Solutions 
Analyte solutions of the drugs were prepared by dissolving 25 mg of pure active 
powder ingredients of drug paracetamol and diclofenac sodium in 5.0 mL of methanol. 
For the solution preparation of formulated drugs, the five tablets of each drug were taken 
and weighed. The tablets were finely grounded into a homogenous powder form. The 
powder equivalent to 250 mg was weighed, transferred into a 50 mL standard volumetric 
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flask, mixed with 25 mL methanol and sonicated for 40 min. The solution was filtered 
through Whatman filter paper (No. 41) and the residue was washed twice with methanol. 
The filtrate and washings were combined in a 50 mL standard volumetric flask and 
diluted to the mark with methanol. This solution contains 5 mg/mL of drug. 
Mobile Phase: The solvent systems were used (Table 5.1) as mobile phases. 
Stationary Phase: Silica gel 11 w iis used as the stationary phase. 
Preparation of PLC Plates 
The plates were prepared by mixing silica gel H with double distilled water in 
1 -.3 ratios by weight. The resultant slurry was mechanically shaken for 10 min after which 
it was applied on well cleaned glass plates to give a layer of 0.25 mm thickness. The 
plates were air dried at room temperature and then heated at 100 ± 5 °C for one hr. After 
the activation, the plates were kept in an airtight chamber. 
Procedure 
The 0.01 mL solutions of pure and formulated drugs were spotted separately on 
TLC plates with the help of a micropipette at a distance of 2.0 cm above the lower edge 
of the plate. The spots were allowed to dry at room temperature and the plates were then 
developed with a chosen mobile phase in 24 cm x 6 cm glass jar by ascending technique. 
The development distance was kept 10 cm in all cases. After development, the plates 
were dried again and placed in a sealed iodine chamber. The spots of both formulated and 
pure drugs were visualized and compared. The RF values for both pure and formulated 
drug spots were calculated. 
The RF value can be calculated as: 
RF = 0.5 X (RL+RT) 
RL= RF of leading front. 
RT=RF of trailing front. 
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In order to study the effect of concentration and type of surfactants on the Rp 
values of drugs, the double distilled water in the mobile phase (Mo) was substituted by 
0.0001-1.0% aqueous (cationic, anionic and nonionic) surfactants (M1-M12) for 
performing the chromatography of drugs. The variation in Rp values, spot color and the 
intensity of spot were examined using the resultant mobile phases (M1-M12). For the 
separation of mixture of drugs, equal volumes of all the drugs were mixed and then 0.01 
mL of the resultant drug solution was applied on TLC plates. The plates were developed 
with most suitable mobile phase M4 and the Rp values of separated drugs [paracetamol 
(Pa) and diclofenac sodium (Ds)] were calculated. 
For examining the effect of pH value of drug solutions (i.e. analyte) on the 
mobility (Rp values) of drugs, the different pH values (2.4, 4.0 and 9.2) of drug solutions 
were adjusted by using buffer solutions. The chromatography of these resultant drug 
solutions was performed on silica gel H plates with M4 and Mg mobile phases. The Rp 
values of the spots were calculated and compared. 
For examining the effect of sunlight on mobility of drug solutions, the solutions 
of drugs (paracetamol and diclofenac sodium) were exposed to direct sunlight for 48 hr of 
duration under normal room temperature conditions in a sealed transparent glass vials. 
The exposed drug solutions (0.01 mL) were spotted on the silica gel H TLC plates and 
developed with solvent system M4 and Ms .The variation in Rp values of detected spots 
were investigated. 
In order to study the effect of the storage temperature on the mobility of the 
drugs, the drug solutions were kept for 48 hr of duration at four different temperatures 
(° C ± 2) as follows. 
(a) 10 (b)20 
(c) 30 (d) 40 
After this the chromatography was performed for these drug samples on silica H 
plates with solvent system M4 and Mg.The variation in Rp values were reported and 
compared. 
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Extraction of Diclofenac sodium from Urine samples 
A sample of Urine is tai<en from a patient after 4-6 hrs of consumption of the 
diclofenac sodium. Take 100 mL of urine sample and was adjusted to pH 7-8 with 1 M 
NaOH solution. Then, the urine sample was mixed with 400 mL of ethylene dichloride 
containing 10% of isoamyl alcohol and was kept for shaking for 15 mins. After this the 
organic layer was separated and evaporated to obtain diclofenc sodium as residue. The 
residue was diluted with 5 mL of methanol. The chromatography of the extracted drug 
(diclofenac sodium) was performed on silica gel H layers with surfactant modified 
solvent system (M4). 
5.3 RESULTS AND DISCUSSION 
Effect of type and concentration of surfactants 
The chromatography of two drugs (paracetamol and diclofenac sodium) was 
performed on silica gel H plates using thirteen solvent systems (M0-M12). The results 
were presented in Table 5.2. In the solvent system Mo (methanol: water: glacial acetic 
acid, 4:5:1 v/v/v) all the two drugs show marginally differential migration in the order as 
paracetamol > diclofenac sodium as evident from Table 5.1. In the hope of achieving 
better separation possibilities of the drugs, water in the solvent system Mo was replaced 
by aqueous solutions of surfactants (viz cationic, anionic or nonionic). The results 
obtained with these mobile phases (M1-M12) are recorded in Table I. In these solvent 
systems, the concentration of surfactants was maintained in the range of 0.0001 -1.0 % in 
order to understand the effect of surfactants as an electrolyte (surfactant concentration 
below CMC) and micelles (surfactant concentration above CMC). The value of CMC (in 
water at 25 °C) of CTAB, TX-lOO and SDS are 9.2x \0-\ 2.05x 10"'^  and 8.1x 10'^  M 
respectively. From the results provided in Table 5.2, it is clear that mobility (RF value) of 
all the two drugs increases with the increase in the concentration of cationic (CTAB) as 
well as nonionic (TX-lOO) surfactants. Conversely, with anionic (SDS) surfactant, the 
mobility of drugs was found to decrease with the increase in the concentration of the 
surfactant. Thus, the mobility of drugs is influenced by the nature of charge of surfactant 
irrespective of its presence in the form of electrolyte or micelles. Amongst these, M4 
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(methanol: 0.0001% aqueous CTAB: glacial acetic acid, 4:5:1 v/v/v) was found most 
favorable from the separation point of view, This may be due to presence of strong 
hydrophobic and electrostatic interactions of cationic surfactants with dissociated silanol 
groups of silica gel layers [31]. Thus it is selected for further studies of these drugs 
because of the following advantages (1) spot compactness, (ii) high color intensity of the 
spots, (iii) better separation possibilities of drugs. This method successfully resolved 
(Fig. 5.1) the co-existing mixture of diclofenac sodium and paracetamol from the mixture 
containing formulated drugs of two different tablets (diclofenac sodium and paracetamol) 
and also from a formulated tablet containing mixture of both diclofenac sodium and 
paracetamol. 
2. Effect of alkanols 
To investigate the retention behavior of paracetamol and diclofenac sodium on 
silica gel H layers and hybrid-mobile phase systems comprising of micelle (1% aqueous 
CTAB)- glacial acetic acid- alcohol (ethanol, propanol or butanol) were also used and 
better chromatographic performance in terms of promotion of differential migration of 
drugs (paracetamol and diclofenac sodium) by these mobile phases was observed. The Rp 
values shown in Table 5.3, clearly indicates a general trend of decreasing Rp value with 
the increase in carbon chain length of alcohol. This retention mechanism is connected 
with the adsorption of surfactant on the surface of stationary phase. The nature and 
polarity of alcohol leads to the reduction in the adsorbed amount of surfactant on the 
stationary phase which causes an increase in retention of solutes and a change in 
selectivity [32]. 
Effect of variation in drug solution pH 
The effect of pH on the mobility (R? value) of drugs was shown in Table 5.3. It 
is evident from this Table that at higher pH, none of the drugs was detected on TLC plate. 
In case of paracetamol and diclofenac sodium, a minor variation in RF values was 
observed for pH change from 4.0 to 9.2. 
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Effect of sun light 
The effect of sun light or the photosensitivity of drugs (parcaetamol and 
diclofenac sodium) on their mobility was examined and the obtained results are presented 
in Table 5.4. It was clearly observed that in solvent systems M4 and Mg, the RF values of 
all the drugs were significantly affected. 
Effect of storage temperature 
The results obtained for investigating the effect of storage temperature on the 
mobility of drugs are presented in Table 5.5. A gradual increase in Rp values was 
observed for all the three drugs with increase in temperature. 
Identification of Diclofenac Sodium from human urine samples 
The proposed chromatographic method (silica gel H layers with MeOH+ 1% aq 
CTAB+ Acetic acid glacial, 4:5:1) successfully identified the diclofenac sodium 
extracted from the human urine samples on the basis of RF value. The spots of the both 
pure diclofenac sodium samples and the urine extracted samples are shown in Fig. 5.3. 
Thus the proposed method is very sensitive for the identification of drugs from urine 
samples. 
179 
Table 5.1: Solvent systems used 
Code 
Mo 
M, 
M2 
Ml 
M4 
M5 
Mfi 
M7 
Mg 
M9 
Mio 
Mn 
M12 
M,3 
M,4 
M,5 
Constituents* 
Methanol: double distilled water: glacial acetic acid 
Methanol: 0.0001% aqueous CTAB : glacial acetic acid 
Methanol: 0.01% aqueous CTAB : glacial acetic acid 
Methanol: 0.1 % aqueous CTAB : glacial acetic acid 
Methanol: 1.0% aqueous CTAB : glacial acetic acid 
Methanol: 0.0001% aqueous SDS : glacial acetic acid 
Methanol; 0.01 % aqueous SDS : glacial acetic acid 
Methanol: 0.1 % aqueous SDS : glacial acetic acid 
Methanol: 1.0 % aqueous SDS : glacial acetic acid 
Methanol: 0.0001% aqueous TX-lOO : glacial acetic acid 
Methanol: 0.01 % aqueous TX-lOO : glacial acetic acid 
Methanol: 0.1% aqueous TX-lOO : glacial acetic acid 
Methanol: 1.0% aqueous TX-lOO : glacial acetic acid 
Ethanol: 1.0% aqueous CTAB : glacial acetic acid 
Propanol: 1.0% aqueous CTAB : glacial acetic acid 
Butanol: 1.0% aqueous CTAB : glacial acetic acid 
Ratio 
(4:5:1) . 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) • 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
a = the leveled specific gravity of glacial acetic acid and methanol were 1.048 and 
791.30 g/cc respectively 
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Table 5.2: Mobility of drugs on silica gel H layers developed with water containing 
(Mo) and surfactant mediated mobile phase systems (M1-M15) 
Mobile phase 
(M) 
Mo 
Ml 
M2 
M3 
M4 
Ms 
Mfi 
M7 
Ms 
M9 
Mio 
Mn 
M12 
M,3 
M,4 
M,5 
RF values 
Paracetamol 
0.56 
0.68 
0.70 
0.77 
0.81 
0.52 
0.46 
0.39 
0.33 
0.60 
0.68 
0.71 
0.76 
0.72 
0.68 
0.59 
Diclofenac Sodium 
0.13 
0.19 
0.24 
0.27 
0.32 
0.12 
0.07 
0.05 
0.00 
0.15 
0.17 
0.22 
0.23 
0.24 
0.18 
0.15 
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Table 5.3: Effect of change of drug plj on their mobility (Rp) through silica gel H 
layers developed with mobile phase M4 and Mg 
pH of drug solutions 
9.2 
4.0 
2.4 
Paracetamol 
M4 
0.80 
0.76 
ND 
Ms 
0.35 
0.31 
ND 
Diclofenac Sodium 
M4 
0.30 
0.33 
ND 
Ms 
0.00 
0.03 
ND 
ND = Not determined 
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Table 5.4: Effect of sunlight on the mobility (Rp value) of drugs on silica gel H 
layers developed with mobile phase M+and Mg 
Exposure time (hr) 
00 
24 
48 
Paracetamol 
M4 
0.79 
0.76 
0.72 
Ms 
0.33 
0.28 
0.24 
Diclofenac Sodium 
M4 
0.32 
0.29 
0.26 
Ms 
0.04 
0.00 
0.00 
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Table 5.5: Effect of storage temperature on the mobility (Rp value) of drug solutions 
through silica gel 'H' layers developed with mobile phase N^and Ms 
Temperature ("Ci 2) 
10 
20 
30 
40 
Paracetamol 
M4 
0.79 
0.81 
0.83 
ND 
Ms 
0.30 
0.34 
0.37 
ND 
Diclofenac Sodium 
M4 
0.30 
0.32 
0.39 
ND 
Ms 
0.00 
0.04 
0.05 
ND 
ND = Not detected 
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Fig. 5.1: Chromatogram showing the resolution of co-existing mixture of diclofenac 
sodium (Ds) and paracetamol (Pa) on silica gel 'H' layers using M4 
solvent system as-
(a) Mixture of two tablets (diclofenac sodium & paracetamol) 
(b) Formulation containing both diclofenac and parcetamol 
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Fig. 5.2: Chromatogram showing the resolution of diclofenac sodium (Ds) from 
formulated drug (A) and from human urine sample (B) on silica 'H' layers 
using M4 solvent system 
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6.1 INTRODUCTION 
Cephalosporins structurally differ from penicillin's by the heterocyclic ring 
system. Cephalosporins are pencillinase resistance antibiotics with significant activity 
against both gram-positive and gram-negative bacteria. They are among the safest and the 
most effective broad spectrum bactericidal antimicrobial agents, therefore they are the 
most prescribed of all the available antibiotics [1, 2]. Because of the high therapeutic 
importance of cephalosporins several analytical techniques have been used for their 
analysis such as, titrimetric [3, 4], High performance liquid chromatography [5], 
Voltametric [6], Spectrophotometry [7, 8] Mass-spectrophotomtery [9]. The most of 
these analytical methods required expensive and sophisticated instruments. This report is 
an attempt in the direction of developing a simple and reliable method for on plate 
identification and separation of cephalosporins in pharmaceutical formulations. Amongst 
all chromatographic techniques, thin layer chromatography (TLC) has been the most 
popular for routine analysis due to its simplicity of use, simultaneous analysis of large 
number of samples, use of specific and colorful reactions, the possibility of two-
dimensional separation and easier manipulation of stationary and mobile phases. The aim 
of this study was to develop a new chromatographic system by impregnating silica gel 
with solutions of surfactants. In this report we have utilized the versatile amphiphotheric 
nature of surfactants in the impregnation of silica layers. It is reported that the 
preliminary impregnation of the adsorbent with surfactant solutions leads to the change in 
elution order and their behavior was observed in the impregnation of both normal and 
reversed stationary phase. The separation of primary aliphatic and aromatic mono- and 
polyamines [9-11], amino acids [12] peptides and dipeptides [13, 14] have been 
sucessfuly achived on surfactant impregnated silica gel layers. The introduction of 
surfactant into the stationary phase leads to dynamic modifications in the stationary 
phase. According to the literature survey, previously Cephalosporins were analyzed by 
various TLC methods on silica gel layers [15, 16] but the use of methanolic surfactant 
modified stationary phase is lacking. 
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6.2 EXPERIMENTAL 
Instrumentation and reagents 
A TLC applicator (Toshiwal India) and pH meter Eiico India Ltd was used. 
Chemical required like silica Gel 'H', Sodium dodecyl sulfate (SDS), N-cetyl-N, N, N-
trimethylammonium bromide (CTAB), Methanol, were purchased from Merck India, 
Iodine crystals. Glacial acetic acid. Boric acid, Phosphoric acid and Sodium hydroxide 
were obtained from CDH India, 
Samples (Cephalosporins) (Fig. 1) 
Cefaclor, Ceftriaxone, Cefaperozone, Cefadroxil and Cephalexin (pure & 
formulated) were from Lupin labs, Mandideep, M.P., India as a gift samples. 
General procedure 
Preparation of Test Solution 
The drug powder (250 mg) was transferred into a 50 mL standard volumetric 
flask and then 25 mL methanol was added and the resulting mixture was sonicated for 40 
mins. The solution was filtered through Whatman filter paper (No. 41) and the residue 
obtained was washed again with methanol. The total filtrate was transferred in a 50 mL 
standard volumetric flask and made-up to the mark with methanol. This solution contains 
5 mg/mL (w/v) of drug. 
Detector: Iodine Vapors were used as detector 
Stationary Phase: The following (Table 1) stationary phases were used for the 
chromatography 
Mobile phase: The solvent systems were used (Table 2) as mobile phases for 
chromatography of all the drugs. 
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Chromatography 
(a) Preparation of TLC plates 
The TLC plates were prepared by mixing silica gel G with double distilled water 
in 1:3 ratios by weight with constant shaking to obtain homogeneous slurry. The resultant 
slurry was applied on the glass plates with the help of a manual applicator to give a 0.25 
mm-thick layer. The plates were dried at room temperature and then activated at 100 ± 2 
°C by heating in an electrically controlled oven for one hr. The activated plates were 
stored in a close chamber at room temperature until used. 
(b) Chromatographic procedure 
Test solutions (10 |iL) were applied on (15 x 3 cm) silica gel thin layer plates 
with the help of micropipette at about 2 cm above the lower edge of the plates. The 
solvent ascent was fixed to 10 cm in all cases for the determination of Rp values of all 
individual drugs. Linear ascending development was carried out in a vapor equilibrated 
TLC twin trough chamber. The optimized chamber saturation time for the mobile phase 
was 15 min at room temperature (25 ± 1°C). Subsequent to the development, TLC plates 
were dried at room temperature. The plates were then detected by using iodine vapors 
and all the drugs are visualized as colored spots. The Rp values of drug were determined 
by the 
following relation -
RF = 0.5(RL + RT) 
where RL = Rp of leading front. 
RT = Rp of trailing front. 
Separation 
For the separation, equal amount of drugs to be separated were mixed [A 
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(Cefaclor, Ceftriaxone and Cefadroxil), B (Ceftriaxone, Ceft)prazone and Cephalexin) 
and C (Cefaclor, Ceftriaxone and Cephalexin)] and lOfiL of the analyte from the resultant 
mixtures were loaded on CTAB impregnated TLC plates (Sio). The plates were 
developed with different solvent systems (Mi, M2 and M3 for A, B and C mixtures 
respectively) and the spots were detected and the Rp values of the separated drugs were 
determined. 
Interference 
For investigating the interference of various organic and inorganic compounds 
like sodium and potassium salts, urea and glucose on the identification and mobility of all 
the five cephalosporins studied, an aliquot (10 |JL) of all drugs were spotted on CTAB 
impregnated TLC plates (Sio) followed by spotting of 10 ^L of the interfering species (1 
mg/mL) on the same spot. The chromatography was performed with solvent system Mi 
on CTAB impregnated silica layers (Sio). The spots were detected and the Rp values of 
drugs were calculated and compared. 
6.3 RESULTS AND DISCUSSION 
The chromatography of cephalosporin was performed on various stationary phases 
impregnated with cationic and anionic surfactants at different concentrations. The various 
buffer systems were also used as solvent systems. The buffer system having pH 3.15 (Mi) 
was first used with all the stationary phases in order to select the most usefiil 
chromatographic system for the identification and separation of Cephalosporin. The 
results of the present study are presented in Table 3. The following conclusions are 
drawn from the results. 
1. On silica surface (unimpregnated) the Cefaclor and Cefaprozone are not detected 
while Ceftriaxone and Cefadroxil show tailed spots and Cephalexin remains at the 
point of application. 
2. In case of SDS impregnated silica layers (S2 - Se), the mobility of Cefaclor, 
Cefadroxil and Cephalexin increases with the increase in concentration of SDS as 
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an impregnant, while the mobility of Cefatriaxone decreases and also 
Cefoperazone remains at the point of application. 
3. On CTAB impregnated silica layers (Sr-Sn), the mobility of all the 
Cephalosporins increases with the increase in the concentration of CTAB as an 
impregnant. 
It is clear from the results that the lower Rp values are observed for all the 
Cephalosporins on SDS impregnated silica layers as compared to CTAB impregnated 
layers except Ceftriaxone where the reverse trend was observed. This may be due to the 
electrostatic interactions between the SDS and the Cephalosporins. This situation is 
caused because SDS is impregnated on negatively charged silica via the hydrophobic 
group and its negatively charged hydrophilic group is oriented away from the surface. As 
compared to SDS, CTAB is impregnated on negatively charged silica via positively 
charged head group and its hydrophobic group is oriented away from the surface. On the 
other hand, the acidic buffer solvent systems show significant interactions with all the 
drugs on CTAB impregnated layers as compared to SDS impregnated layers. The 
significant influence of solvent system Mi on the stationary phase Sio (Si Impregnated 
with 4 % MeOH solution of CTAB) results in the beneficial mobilitys of all the 
cephalosporins and high compactness and high visibility of spots. The mutual separation 
possibility of Cephalosporins also increases on the stationary phase Sio. The stationary 
phase Sio (Si Impregnated with 4 % MeOH solution of CTAB) was used for the 
further study. Different buffer systems were used as eluents for the chromatography of 
Cephalosporins on the stationary phase Sio. The results are presented in Table 4. From 
the point of chromatographic conditions all the Cephalosporins provide efficient results 
in the acidic buffer solvent systems as compared to the alkaline buffer solvent systems. 
This might be due to the presence of Na "^  ion in Cephalosporins which facilitates the 
release of an electron, leading to the formation of a polar compound. In acidic medium it 
was possible to resolve three combinations of Cephalosporins (Table 5) such as: (a) 
Cefaclor, Ceftriaxone and Cefadroxil, (b) Cefaclor, Ceftriaxone and Cephalexin (c) 
Ceftriaxone, Cefaprozone and Cephalexin in the solvent systems Mi, M2 and M3 
respectively. These separations are not possible in the alkaline buffer solvent systems. 
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The results of the influence of interfacing species on the chromatography of 
Cephalosporins on stationary phase Sio developed with solvent system Mi are presented 
in Table 6. It is clear from the results that in NaCl as KCl as interfering species, 
ceftriaxone and cefadroxil show tailed spots while all other three drugs are not greatly 
influenced by their presence. In urea, all the cephalosporins are not detected. In case of 
glucose as an interfering species cefaclore and cefadroxil show tailed spots while all 
other three drugs are not detected. Therefore, it is concluded that the presence of these 
interfering species greatly influence the chromatography of Cephalosporins. 
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Table 6.1: Stationary phase 
Code 
Si 
S2 
S3 
S4 
S5 
Se 
S7 
Sg 
S9 
Sio 
SM 
Composition 
Silica gel G 
Si Impregnated with 0.1% MeOH solution of SDS 
Si Impregnated with l%MeOH solution of SDS 
Si Impregnated with 2 % MeOH solution of SDS 
Si Impregnated with 4 % MeOH solution of SDS 
Si Impregnated with 7 % MeOH solution of SDS 
Si Impregnated with 0.1% MeOH solution of CTAB 
Si Impregnated with 1 % MeOH solution of CTAB 
Si Impregnated with 2 % MeOH solution of CTAB 
Si Impregnated with 4 % MeOH solution of CTAB 
Si Impregnated with 7 % MeOH solution of CTAB 
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Table 6.2: Mobile phases 
Code 
M, 
M2 
M3 
M4 
M5 
Composition 
Citrate buffer (0.2M citric acid + 0.2 M NaOH) pH 3.15 
Citrate buffer (0.2M citric acid + 0.2 M NaOH) pH 4.05 
Citrate buffer (0.2M citric acid + 0.2 M NaOH) pH 5.05 
Borate buffer (0.2M boric acid + 0.2 M NaOH) pH 9.10 
* 
Borate buffer (0.2M boric acid + 0.2 M NaOH) pH 10.03 
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Table 6.4: RF value of cephalosporin's developed with CTAB impregnated silica 
layers (Sio) using different buffer solvent systems 
Drugs 
Cefaclor 
Ceftriaxone 
Cefadroxil 
Cefaprozone 
Cephalexin 
Solvent Systems 
M, 
0.86 
0.14 
0.71 
0.04 
0.67 
Mz 
0.76 
0.00 
0.00 
0.00 
0.11 
Ms 
0.81 
0.00 
0.76 
0.31 
0.70 
M, 
0.92 
0.14 
0.41 
0.43 
0.91 
Ms 
0.97 
0.36 
0.36 
0.43 
0.43 
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Table 6.5: Separations (Rp values) of different cephalosporins achieved from their 
mixtures on CTAB impregnated silica layers (Sio) using v^ ith different solvent 
systems 
Mobile Phase 
M, 
M3 
M2 
Drug Mixture 
A 
B 
C 
Cefaclor (0.91) 
Ceftriaxone(O.OO) 
Cefaclor (0.79) 
Ceftriaxone (0.09) 
Cefaprozone (0.37) 
Ceftriaxone(O.OO) 
Cefadroxil (0.66) 
Cephalexin (0.81) 
Cephalexin (0.17) 
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Table 6.6: Effect of various organic and inorganic impurities on the mobility (Rp) 
of different cephalosporins on silica gel layers (Sio) developed with Solvent System 
M, 
Impurity 
NaCl 
KCI 
Urea 
Glucose 
Drugs 
Cefaclor 
0.84 
0.81 
ND 
(T) 
Ceftriaxone 
0.11(1) 
0.09 (T) 
ND 
ND 
Cefadroxil 
0.72 (T) 
0.74 (T) 
ND 
(T) 
Cefaprozone 
0.00 
0.14 
ND 
ND 
Cephalexin 
0.66 
0.67 
ND 
ND 
ND = Not detected 
T = Trailing 
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COOH 
Fig. 1: Structure of cephalosporin 
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7.1 INTRODUCTION 
Ketoprofen [RS-2-(3-ben2oyl- phenyl) propionic acid], is a non steroidal anti-
inflammatory drug [1]. It is used in musculoskeletal, joint disorders, dysmenorrheal, 
postoperative pains and gouts [2]. Ketoprofen has been analysed by different techniques 
viz: HPLC [3, 4], HPFA [5], GCMS [6, 7] and spectrophotometry [8] But these 
techniques require highly specified analytical samples, due to which these techniques are 
not found too appropriate in the analysis of drugs from biological samples [9]. 
Thin layer chromatography (TLC) enables a simple fast and effective separation 
of the complex mixtures present in various biological samples enzymes [10], porphyrins 
[11], alkaloid and drugs [12] from urine samples. Surfactant-modified thin layer 
chromatography (TLC) has found wider applications in separation studies [13-16]. It 
provides enhanced selectivity as a result of difference in the degree of binding of 
separated mixture components with mobile and stationary phases. The selective 
solubilization of mixture components with micelles is caused by complex electrostatic, 
hydrophobic, donor-acceptor and polarization interactions. All types of surfactants 
(cationic, anionic and nonionic) have been used in the mobile phase for the successful 
separation of vitamins [17], amino acids [18]. TLC proved its applicability during 
successful separation of bio-active amines, penicillin's and steroids [19], 
Recently the usefulness of mixed surfactants systems containing ionic - nonionics 
or mixed-ionic micelles has been realized by physical chemists [20, 21]. Mixed 
surfactants often exhibit synergism in their physicochemical properties and sometimes 
offer superior performance compared to the pure surfactant components. Thus the 
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coupling of anionic and nonionic surfactants will provide a novel thin layer 
chromatographic system for excellent resolution of ketoprofln from human urine as well 
as drug formulations. The human urine analysis for identification of selected drugs and 
their metabolites has emerged as an important investigation tool in forensic drug analysis 
[22]. This report is an attempt in the direction of developing a simple and reliable method 
for on plate identification and quantification of ketoprofen in pharmaceutical 
formulations as well as from human urine samples, for this purpose, several approaches 
have been adopted to develop new sorbent phases to realize a desired separation with a 
particular mobile phase. Bhushan and Parshad, [23] have achieved separation of two 
isomers of ketoprofen from drug samples on silica gel layers impregnated with L-
arginine. Literature survey revealed that no information is available on the use of 
differentially charged amino acids impregnated silica gel layers with mixed micellar 
solvent systems for analysis of ketoprofen from formulated and spiked human urine 
samples. On the basis of above facts it was considered worthwhile to study identification 
of ketoprofen from pharmaceutical formulation and spiked human urine samples. A novel 
and quick high-perfprmance liquid chromatography (HPLC) method was employed for 
the determination of ketoprofen in formulated drug and spiked human urine samples 
7.2 EXPERIMENTAL 
Apparatus 
A TLC applicator (Toshiwal, India) was used for coating silica gel on 20cmx 3cm 
glass plate. High Performance liquid chromatograph by Able & Jasco with PU-1580 
Pump, UV-1575 detecting module, Rheodyne injector, Neulosil 150 C-18, 5^m, 150x4.6 
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mm chromatographic column. A glass sprayer was used to locate the position of spot of 
analyte. A pH meter (Elico, India) was used. 
Chemical and Reagents 
Silica Gel 'G', t- octyl phenoxydacaethoxy ethanol (TX-lOO), sodium dodecyl 
sulfate (SDS), methanol, ethanol, K4FeCN6, FeCI} and acetonitrile (HPLC-grade) were 
obtained from Merck Reagents, Mumbai, India. Iodine, isoamyl-alcohol and ethylene 
dichloride were from CDH India. Ketoprofen (Fig. 1) pure and formulation were from 
Lark Labs, Bihwadi, India. 
Preparation of Test Solution 
Ten tablets equivalent to 50 mg of the ketoprofen were powdered and transformed 
into a 50 mL standard flask and dissolved with 50 mL of acetonitrile I followed by 
stirring. The solution was filtered with Wattman No. 41 and the volume was make upto 
mark with acetonitrile. The solution contains Img/ mL of drug. 
Extraction of ketoprofen from human urine samples 
Preparation of spiked drug urine samples -
A sample of Urine was taken from a healthy person. Take 50 mL of this urine 
sample and adjusted to pH 7-8 with 2% bicarbonate solution. Add 50 mg of ketoprofen 
drug powder to the urine sample. The resulting mixture was kept for shaking (20 
minutes) at room temperature (15 - 20°C) for achieving complete dissolution of drug in 
urine. 
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Isolation of drug from spiked drug urine samples 
The 50 ml of spiked urine sample was filtered with whatman filter paper (No-41) 
and then the filtrate was mixed with 200 mL of ethylene dichloride containing 10%. of 
isoamyl alcohol and 10 % diethyl ether which was kept for shaking for 15 min. After this 
the organic layer was separated and evaporated to obtain ketoprofen drug as residue. The 
residue was diluted with 50 ml acetonitrile. The chromatography of the extracted drug 
(ketoprofen) was performed on best proved chromatographic system and the Rp value of 
ketoprofen from urine Is compared with Rp value of pure ketoprofen drug. 
Chromatography 
Mobile phases 
The following solvent systems (Table 1) were used for the chromatography. 
Stationary phase 
The following (Table 2) were used as a stationary phases. 
Detector 
Mixture of 5% aqueous solution of IQFeCNe and FeCb (1:1, v/v/) were used as 
detector. 
Preparation of TLC plates 
(a) Plain Silica gel TLC plates-
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The TLC plates were prepared by mixing silica gel G with double distilled water 
in 1:3 ratio by weight with constant shaking to obtain homogeneous slurry. The resultant 
slurry was applied on the glass plates with the help of a manual applicator to give a 0.25 
mm-thick layer. The plates were dried at room temperature and then activated at 100 ± 2 
°C by heating in an electrically controlled oven for one hr. The activated plates were 
stored in a close chamber at room temperature until used, 
(b) Amino acid impregnated TLC plates: 
Impregnated TLC plates were prepared by mixing silica gel with aqueous amino 
acids solution in 1:3 ratios with constant stirring until homogeneous slurry was obtained. 
Thin layers of resultant slurry were prepared by following the method as described in 
above section (a). 
Chromatographic procedure 
Test solutions (10 |iL) were applied on (15 x 3 cm) silica gel G thin layer plates 
with the help of micropipette at about 2 cm above the lower edge of the plates. The 
solvent ascent was fixed to 10 cm in all cases for the determination of RF values of all 
individual drugs. Linear ascending development was carried out in a vapor equilibrated 
TLC twin trough chamber. The optimized chamber saturation time for the mobile phase 
was 15 min at room temperature (25 ± 1°C). Subsequent to the development, TLC plates 
were dried at room temperature. The plates were then detected by using iodine vapors 
and dragondroff solution as chromogenic reagents and the drugs is visualized as colored 
spots. The RF values of drug were determined by the 
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Following relation -
RF = 0.5(RL + RT) 
Where RL = Rp of leading front. 
RT = Rp of trailing front. 
Interference 
For investigating the interference of various organic and inorganic metabolites 
like sodium and potassium salts, urea, liquor ammonia nitrate and glucose normally 
found in human urine samples, on ketoprofen were studied. An aliquot (5 |iL) of drug 
were spotted on silica gel TLC plate followed by spotting of 5nL of the interfering 
species (Img/mL) on the same spot. The chromatography was performed on amino acid 
impregnated silica gel layer (S3) with solvent system M14. The spots were detected and 
the Rp values of drug were calculated and compared. 
Quantitative determination of ketoprofen from spiked human urine samples 
The HPLC technique was applied for the quantitative determination of on plate 
identified ketoprofen drug from spiked human urine samples. For this purpose 10 nL of 
ketoprofen solutions of different concentration (10-30 |ig) were spotted on TLC plates. 
After complete drying of the spots, the TLC plates were developed with solvent system 
MM At the same time, a pilot plate was also run simultaneously to locate the position of 
spot. After development the area corresponding to spot was scarped from the plate. The 
scraped silica powder was mixed with 2 mL of acetonitrile for the extraction of 
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ketoprofen from adsorbent. After that, it was filtered with Whatman filter paper no-41. In 
order to ensure complete extraction of drug the adsorbent was again washed with 3 mL of 
acetonitirile. All the filtrate was collected in a test tube and analyzed at >,=270 nm with 
mobile phase comprising of acetonitrile: double distilled water: acetic acid (1:1:1) by 
HPLC. A calibration curve was plotted between the Peak area vs Concentration of 
ketoprofen drug. The content of ketoprofen in the formulated and urine spiked samples 
was determined from the standard curve by five replicate readings under similaf 
conditions. 
7.3 RESULTS AND DISCUSSION 
The results obtained are summarized in Tables 7.1-7.2. Initially the mobility of 
Ketoprofen was examined on plain silica gel G layers with different concentrations of 
aqueous solutions of anionic (SDS), nonionic (TX-lOO) and anionic-nonionic mixed 
surfactants as mobile phases. The selected best proved mobile phase were utilized for 
optimization of experimental conditions on the basis of mobility of ketoprofen with 
various factors, such as charge and concentration of amino acids used as impregnates of 
stationary phase, nature and concentration of added alkanols, acetone and weak acid in 
the micellar mobile phases and interference effect due to various organic and inorganic 
metabolites normally found in urine samples. 
Effect of type and concentration of surfactants 
The chromatography of ketoprofen was performed on Si plain silica gel layers 
using distilled water and aqueous solutions of anionic, nonionic and mixed surfactants as 
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mobile phase systems (Mi- Mn). The results of the effect of type and concentration of 
different classes of surfactants are presented in Table 7.1. The following conclusions are 
drawn from the data listed in Table 7.1. 
(1) In double distilled water (zero concentration of surfactant), the drug ketoprofen 
was not detected 
(5) The mobility of ketoprofen decreases with the increase in concentration of SDS in 
the solvent systems. 
(6) Reverse trend was observed in case of TX-lOO as compared to SDS, the mobility 
of ketoprofen increases with the increase in concentration of TX-lOO in solvent 
system. 
(7) In case of mixed surfactant-mediated mobile phase systems (M9 - Mn), initially 
the mobility of ketoprofen increases with the increase in concentration of 
surfactant but on further increase in concentration causes a slight decrease in 
mobility for ketoprofen drug. 
It may be concluded from the present study that in case of SDS and TX-IOO, the 
ion-pair TLC situation is observed. Thus the mobile phase in this system contains only 
ions of a surfactant. An increase in their concentration in the mobile phase increases the 
concentration of surfactant ions adsorbed on the stationary phase. As a result the retention 
of adsorbates increases [24]. 
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Effects of different solvent system modifiers 
The different alcohols (methanol and ethanol) were added to 0.5% mixed aqueous 
SDS and TX-lOO mobile phases (Mio) for the chromatography of ketoprofen on plain 
silica gel layer. From the results presented in Table 1, it is clear that the presence of 
traces of alcohol in mixed micellar mobile phase increases the mobility of ketoprofen 
drug but mobility decreases with increase in the chain length of alcohols. This may be 
due to the fact that addition of alcohols in the micellar solvent systems may result in the 
less population of surfactants molecules on the adsorbent and this may provide some free 
silanol groups on the silica surface for the adsorption of ketoprofen [25]. This may cause 
the increase in the retention of ketoprofen on the silica surface and hence decreases the 
mobility. 
From Table 7.1 and Fig. 7.2, it is clearly concluded that acetone containing 
mixed aqueous surfactant solvent system (MM) offers better chromatographic 
performance by providing more compact and well defined spots for ketoprofen drug at 
optimum RF range (0.62). Thus it is selected as the optimum mobile phase for further 
studies on ketoprofen drug. 
Effect of type and concentration of amino acids used as impregnants 
In order to investigate variation in mobility pattern during chromatography of 
ketoprofen drug was performed on variably charged amino acids (alanine, arginine and 
glutamate) modified silica gel G layers (S2-S10) developed with MM solvent system. 
The results summarized in Table- 2, shows that-
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(1) When L-arginine was used as an impregnant, a diffused and compact spot of 
ketoprofen drug was observed. This may be due to partial conversion of surface 
silianols to a new organic functional surface that acquires organophillic properties 
which enhances the surface adsorption.[26] 
(2) In case of glutamte impregnated silica gel layers no spot was detected for 
ketoprofen drug 
(3) No mobility was observed for ketoprofen drug when alanine impregnated silica 
gel layers were used during chromatography. 
Identification of ketoprofen in presence of impurities 
To widen the applicability of the developed TLC system (amino acid impregnated 
silica gel layer (S3) with 0.5% mixed aqueous SDS and TX-lOO mobile phases (MM) for 
identification and isolation of ketoprofen from formulated drug and urine samples in 
presence of various metabolites normally found in urine are presented in Table-7.3. It is 
clear that sodium and potassium salts do not affects the mobility of drug, but in case of 
urea and liquor ammonia a long trailing spot was observed. In case of nitrate and glucose 
no spot was detected possibly due to complex formation with drug. 
. Identification of ketoprofen from human urine samples 
The proposed chromatographic method (arginine impregnated silica gel layers 
(S3) with 0.5% mixed aqueous SDS and TX-lOO mobile phases (MM), successfully 
identified the ketoprofen drug extracted from the human urine samples on the basis of RF 
value. The spots of the formulated and the urine extracted ketoprofen samples are shown 
213 
in Fig. 7.2. Thus the proposed method is very sensitive for the identification of 
ketoprofen from urine samples. 
TLC-HPLC of ketoprofen: 
The analytical parameters for the HPLC determination of-ketoprofen by the 
proposed method are given in Table 4. The linear response of the detector obtained for 
the concentrations are between 0.1 and 0.005 mg/mL, with a correlation coefficient of 
0.9997. These values suggested that the proposed method is very sensitive for the 
determination of ketoprofen from formulation as well as spiked urine samples. The 
accuracy and validity of the proposed method were ascertained by performing recovery 
studies. The recovery studies of pure, formulated and urine spiked ketoprofen samples at 
different concentrations indicates that the recovery was good. The percentage recovery 
values were found in the range 97.0 -100.2 % with relative standard deviation of less than 
2%. 
214 
TableV.l: Rp value of ketoprofen on silica gel G layers developed with mobile phases 
Ml- M20 
Code 
M, 
M2 
M3 
M4 
Ms 
Me 
Mg 
M9 
Mio 
Mn 
M12 
M,4 
M,5 
M,6 
M,7 
M18 
M20 
M21 
Mobile phase 
Double distilled water 
0.2% Aqueous SDS 
0.5% Aqueous SDS 
1.0% Aqueous SDS 
0.2% Aqueous TX-100 
0.5% Aqueous TX-100 
1.0% Aqueous TX-100 
M2+M5(l:l) 
M3 + M6(l:l) 
M4+M8(l:l) 
M10+Acetone (9:1) 
M|o+Acetone (8.5:1.5) 
M|o+Acetone (8:2) 
M10+Methanol (9.5:0.5) 
M10+ Ethanol (9.5:0.5) 
M10+Formic acid (9.5:0.5) 
M10+Acetic acid (9.0.5:0.5) 
Mio+Formamide (9.5:0.5) 
Ketoprofen pure 
ND 
ND 
0.43(T) 
0.40 (T) 
0.56 (T) 
0.61 
0.64 
0.66 
0.69 
0.73 
0.59 
0.62 
0.64 
0.75 
0.79 
0.57 (T) 
ND 
0.39 (T) 
[IF value 
Ketoprofen fomulation 
ND 
ND 
0.44 (T) 
0.38 (T) 
0.59(T) 
0.60 
0.62 
0.64 
0.69 
0.75 
0.57 
0.63 
0.68 
0.71 
0.80 
0.58 (T) 
ND 
0.41 (T) 
ND = Not detected 
T - Trailing 
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Table 7.2: Rp value of ketoprofen on silica gel layers (Si-Sio) developed vi^ ith mobile 
phases MM 
Code 
SI 
S2 
S3 
S4 
Ss 
S6 
S7 
Ss 
S9 
Sio 
Stationary phase 
Plain silica gel 'G' 
Silica gel 'G' slurry in 0.2% arginine 
Silica gel 'G' slurry in 0.6% arginine 
Silica gel 'G' slurry in 1.0%) arginine 
Silica gel 'G' slurry in 0.2%) alanine 
Silica gel 'G' slurry in 0.6% alanine 
Silica gel 'G' slurry in 1.0%) alanine 
Silica gel 'G' slurry in 0.2%) glutamate 
Silica gel 'G' slurry in 0.6%) glutamate 
Silica gel 'G' slurry in 1.0%) glutamate 
Ketoprofen pure 
0.63 
0.57 
0.61 
0.64 
0.06 (T) 
0.00 
0.00 
ND 
ND 
ND 
F^ value 
Ketoprofen formulation 
0.59 
0.61 
0.63 
0.60 
0.02 
0.00 
0.00 
ND 
ND 
ND 
ND - Not detected 
T = Trailing 
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Table 7.3: Effect various organic and inorganic metabolites found in urine on 
mobility (Rp) of l<etoprofen drug 
Impurity 
NaCl 
KCl 
Urea 
Liquor Ammonia 
Nitrate 
Glucose 
Rp value 
0.61 
0.63 
0.66 (T) 
0.69 (T) 
ND 
ND 
T = Trailing 
ND - Not detected 
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Table 7.4: Statical data for HPLC analysis of ketoprofen drug 
Limit of detection (mg/mL)- 0.00003 
Limit of quantification (mg/mL)- 0.00056 
Recovery 
(1) Formulation 
(2) Urine sample 
Amount taken 
0.004 
0.04 
Concentration of Ketoprofen 
(mg/mL) 
0.005 
0.01 
0.02 
0.05 
0.1 
Amount found 
0.0397 
0.0379 
Percent 
99.25 
94.75 
Peak area (mAU/ sec) 
551918 
1116049 
2300671 
5585673 
11142927 
RE 
0.37 
0.62 
RSD % 
0.60 
0.86 
0.46 
0.82 
0.66 
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Fig. 7.1: Structure of ketoprofen 
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Fig. 7.2: Chromatogram showing identification of ketoprofen in formulated and 
spiked urine samples on silica gel layers (Si- S?) developed with mobile 
phase Mi4 
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The chromatography of five co-admmistered drugs i e parcetamol, ibuprofen, diclofenac sodium, aspinn and ascorbic 
acid was performed on vanous reversed phase layers The surfactant mediated solvent systems were used with various 
impregnated silica gel H layers for the chromatography of these five drugs The various experimental conditions were 
optimized for the selection of optimum concentration of impreganants The mutual separation of a mixture of paracetamol, 
diclofenac sodium and ibuprofen, and paracetamol, aspirin and ascorbic acid are achieved on various impregnated silica gel 
H layers, using surfactant mediated solvent systems containing /i-hexane 1% CTAB in MeOH ethyl acetate acetic acid, 
(13 1 4 2, v/v) and toluene 1% CTAB in MeOH n-propanol formic acid, (14 1 3 2, v/v) respectively 
Keywords Thin layer chromatography. Paracetamol, Diclofenac sodium, Ibuprofen, Aspirin and Ascorbic acid 
Thin layer chromatography (TLC) is the simplest and 
conveiuent analytical technique for identification and 
separation of several pharmaceutical products and 
])ermits separation by mampulation of mobile and 
stationary phases As a result, numerous stationary 
and mobile phases ha\ e been developed for achieving 
improved chromatographic performance of drugs in 
terms of selectivity, resolution, rapidity and 
reproducibility' ^ Paracetamol (Fig 1), ibuprofen 
(Fig 2), diclofenac sodium (Fig 3) and aspinn 
(Fig 4) are the most widely recommended co-
admimstered analgesic and antipyretic drugs'*^ while 
vitamin C (ascorbic acid) (Fig 5) works as a cofactor 
in numerous amidation and hydroxylation reactions of 
body Analysis of paracetamol, diclofenac sodium, 
ibuprofen, aspinn and.ascorbic acid by thin layer 
chromatography have been investigated by some 
researchers** Reversed phase TLC offers distinct 
advantages such as organization of the hydrocarbon 
ligands on the silica surfaces, interaction of solvent 
into the bonded layers, and the activity of residual 
silanols on the solid support''° Reversed phase TLC 
has shown remarkable analytical potential dunng 
identification and separation of transition metal 
cations" '^  Literature survey reveals that, not much 
information is available on reversed phase TLC for 
identification and mutual separation of co-
administrated drugs (paracetamol, diclofenac sodium, 
ibuprofen, aspirin and ascorbic acid) using surfactant 
mediated mobile phases Keeping m view of the 
excellent capability of reversed phase TLC towards 
pharmaceuticals espec.ally the surface active 
pharmaceutical molecules'' '^ it is considered 
worthwhile to study the selective identification and 
mutual separation of above-mentioned drugs on sihca 
gel H layers, impregnated with different 
concentrations of tert-butyl phosphate, tert-butyl 
amine, paraffin and silicone oil, in the presence of 
surfactant mediated mobile phase systems 
Experimental Procedure 
Apparatus 
A TLC applicator was used for coating silica gel on 
glass plates (18x3 5 cm) The chromatography was 
performed in the glass jars (24 x 6 cm) Iodine gas 
chamber was used to locate the position of the spot of 
analyte 
Chemicals and Reagents 
The following chemicals were used in the 
expenments paraffin oil, tnbutyl phosphate (TBP), 
tnbutyl amine (TBA), silicone oil, N-cety\-N, N, 
A -^tnmethyl ammomum brormde (CTAB) and iodine 
(All CDH, Delhi, India), silica gel H, acetone, formic 
*Correspondent author 
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dLiu dad glatiai aceuc a i^il (Men^k, muiiibai, Liuia), vvcic dipped u" abo'vC prcpar 
methanol (MeOH), ethyl acetate and hexane 
(Qualigen Chemicals, Mumbai, India), paracetamol ' 
(Paracip, Cipla, Mumbai, hndia), diclofenac sodium 
(Voveran, Emcure Pharma, Gujrat, India), ibuprofen 
(Ibugesic, Cipla, Mumbai, India), aspirin (Disprin, 
Reckitt benckiser, India) and ascorbic acid (Celin, 
G S K, Mumbai, India) All the chemicals and 
reagents used were of Analar grade 
Test solutions 
The five tablets of each drug weighed and finely 
powdered The drug powder (250 mg) was transferred 
into a 50 mL standard volumetric flask and then 
25 mL methanol was added and the resulting mixture 
was sonicated for 40 nun The solution was filtered 
through whatman filter paper (No 41) and the residue 
obtained was washed again with methanol The total 
filtrate was transferred m a 50 mL standard 
volumetnc flask and made-up to the mark with 
methanol This solution contains 5 mg/mL (vv/v) of 
drug 
Detection reagent 
Iodine vapors were used for the detection of all the 
five drugs Different coloured spots were detected as 
follows Paracetamol (black brown), ibuprofen 
(brown), ascorbic acid (yellow), diclofenac sodium 
(light brown) and aspinn (sunset yellow) 
Chromatography 
The details of various stationary phases and mobile 
phases used in the study are given in Table 1 
Preparation of TLClayers 
(a) Plain silica gel H Plates Silica gel H plates 
were prepared by mixing silica gel H with double 
distilled water in 1 3 ratio (w/v) The resultant slurry 
was mechanically shaken for 10 mm, after which it 
was applied to well clean glass plates with the help 
of TLC applicator to give a layer of approximately 
0 25 mm thickness The plates were dried at 
room temperature and then activated by heating at 
100 ± r C for 1 h After activation, plates were stored 
in dessicator 
(b) Impregnated silica gel H plates Solutions of 
desired concentrations of impregnants, paraffin oil 
(1, 2, 5 and 8%), tributyl phosphate (5, 10, 15 and 
20%), tnbutyl amine (5, 10, 15 and 20%) and silicone 
oil (0 001, 0 01, 0 1 and 0 2%) were prepared in 
petroleum ether Afler that, plain silica gel H plates 
developed plates weie then activated by heating at 60 
± rC for 1 h 
Chromatogiapluc Procediiie 
Thin layer cliromatography was performed on 
unimpregnated and impregnated silica gel H layer 
plates Test solution (1 jiL) were applied on 
(15 X 3 cm) silica gel H impregnated and ummpre-
ganted thin layer plates with the help of micropipettes 
at about 2 cm above the lower edge of the plates The 
solvent ascent was fixed to 10 cm in all cases for the 
determination of Rf values of all individual drugs 
Linear ascending development was earned out in a 
vapor equilibrated TLC twin trough chamber The 
optimized chamber saturation time for the mobile 
phase was 15 mm at room temperature (25 ± TC) 
Subsequent to the development, TLC plates were 
dned at room temperature 
The spots were then detected by using iodine 
vapours and all the drugs were visualized as coloured 
spots The Rf value (retardation factor) of drugs were 
determined by the following relation 
Rf = 05{Ri + Rr) 
where Ri = 7?F of leading front and Rj - Rj: of trailing 
front 
Separation 
For separation, equal amount (5 mg/mL) of drugs 
(paracetamol, diclofenac sodium, and ibuprofen) and 
similarly the drugs (paracetamol, aspinn and ascorbic 
acid) were mixed to form two drug mixtures The 
resulting solution (0 01 mL) of each drug mixture was 
chromatographed on silica gel H impregnated layers 
using solvent systems Mi and M3 
Results and Discussion 
(a) Chromatography on surfactant modified solvent 
systems The reported Rp value of paracetamol, 
ibuprofen and diclofenac sodium are 0 50, 0 78 and 
0 36 respectively in the solvent system containing 
«-hexane + ethyl acetate + acetic acid (7 2 5 0 5, 
v/vf " Addition of 1% CTAB m MeOH to the above 
system (MQ) results in increase in mobility (Fig 6) of 
ibuprofen {Rp 0 81), whereas the mobility of 
paracetamol {Rf 0 46) and diclofenac sodium 
{Rr 0 20) decreases Similarly m the reported solvent 
system containing toluene + n-propanol + formic acid 
(5 04 01) the Rf: value of paracetamol, aspinn and 
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The addition of 1% CTAB in MeOIi in the above 
discussed solvent system (M2), results in increase of 
Rf value of aspirin (7?F 0.32) and ascorbic acid 
(/?F 0.14) (Fig. 7) whereas the R^ value of paracetamol 
(/?F 0.62) decreases. This alteration in R^ value of 
these drugs in the presence of surfactant in solvent 
systems, may be due to variable hydrophobic or 
hydrophilic interactions with these drugs. 
(b) Chromatography on silica gel H layers 
impregnated with different concentrations of Paraffin 
oil, TBP, TBA and Silicon oil as impregnanat: In 
order to find out the optimum concentration of 
paraffin oil, TBP, TBA and silicon oil as an 
impregnant. The drugs (paracetamol, diclofenac 
sodium, aspirin, ibuprofen and ascorbic acid) were 
chromatographed on silica gel H layers (S^ - Sig) 
impregnated with different concentrations (1, 2, 5 and 
8%) of paraffin oil, (2, 5, 10, 15 and 20%) of TBP, 
(5, 10, 15 and 20%) of TBA and (0.001, 0.01, 0.1 and 
0.2%) of silicon oil using M| and M2 as mobile 
phases. From Table 2, it is clear that with the increase 
in concentration of paraffin oil, TBP and TBA, there 
occurs a considerable decrease in the R^ value of all 
the five drugs as compared to R^ value of these drugs 
on unimpreganted silica gel H layers. While in case of 
silicon oil as an impregnant, an increase in R^ value of 
all the five drags is observed as compared to i?p 
values obtained on unimpregnated layers. The 
decrease in Rf value of all the five drugs on the silica 
gel H layers impregnated with paraffin oil, TBP, TBA 
and silicon oil indicates the strong partitioning of 
drugs with these impregnants. The increase in R^ 
value of all drugs on silica gel H layers impregnated 
with silicone oil indicates the weak partitioning of 
drugs with the impregnant (silicon oil). This weak 
portioning, of drugs in silicone oil may be due 
to the presence of long and complex silicone 
oxygen (siloxane) molecule" as compared to the 
other impregnants. 
The higher concentrations of all the four 
impregnants shows several draw backs, such as 
prolonged development time, poor detectidii, 
difficulty in plate drying and poor adhesion of 
modified silica to glass surfaces. Therefore, the 
concentrations of impregnants, 2% paraffin oil, 10% 
TBP, 10% TBA and 0.01% silicon oil were found to 
be the best for the chromatography of all five drugs, 
due to following advantages 
\i) lycii-i^uOii v-idiit^ 
(ii) Formation of compact spots 
(iii) Beneficial mobilities of drugs for mutual 
separation from their mixtures. 
It is also observed that the dmgs (aspirin and 
ascorbic acid), (diclofenac sodium and ibuprofen) are 
not detected in the solvent system Mi and M3, 
respectively. 
The positive A R^ value [i\R^ = R^ unimpregnated 
layer - Rf impregnated layer] of all the five drugs 
(paracetamol, diclofenac sodium, ibuprofen, aspirin 
and ascorbic acid) indicates the enhanced selectivity 
of silica gel H layers impregnated with paraffin oil 
[A y?F = 0.06 (Pa), A /?F = 0.08 (Ds), A i?F = 0.11 (lb), 
A 7?F = 0.05 (As), A /?F = 0.06 (Ac)] TBP [A R^. 0.02 
(Pa), A 7?F = 0.13(Ds), A i?F = 0.17 (lb), LR^ = 0.02 
(As), A i?F = 0.06 (Ac)] and TBA [A R^ = 0.05 (Pa), 
A 7?F = 0.06 (Ds), A 7?F = 0.18 (lb), A ^F = 0.01 (As), 
A 7?F = 0.1 (Ac)] for these drugs. The negative A/?F 
value [A R^ . -0.04 (Pa), A i?F = -0.08 (Ds), 
A /?F = -0.12 (lb), A ;?F = 0.04 (As), A i?F = 0.03 (Ac)] 
obtained on silicone oil impregnated layers shows 
weak interaction and low selectivity for these drugs. 
This mobility trend on silica gel H layers impregnated 
with optimum concentrations of paraffin oil, TBP, 
TBA and silicon oil are utilized for the mutual 
separation of drugs from their mixture (paracetamol, 
ibuprofen and diclofenac sodium) and (paracetamol, 
aspirin and ascorbic acid) using solvent systems 
Ml and M3. The resolutions of mixtures of drugs are 
shown in Figs 8 and 9. 
Conclusion 
The mutual separation of drugs (paracetamol, 
diclofenac sodium and ibuprofen) or (paracetamol, 
aspirin and ascorbic acid) was achieved on different 
impregnated silica layers with solvent system 
containing /i-hexane: 1% CTAB in MeOH: ethyl 
acetate: acetic acid, (13:1:4:2, v/v) and toluene: 1% 
CTAB in MeOH: «-propanol: formic acid, (14:1:3:2, 
v/v), respectively. The concentration of impregnants 
-(2% paraffin oil, 10% TBP, 10% TBA and 0.01% 
silicon oil) were found to be the best for the 
chromatography of all five drugs 
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MOHAMMAD ei al RIVERSED PHASE THIN LAYCR CHROMATOGRAPHY 
Table I—Details ot stationary phases and solvent systems used 
as mobile phases for chiomatography 
Symbol Stationary phase 
S| Unimpregnated silica gel H 
S2-S5 Silica gel H impregnated with 1, 2, 5 and 8% 
paraffin Oil, respectively 
Se-Sio Silica gel H impregnated with 2,5, 10, 15 and 20% 
tnbutyl phosphate, respectively 
Si i -Su Silica j:el H imorejinated with 5, 10, 15 and 20% 
tnbuytl amine, respectively 
S|5 - S|g Silica gel H impregnated with 0 001, 0 01, 0 1 and 
0 2% silicone oil, respectively 
Symbol 
Mo 
Ml 
M2 
M3 
Solvent systems used as mobiU 
Constituents' 
n-Hexane ethyl acetate 
acetic acid 
n-Hexane 1% CTAB in 
MeOH ethyl acetate 
acetic acid 
Toluene /i-propanol 
formic acid 
Toulene 1% CTAB in 
MeOH n-propanol formic 
acid 
; phase 
Composition (v v) 
7 25 05 
13 1 4 2 
5 4 10 
14 1 3 2 
a = Specific gravity of methanol (MeOH), hexane, 
ethylacetate, glacial acetic acid, formic acid and n propanol 
were 0 793, 0 65, 0 901, 1051, 198, and 0806 gm/cc 
respectively 
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Table 2—/?r values of dmgs (P 
and iinpregnatcd (S; 
Stationary phases 
s, 
Si 
S3 
s. 
S5 
S6 
S7 
Ss 
S, 
Sio 
Su 
S,2 
S,3 
S|4 
S,5 
S\6 
S,7 
s,« 
n d = not delected 
-SIS) silica 
aracctamol 
gel H layeis 
Paracetamol 
M| M3 
0 46 
0 44 
0 39 
0 36 
031 
0 45 
0 40 
0 37 
0 33 
0 29 
0 42 
041 
0 40 
0 36 
0 43 
0 45 
0 49 
0 54 
0 62 
0 59 
0 56 
051 
0 44 
0 58 
0 53 
0 42 
0 40 
0 36 
0 60 
0 47 
0 42 
0 40 
0 59 
0 61 
0 64 
0 67 
Diclotcnjc 
; developed 
sodium, 
with M| 
rbuf jiotcii, Aspi iin and Ascoibic ac: 
and M5 mobile phases 
Mobile 
Diclofenac sodium 
Ml Mj 
0 20 
0 19 
0 12 
0 08 
0 05 
0 18 
0 12 
0 07 
0 04 
0 00 
021 
0 15 
0\2 
0 00 
021 
0 24 
0 28 
0 32 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
phases 
Aspirin 
M, Mj 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
0 32 
0 29 
0 27 
0 24 
0i9 
0 30 
0 27 
0 25 
0 19 
0 12 
0 34 
031 
0 30 
0 29 
0 34 
0 36 
0 36 
041 
id) obtained on 
Ibuprofin 
M, M3 
0 85 
0 82 
0 74 
0 69 
0 60 
0 83 
0 77 
0 68 
061 
0 57 
0 79 
0 67 
0 65 
0 62 
0 82 
0 84 
0 87 
0 90 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
unimpiagr 
Ascorb) 
M, 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
latcd (S|) 
!C acid 
Mj 
0 14 
0 11 
0 08 
0 07 
0 02 
0 13 
0 08 
0 08 
0 05 
0 00 
0 10 
0 04 
0 01 
0 00 
0 13 
0 15 
0 18 
0 20 
Figure captions-
Fig I—Structure of paracetamol 
Fig 2—Structure of ibuprofen 
Fig 3—Structureof diclofenac sodium 
Fig 4—Structureofaspinn 
Fig 5—Structureof ascorbic acid 
Fig 6—Bar diagram showing influence of surfactant m the solvent systems on the mobility of drugs Mo-n-Hexane ethyl acetate acetic 
acid,7 2 5 0 5, v/v M|-n-Hexane l%CTABinMeOH ethyl acetate acetic acid, 13 1 4 2, v/v 
Fig 7—Bar diagram showing influence of surfactant in the solvent systems on the mobility of drugs Mj - Toluene n-propanol fonnic 
acid, 5 4 I 0, v/v Ms-Toluene l%CTABinMeOH w-propanol fomiit acid, 14 1 3 2, v/v 
Fig 8—Chromatogram showing the resolution of a mixture of paracetamol (Pa), diclofenac sodium (Ds) and ibuprofen (lb) on 
unimpregnated (S|) and impregnated (S3, Sj S12 and Si^ ) silica gel H layers using solvent system M| 
Fig 9—Chromatogram showing the resolution of a mixture of paracetamol (Pa), aspirin (As) and ascorbic acid (Ac) on unimpregnated 
(S|) and impregnated (S3, Sj Su and S15) silica gel H layers using solvent system M3 
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Identification and Quantification of Lisinopril from Pure, 
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Abstract: A simple, selective and economical micellar thin layer chromatographic method for on-plate analysis of lisinopril 
from pure, formulated and spiked urine samples was developed. The proposed method involves use of silica gel H layers as 
stationary phase and 4% aqueous N-cetyl-N, N, N-trimethylammonium bromide (CTAB) as solvent system. The natiu^ as well 
as the concentration of surfactants influences the mobility of lisinopril. The effects of alkanols usually used as organic 
modifiers in the solvent system, pH of the solvent system and the presence of nonelectrolytes (organic) and electrolytes 
(inorganic) in the solvent system on the mobility of lisinopril were studied. The interference study was carried out by using 
various organic and inorganic metabolites usually present in human urine. The spectrophotometric determination of lisinopril 
(pure, formulated and spiked urine) samples was carried out at 595nm using ninhydrin as chromogenic reagent. The beers law 
is obeyed in a concentration range of 10-150 'g/mL with correlation coefficient of 0.9778 and molar absorptivity of 4.083 x 
lO' mol' cm"'. The recoveries of lisinopril (pure, formulated and urine spiked) were within range of 93.0 -100.2% with 
relative standard deviation ranging from 0.90 -2.8 %. 
Keywords: Micellar thin layer chromatography, Lisinopril, Urine, Surfactants, Spectrophotometer 
Introduction 
Lisinopril, 1-[N- {(s)-I- carboxy- 3 phenyl propyl}-L-
proline dehydrate (Fig-1) is a lysine analog of enalaprilat, 
the active metabolite of enalapril. It is long-acting, 
nonsulhydryl angiotensin- converting enzyme (ACE) 
inhibitor that is used for the treatment of hypertension 
and congestive heart failure in daily dosage 10-80 mg '. 
Pharmacological activity of lisinopril has been proved in 
various experimental and clinical studies •^^  Owing to its 
importance and widespread use, efforts have been made 
towards the development of simple and reliable analytical 
methods. As per our literature survey, lisinopril in 
pharmaceutical formulations has been determined by 
various analytical methodologies like polaragraphy, 
potentiometry ' and spectrophotometry ' , but most of 
these analytical methods are not too suitable for the 
Identification of lisinopril from clinical samples because 
of the interferences caused by the amino acids and amino 
groups containing metabolites present in biological 
samples '. This report is an attempt in the direction of 
developing a simple and reliable method for on plate 
identification and quantification of lisinopril in 
pharmaceutical formulations as well as from human urine 
samples using silica gel H layers developed with a new 
mobile phase comprising of micellar solutions of N-cetyl-
N, N, N- trimethylammonium bromide (CTAB). Micellar 
solutions have found numerous practical applications in 
many areas of separation science. Micellar liquid 
chromatography (MLC) has gained immense popularity 
and wider applicability due to operational simplicity, cost 
effectiveness, relatively non toxicity and enhanced 
separation efficiency, low aggressiveness '"". 
Incorporation of aqueous micellar solutions as mobile 
phase was pioneered by Armstrong and Terrill " as they 
accentuated the importance of TLC where simultaneous 
separation of ionic or non-ionic species in a variety of 
matrices is required. A peculiarity of the micellar mobile 
phases (MMPs) is that they have no macroscopic 
analogues '•*, as a result the typical separations can be 
easily achieved by using MMPs than aqueous organic 
mobile phases. Previously MMPs were successfully 
employed in TLC based critical separations of aromatic 
hydrocarbons ''', nucleotides " , vitamin Ki and K5 ", 0-
,m- and p- aminophenol " , amino acids " , separation of 
penicillins . 
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The human urine analysis for identification of selected 
drugs and their metabolites has emerged as an important 
investigation tool in forensic drug analysis '^'. Among all 
chromatographic methods available only thin layer 
chromatography (TLC) enables a simple fast and 
effective separation of the complex mixtures present in 
various biological samples '^ and is recommended as a 
approved testing for forensic drug analysis by federal 
Law " . TLC proved its applicability during successful 
separation of bio-active amines ^\ carbohydrates ^*, 
enzymes ^', porphyrins and their precursors ' , alkaloid 
and drugs ^' from urine samples. 
Figure No. 1: Structure of lisinopril drug. 
.COjH 
. 2H2O 
Experimental 
Instrumentation and reagents 
A UV-VIS Spectrophotometer connected with P IV IBM 
computer, TLC applicator (Toshiwal India) and pH meter 
Elico India Ltd was used. Chemical required like silica 
Gel 'H ' , sodium dodecyl sulfate (SDS), N-cetyl-N, N, N-
trimethylammonium bromide (CTAB) and t- octyl 
phenoxydacaethoxy ethanol (TX-lOO), methanol, ethanol, 
prpoanol and butanol, ninhydrin, isoamyl-alcohol, 
ethylene dichloride were purchased from Merck India, 
Iodine crystals, glacial acetic acid , dimethyl formamide 
(DMF) were 
obtained from CDH India, Lisinopril (pure & formulated) 
was from Lupin labs, Mandideep, M.P., India as a gift 
sample. 
General procedure 
Preparation of Test Solution 
Ten tablets equivalent to 100 mg of the lisinopril were 
powdered and transformed into a 50 mL standard flask 
and dissolved with 50 mL of methanol followed by 
stirring. The solution was filtered with Wattman no-41 
and the filtrate was transferred again into a 100 mL 
standard flask and diluted to volume with DMF. In case 
of pure lisinopril drug the 100 mg of powder was 
dissolved with 10 mL double distilled water and the final 
volume (100 mL) was made up with DMF. Standard 
lisinopril solutions (2mg/mL and 1-lOOng mL) were 
prepared from above prepared stock solution by 
appropriate dilution with DMF and water (9:1). 
Preparation of ninhydrin solution 
2% solution of ninhydrin was prepared in DMF. 
Extraction of Lisinopril from human urine samples 
Preparation of spiked drug urine samples -
A sample of Urine was taken from a healthy person. Take 
100 mL of this urine sample and adjusted to pH 7-8 with 
1 M NaOH solution. Add 100 mg of lisinopril drug 
powder to the urine sample. The resulting mixture was 
kept for shaking (20 minutes) at room temperature (15 -
20 "C) for achieving complete dissolution of drug in 
urine. 
Isolation of drug from spliced drug urine samples 
The 100 ml of spiked urine sample was filtered with 
Whatman filter paper (No-41) and then the filtrate was 
mixed with 400 mL of ethylene dichloride containing 
10% of isoamyl alcohol which was kept for shaking for 
15 mins. After this the organic layer was separated and 
evaporated to obtain lisinopril drug as residue. The 
residue was diluted with 50 mL of DMF: double distilled 
water mixture (9:1). The chromatography of the extracted 
drug (lisinopril) was performed on silica gel H layers 
with solvent system M5 and the Rp value of spiked 
lisinopril is compared with Rp value of pure lisinopril 
drug. 
Detector Iodine Vapors were used as a detector. 
Stationary Phase Silica Gel ' H ' layers were used as a 
stationary phase. 
Mobile phase 
The solvent systems were used (Table 1) as mobile 
phases. 
Chromatography 
(a) Preparation of TLC plates 
The TLC plates were prepared by mixing silica gel H 
with double distilled water in 1:3 ratio by weight with 
constant shaking to obtain homogeneous slurry. The 
resultant slurry was applied on the glass plates with the 
help of a manual applicator to give a 0.25 mm-thick 
layer. The plates were dried at room temperature and then 
activated at 100 ± 2 "C by heating in an electrically 
controlled oven for one hr. The activated plates were 
stored in a close chamber at room temperature until used. 
(b) Chromatographic procedure 
Test solutions (lOuL) were applied on (15 x 3 cm) silica 
gel H thin layer plates with the help of micropipette at 
about 2 cm above the lower edge of the plates. The 
solvent ascent was fixed to 10 cm in all cases for the 
determination of RF values of all individual drugs. Linear 
ascending development was carried out in a vapor 
equilibrated TLC twin trough chamber. The optimized 
chamber saturation time for the mobile phase was 15 min 
at room temperature (25 ± 1 "C). Subsequent to the 
development, TLC plates were dried at room 
temperature. The plates were then detected by using 
iodine vapors and all the drugs are visualized as colored 
spots. The Rp values of drug were determined by the 
following relation -
RF = 0 . 5 ( R L + R T ) 
where RL = Rp of leading front. 
RT = Rp of trailing front. 
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Interference 
For investigating the interference of various metabolites 
like sodium and potassium salts, urea and liquor 
ammonia, normally found in human urine on mobility of 
lisinopnl An aliquot (5* L) of lisinopnl was spotted on 
silica gel H TLC plate followed by spotting of S^L of the 
interfenng species (Img/mL) on the same spot The 
chromatography was performed with solvent system M5 
The spots were detected and the RF values of drug were 
calculated and compared 
Quantitative determination oflisinopril 
The visible spectrophotometenc technique was applied 
for the quantitative determination of on plate identified 
lisinopnl drug from formulated and human unne spiked 
samples For this purpose 10|iL of lisinopnl solutions of 
different strength (10 -30|ig) were spotted on TLC plates 
After complete drying of the spots, the TLC plates were 
developed with solvent system M5 At the same time, a 
pilot plate was also developed to locate the position of 
lisinopnl spot After such development the area was 
scarped from the plate The scraped silica powder was 
then mixed with 2 mL of DMF for the extraction of 
lisinopnl from adsorbent Then it was filtered with 
Whatman filter paper no-41 In order to ensure complete 
extraction of drug the adsorbent was again washed with 3 
mL of DMF double distilled water mixture (9 1) All the 
filtrate was collected in a test tube, and then 1 5 mL of 
ninhydnn solution was added to it and kept for 90 mm at 
room temperature for complete color development The 
absorbance was measured at 595 nm against reagent 
blank^^ A calibration curve was plotted between the 
absorbance Vs concentration of lisinopnl drug The 
content of lisinopnl in the formulated and unne spiked 
samples was determined from the standard curve by six 
replicate readings under similar conditions by using the 
following relationship 
Relative Amount Amount 
recovered - loaded 
Recovery^ 100 x 100 
(%) Amount loaded 
Results and discussion 
The mobility of lisinopnl drug (pure and formulated) 
was examined on silica gel H layers using aqueous 
solutions of cationic (CTAB), anionic (SDS) and 
nonionic (TX-lOO) surfactants The expenmental 
conditions were optimized on the mobility of lisinopnl 
with vanous factors, such as type and concentration of 
surfactants used, nature and concentration of added 
alkanols in the micellar mobile phases, acidity or basicity 
of the medium, presence of urea and NaCl (electrolyte) in 
the surfactant- containing mobile phase and effect of 
vanous organic and inorganic metabolites nomially 
found in unne samples 
Effect of type and concentration of surfactants 
The chromatography of lisinopnl was performed on silica 
gel H layers using different concentrations of cationic, 
anionic and nonionic surfactant-mediated mobile phase 
systems (M2- M19) The results of the effect of type and 
concentration of different classes of surfactants are 
presented m Table 2 The following conclusions are 
drawn from the Table 2 
(1) In double distilled water (zero concentration of 
surfactant), the lisinopnl remains at the point of 
application 
(2) The mobility of lisinopnl increases with the increase 
in concentration of CTAB in the solvent systems 
(3) Reverse trend was observed in case of SDS as 
compared to CTAB, the mobility of lisinopnl decreases 
with the increase in concentration of SDS in solvent 
system 
(4) The same trend was obtained in case of Tnton X-
100 as observed in case of CTAB containing solvent 
system The mobility of lisinopnl increases with the 
increase in concentration of Tnton X-100 in the solvent 
system 
It may be concluded from the present study that in case of 
both CTAB and Tnton X-IOO, the micellar thm layer 
chromatography is involved The surfactant in the solvent 
system occurs in both the micellar and ionic forms In 
this case concentration of surfactants in the mobile phase 
leads to an increase only in the concentration of micelles 
in MMPs and the concentration in the stationary phase 
remains nearly constant This may result m decrease in 
retention of adsorbates While in case of SDS, the lon-
pair TLC situation is observed The mobile phase in the 
system contains only ions of a surfactant An increase in 
their concentration in the mobile phase increases the 
concentration of surfactant ions adsorbed on the 
stationary phase As a result the retention of adsorbates 
increases ^ 
Effect of alkanols 
The different concentrations of alcohols (methanol, 
ethanol, n-propanol, or n-butanol) of varying chain 
lengths were used with the 4% aqueous CTAB (M5) for 
the chromatography of lisinopnl on silica gel H layer 
The effect of nature of alcohols is presented in Table-2 
From the results obtained, it is clear that with the increase 
in the concentration of alcohols the mobility decreases 
At higher concentrations of different alcohols the 
visibility of lisinopnl decreases and is not detected The 
addition of alcohols in the micellar solvent systems may 
result in the less population of surfactants molecules on 
the adsorbent and this may provide some free silanol 
groups on the silica surface for the adsorption of 
lisinopnl ^' This may cause the increase m the retention 
of lisinopnl on the silica surface and hence decreases the 
mobility 
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Tablel: Solvent systems used. 
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Code 
M| 
M2 
M3 
M4 
M5 
Mi 
M^ 
Mg 
M, 
M,o 
M„ 
M,2 
ML, 
M,4 
M,5 
M,6 
M|7 
M|g 
M„ 
M20 
M2, 
M„ 
M23 
M24 
M25 
M26 
M27 
MIS 
M29 
M,o 
M3, 
M„ 
M,, 
M34 
M,5 
M„ 
M37 
M38 
M„ 
M40 
M41 
M42 
Constituents 
Water 
0.5% aqueous CTAB 
1% aqueous CTAB 
2% aqueous CTAB 
4% aqueous CTAB 
5% aqueous CTAB 
7% aqueous CTAB 
0.5% aqueous SDS 
1% aqueous SOS 
2% aqueous SDS 
4% aqueous SDS 
5 % aqueous SDS 
7% aqueous SDS 
0.5% aqueous TX-100 
1% aqueous TX-100 
2% aqueous TX-100 
4% aqueous TX-100 
5% aqueous TX-100 
7% aqueous TX-100 
4% aqueous CTAB + Methanol (9 -. 1) 
4% aqueous CTAB + Methanol (8 : 2) 
4% aqueous CTAB + Methanol (7 : 3) 
4% aqueous CTAB + Methanol (6 : 4) 
4% aqueous CTAB + Methanol (5 : 5) 
4% aqueous CTAB + Methanol (4 : 6) 
4% aqueous CTAB + Ethanol (8 : 2) 
4% aqueous CTAB + Ethanol (5 : 5) 
4% aqueous CTAB + Ethanol (2 : 8) 
4% aqueous CTAB + Popanol (8 : 2) 
4% aqueous CTAB + Popanol (5 : 5) 
4% aqueous CTAB + Popanol (2 : 8) 
4% aqueous CTAB + Butanol (8 : 2) 
4% aqueous CTAB + Butanol (5 : 5) 
4% aqueous CTAB -•- Butanol (2 : 8) 
4 % aqueous CTAB containing 1 g NaCl per 100 mL 
4 % aqueous CTAB containing 5 g NaCl per 100 mL 
4 % aqueous CTAB containing 1 g Urea per 100 mL 
4 % aqueous CTAB containing 5 g Urea per 100 mL 
4% aqueous CTAB in buffer solution of pH 2.3 
4% aqueous CTAB in buffer solution of pH 4.2 
4% aqueous CTAB in buffer solution of pH 5.7 
4% aqueous CTAB in buffer solution of pH 9.1 
Effect of acidity and basicity of tlie solvent systems 
used 
TLC of lisinopril was peiformed with solvent systems 
M39- M42 prepared by using 4% aqueous CTAB in borate 
phosphate buffers of different pH values (pH -2.3, 4.2, 
5.7 and 9.0). The results summarized in table- 2, shows 
that at strongly acidic pH no spot was detected for 
lisinopril, while at pH (4.2 and 5.7) a decrease in the 
mobility of drug was observed with compact spots. At pH 
9.0 a slight increase in mobility was observed for 
lisinopril drug with an elongated spot. 
Effect of electrolytes and non electrolytes addition in 
solvent systems 
It has been reported that the microenvironment of 
micellar system is greatly influenced by the presence of 
added organic substance or inorganic electrolytes. Thus 
the effect of addition of urea (organic non electrolyte) 
andNaCl 
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(inorganic electrolyte) at two different concentration 
levels in the solvent system M5 (4% CTAB) on mobility 
of lisinopril were examined. The results presented in 
Table-2 and from the available data following trends are 
noticeable -
(1) A tailed spot was observed at lower 
concentration of urea but at higher concentration no spot 
was detected. 
(2) In case of NaCI mobility of lisinopril increases 
but at higher concentration spot compactness and 
intensity decreases. 
Table 2: RF values (mobility) of lisinopril on silica gel H layers with different (MrM42) mobile phases. 
Mobile 
Phases 
M| 
M2 
M3 
M4 
M, 
M6 
M, 
Mg 
M, 
M,o 
MM 
M,2 
M„ 
M„ 
M,5 
M,6 
M„ 
M|8 
M„ 
M20 
M2, 
M22 
M23 
M24 
M25 
M26 
M27 
M28 
M29 
M30 
M„ 
M,2 
M33 
M34 
M35 
M56 
M,7 
M38 
M„ 
M40 
M41 
M42 
Ri. Values 
Lisinopnl 
(Pure) 
000 
020 
p.24 
0 27 
0 32 
O-'f, 
0 36 
0.2s 
0 26 
0 24 
0.21 
0 20 
0 20 
0.24 
0 26 
0 29 
0 33 
0 34 
0 34 
046 
0 42 
0 39 
0 36 
0,31 
n d. 
0 49 
044 
nd 
0 50 
0 48 
nd 
0 49 
0 46 
" • " l . 
0 36 
0,38 
0 37 ( T ) 
nd 
n"" 
031 
0 29 
0.36 
Lisinopnl 
(formulated) 
0.02 
018 
0.22 
0.29 
0 35 
0.36 
0 38 
0.29 
0 25 
0 23 
0.21 
0 19 
0 18 
0.22 
0 25 
0 30 
0 35 
0 35 
0 34 
0.44 
041 
0 37 
0 34 
0.30 
nd 
051 
0 43 
nd 
0.53 
0 49 
n.d 
0 50 
0.48 
nd 
0 35 
0 38 
0.35 m 
nd 
n.d. 
0 28 
0 25 
0.36 
(T)- Tailed spot 
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Identification of lisinopril in presence of impurities 
To widen the applicability of the developed TLC system 
(silica gel H layers with Ms solvent system) for 
identification and isolation of lisinopril from formulated 
drug and urine samples in presence of various 
metabolites normally found in urine are presented in 
Table-3. It is clear that potassium and sodium salts does 
not affect the mobility of the drug, but m case of liquor 
ammonia a long trailing spot was observed , In case of 
urea two spots were observed. 
Identification of lisinopril from human urine samples 
The proposed chromatographic method (silica 
gel H layers with 4% aqueous CTAB) successfully 
identified the lisinopril extracted from the human urine 
samples on the basis of RF value. The spots of the pure, 
formulated and the urine extracted lisinopril samples are 
shown in Fig 2. Thus the proposed method is very 
sensitive for the identification of lisinopril from urine 
samples. 
Table 3: Effect of various organic and 
inorganic metabolites found in urine 
on mobility (Rp) of lisinopril Drug. 
Impurity 
NaCl 
KCl 
Urea 
Liquor Ammonia 
Rp Value 
0 34 
0 35 
0 33,0 68 
0 39 (T) 
(T) Trailing 
Table 4: Optical characteristics and statistical data 
for the regression equation of the proposed method 
Sr. 
No 
1 
2 
3 
4 
5 
6 
7 
g 
9 
10 
Parameter 
X_max 
Beer's law limit (jig/mL) 
Molarabsorptivity (L mole-1 cm-1) 
Sandell's sensitivity (ng/mL perO 001 A) 
Regression equation (Y*) 
Slope (m) 
Intercept(c) 
Correlation coefficient (r' 
Relative Standard Deviation** (%) 
Limit of Detection (ng/mL)*** 
Value 
595 nm 
10-150 
4 083 X 10^  
1 2 X 10-' 
6.28 X 10"' 
2 8 x 1 0 ' 
0 9778 
0 883 
5 587 
Y* = mx + C 
Where X is the concentration of analyte (ng/mL) and Y is absorbance unit. 
** = Calculated from six determinations 
*** Calculated as per ICH guidelines 
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TLC-Spectrophotometry of lisinopril 
The analytical parameters for the spectrophotometnc 
determination of lisinopnl by the proposed method are 
given in table-4 Linear correlation was found between 
the absorbance and the concentration of lisinopnl Beers 
law was obeyed in a concentration range from 10-150 
pgm/mL The regression analysis of beer law data using 
the method of least square was made to evaluate the slope 
(b), the intercept (a), correlation coefficient (r^), molar 
absorptivity and sandell sensitivity for each system 
These values suggested that the proposed method is very 
sensitive for the determination of lisinopnl The accuracy 
and validity of the proposed method were ascertained by 
performing recovery studies The recovery studies of 
pure, formulated and unne spiked lisinopnl samples at 
different concentrations indicates that the recovery was 
good The percentage recovery values ranged between 
93 0 -100 2% with relative standard deviation of less than 
3% 
Table 5: Spectrophotometric determination oflisinopril from pure 
formulated and urine spiked samples. 
Drug samples 
(Hg/ml) 
Amount taken 
10 
12 
14 
16 
18 
20 
22 
24 
26 
Formulated drug 
50 
100 
Unne sample 
20 
Found 
(Hg/ml) 
93 
112 
132 
15 5 
173 
194 
216 
23 7 
25 6 
50 3 
100 2 
188 
Relative 
Recovery 
(%) 
93 0 
93 3 
94 2 
96 8 
96 1 
97 0 
98 1 
98 7 
98 6 
1006 
100 2 
94 0 
Relative Error 
(%) 
-6 9 
-6 6 
-5 7 
-3 1 
-3 8 
-3 0 
-18 
-12 
1 15 
+0 59 
+0 20 
-5 9 
RSD 
28 
20 
22 
26 
19 
17 
29 
15 
16 
13 
09 
23 
Figure No. 2: Chromatogram showing identification oflisinopril 
in pure and formulated as well as spiked urine samples on silica 
gel H layers developed with mobile phase Ms 
Solvea: 6oat 
Le^aflPuK lismpnl Fomfulited 
0 0 
L-al ef applicaaoc 
liinopnl 
Unne Extracud 
0 
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Identification and Separation of Cannabis sativa, Embleia ribes, 
Myristica fragrans and Piper longum from Organic Extract on Silica 
Gel Surface with Anionic Micellar Solvent System: Application in 
Ayurvedic Medicine 
A. Mohammad'-*, S. Sharma^, S.A. Bhawani^ and Ram B. Singh'* 
'•^•^ Analytical Research Laboratory, Department of Applied Chemistry, Faculty of Engineering & Technology, Aligarh 
Muslim University, Aligarh-202002, India 
^Halberg Hospital and Research Institute, Civil Lines Moradabad-10, (U.P)-India 
Abstract: Cannabis saliva, Myristica fragrans, Piper longum and Embleia ribes are the active phanna ingredients of an 
ayurvedic herbal formulation Jatiphaldya, which is beneficial in many typical stomach related disorders. 
The present study is aimed to develop a simple and reliable thin layer diromatognqihic (TLC) method using micellar 
solution of sodium dodecyl sulfate (SDS) as mobile phase for the identification of all the four herbal drugs with 
preliminary separation on silica gel 'G' TLC plate. The active components of drug were extracted in a mixture of ethanol 
and water (4:1), chromatographed on silica gel TLC plate using aqueous SDS (5%) as mobile phase and the resolved spots 
for Cannabis sativa (RrO.95), Myristica fragrans (Rp-0.64), Piper longum (RF-0.41) and Embleia ribes (RF-0.26) were 
identified using vanillin-sulfliric acid (2% solution of vanillin in 5% methanolic sulfuric acid). In order to realize most 
favorable mobile phase system in combination with silica gel 'G' as stationary phase, Ae effect of nahire of surfactants 
(anionic, cationic or nonionic) and the level of concentration of each surfactant [sodium dodecyl sulfate (SDS), N-cetyl-N, 
N, N-trimethylammonium bromide (CTA6) or t- octyl phenoxydacaedioxy e&anol (TX-lOO)] on the mobility of all four 
active components was examined. In addition, the effect of organic (urea and alkanols) and inorganic (NaCl) additives 
in 5% aqueous SDS solution on mobility pattern of active herbal pharma ingredients was examined. The presence of 
ammonia and nitrate in the drug sample was found to hamper the resolution and identification of all active components. 
However, NaCl, KCl and glucose do not offer serious interference. 
Key Words: Thin layer chromatography, Herbal, Jatiphaladya, Ayurvedic, Surfactant 
INTRODUCTION 
Jatiphaladya is a powdered herbal formulation of 6000 
year old Indian ayurvedic system of medicine. Therapeuti-
cally Jatiphaladya is beneficial in many human intestinal 
disorders like tastelessness (anici). Diarrhea (Atisara), 
Malabsorption syndrome (Graha), Dysentery (Pravahika), 
Cough (Kasa) and Rhinitis (Vatsale-ma-Pratisyaya). The 
main constituents of Jatiphaladya formulation are Cannabis 
sativa (Bhang), Myristica fragrans (Jatiphala), Piper longum 
(Pippali) and Embleia ribes (Vidanga) {!], Cannabis 
sativa (Bhang) is a major constituent of the Jatiphaladya 
formulation (20 % wt/vol). It is a commonly grown herb 
of high medicinal importance [2]. Myristica fragrans 
(Jatiphala) commonly known as nutmeg, is a popular 
herbal plant used in traditional Ayurvedic, Chinese and 
Thai medicine as aphrodisiac, antimicrobial, antipyretic, 
abortifacient and stomachic [3]. This plant is pharmacologi-
cally studied for various activities like chemo protective. 
•Address correspondence to this author at the Analytical Research Labora-
tory, Department of Applied Chemistry, Faculty of Engineering & Technol-
ogy, Aligarh Muslim University, Aligarh-202002, India; 
E-mail: alimohammad08@gmail.com 
antioxidant, aphrodisiac, antimicrobial, hepatoprotective, and 
anti-inflammatory [4]. Piper longum (Pippali) is a widely 
available species of the genus piper. Because of high 
therapeutic values, pipali has been used as antibacterial, 
anti-inflammatory and as a local anesthetic [5]. Embleia 
ribes (Vidanga) is a climbing herb found in Sri-lanka, 
India and Singapore. Therapeutically Embeleia inhibited 
pregnancy, possessed anti-estrogenic and weak progesta-
tional activity, shows analgesic, anti-inflammatory, antibac-
terial, antitumor and free radical scavenging activities [6, 7]. 
As per our literature survey there is no analytical study 
available for Jatiphaladya formulation. But Previously 
Cannabis was analysed by various analytical methods 
including immunoassays (EMIT, Elisa fluorescence polariza-
tion, radioimmunoassay) [8], Gas Chromatography- Mass 
spectrometry [9], High performance liquid chromatography-
Mass spectrometry [10] and TLC [11]. However in case of 
Myristica fragrans (Jatiphal), Piper longum (Pippali) and 
Embleia ribes (Vidanga) a very few analytical studies 
are available using GC or HPLC [12-14]. Most of these 
techniques involves costly instruments and require 
highly purified standard reference samples [15]. Thin 
Layer Chromatography is a suitable method to screen 
simultaneously numerous samples extracted directly from 
18764960/09 2009 Benthim Open 
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plants. It has become a modem technique with the 
commercialization of numerous adsorbents and solvent 
systems [16]. 
Micellar liquid chromatography involving the use of 
surfactant ions above their critical micellar concentration 
(CMC) as mobile phase for controlling the retention of a 
solute has been the focus of numerous studies [17-19]. 
The use of surfactants (cationic, anionic, and nonionic) in 
TLC has expanded its potentiality by providing efTicient 
separations of peptides [20], vitamins [21], steroids [22] etc. 
Surfactant-modified TLC provides enhanced selectivity as a 
result of difference in the degree of binding of separated 
mixture components with mobile and stationary phases [23]. 
The selective solubilization of mixture components with 
micelles is caused by complex electrostatic, hydrophobic, 
donor-acceptor and polarization interactions. Micelles are 
capable by differentially solubilizing and binding a variety of 
solutes leading to their potential usefulness for achieving 
several new separations including the resolution of optical 
isomers [24]. The present communication is probably 
the first report on the use surfactant in TLC analysis of an 
herbal formulation (Jatiphaladya). 
MATERIALS AND METHODOLOGY 
Apparatus 
A TLC applicator (Toshiwal, India) was used for coating 
silica gel on 20cmX 3cm glass plate. A glass sprayer and 
iodine gas chamber was used to locate the position of spot of 
analyte. A pH meter (Elico, India) and a reflux assembly of 
Borosil India were also used. 
Chemicals and Reagents 
Silica Gel 'G', sodium dodecyl sulfate (SDS), N-cetyl-N, 
N, N-trimethylammonium bromide (CTAB), t- octyl 
phenoxydacaeflioxy ethanol (TX-lOO), methanol, propanol, 
butanol and buffer capsules for pH 2.4, 4.0 and 9.2 
(on dilution with 100 mL distilled water) were obtained 
from Merck Reagents, Mumbai, India. Sulfuric acid, 
iodine, vanillin and ethanol were from CDH India, Jatiphal-
daya formulation was from Baidyanath Pharmaceutical Ltd 
India. 
Parent API herbs. Cannabis saliva (Bhanga), Myrislica 
fragrans (Jatiphala), Piper longum (Pippali) and Embleia 
ribes (Vidanga) were obtained from Ashyuwani herbal 
Pharmaceuticals, U.P., India. 
Chromatography 
Mobile Phases 
The following solvent systems (Table 1) were used for 
the chromatography. 
Stationary phase: Silica get G was used as a stationary 
phase. 
Detection Reagent 
(a) Iodine vapors 
(b) 1% solution of vanillin in methanolic sulfuric acid. 
(c) Sulfuric-acid anisaldehyde solution. 
Mohammad et aL 
Table 1. Solvent Systems 
Code 
M, 
M] 
M, 
M4 
M, 
H 
M, 
M l 
M, 
M„ 
MM 
M„ 
M„ 
M„ 
M,5 
M,. 
M„ 
M„ 
M„ 
Mx 
M„ 
Ms 
M» 
M,, 
MM 
Ma 
M:, 
M. 
M„ 
M„ 
Mj, 
Mn 
M„ 
Mj4 
M„ 
M» 
Mn 
M» 
M« 
M^i 
Mo 
Constituents 
Water 
O.Sy. aqueous CTAB 
!*/• aqueous CTAB 
2% aqueous CTAB 
4% aqueous CTAB 
5% aqueous CTAB 
7% aqueous CTAB 
O.SVt aqueous SDS 
1% aqueous SDS 
2% aqueous SDS 
4*A aqueous SDS 
S*/» aqueous SDS 
7% aqueous SDS 
0.5% aqueous TX-100 
1% aqueous TX-lOO 
2% aqueous TX-100 
4% aqueous TX-lOO 
5'/.aqueous TX-lOO 
7% aqueous TX-lOO 
5% aqueous SDS + Methanol (9:1) 
5% aqueous SDS + Methanol (8:2) 
S% aqueous SDS -•- Methanol (7:3) 
5*/o aqueous SDS + Methanol (6:4) 
5% aqueous SDS -•- Methanol (S: S) 
5% aqueous SDS + Methanol (4:6) 
S'/t aqueous SDS -•- Ethanol (8:2) 
5% aqueous SDS + Ethanol (S: S) 
S% aqueous SDS + Ethanol (2: 8) 
5% aqueous SDS -•- Propanol (8 :2) 
5% aqueous SDS + Propanol (5:5) 
5V< aqueous SDS + Propanol (2:8) 
5% aqueous SDS + Butanol (8:2) 
5% aqueous SDS -i- Butanol (S: S) 
5% aqueous SDS -•- Butanol (2:8) 
5 */• aqueous SDS containing 1 g NaCl per 100 mL 
5 % aqueous SDS containing 5 g NaCI per 100 mL 
S*/< aqueous SDS containing 1 g Urea per 100 mL 
S*/o aqueous SDS containing S g Urea per 100 mL 
SVa aqueous SDS in buffer solution of pH 2.3 
5% aqueous SDS in buffer solution of pH 4.2 
S% aqueous SDS in buffer solution of pH S.7 
5% aqueous SDS in buffer solution of pH 9.1 
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Extraction of Drug 
A powdered sample of herb was dried at 65 °C for 17 
hours. A weighed amount of material (5 gm herb powder) 
was added to 20 ml of ethanol: water (8:2) solution and 
allowed to stand at room temperature for four hr. After that 
solution was refluxed on water bath for 30 min, cooled and 
then filtered through a small funnel plugged with cotton 
wool and Watman filter paper (41). TTie solid residue ob-
tained was again washed with 10 ml of Ethanol: water (4:1) 
solution. After that all filtrates and washings were collected 
and solvent was evaporated. The final residue obtained after 
drying was further dissolved in 10 ml of toluene containing 
0.5mg/mL of drug as standard [25]. 
Preparation of TLC Plates 
The TLC plates were prepared by mixing silica gel G 
with double distilled water in 1:3 ratios by weight with 
constant shaking to obtain homogeneous slurry. The 
resultant slurry was applied on the glass plates with the help 
of a manual TLC applicator to give a 0.25 mm-thick layer. 
The plates were dried at room temperature and then activated 
at 100 ± 2 "C by heating in an electrically controlled oven for 
one hr. The activated plates were stored in a close chamber 
at room temperature until used. 
Chromatographic Procedure 
Test solutions (10)iL) were applied on (15 x 3 cm) silica 
gel G thin layer plates with the help of micropipette at about 
2 cm above the lower edge of the plates. The solvent ascent 
was fixed to 10 cm in all cases for the determination of RF 
values of all individual drugs. Linear ascending development 
was carried out in a vapor equilibrated TLC twin trough 
chamber. The optimized chamber saturation time for the 
mobile phase was 15 min at room temperature (25 ± 1 "C). 
Subsequent to the development, TLC plates were dried 
at room temperature. The spot were then detected and 
compared by using iodine vapors, vanillin sulfuric acid 
and sulfuric acid aniseldhyde solution as chromogenic 
reagents and all the drugs are visualized as colored spots. 
For comparing spot intensity, lOpL aliquot (0.5 mg/mL) 
were loaded on silica gel TLC plate and chromatography was 
performed with different mobile phases (M1-M41) and then 
spots were visualized using a common detector. The identi-
fied spots were visually compared for spot intensity. The RF 
values of drug were determined by the following relation -
RF = 0 . 5 ( R L + R T ) 
Where RL = RF of leading front. 
RT = RF of trailing front. 
Separation 
For the separation, equal amount of solution of drugs to 
be separated were mixed and lO^L of the resultant mixture 
was loaded on the TLC plates. The plates were developed 
with solvent system (M12) and the spots were detected and 
the RF values of the separated drugs were determined. For 
separation of active constituents from Jatiphaladya formula-
tion drug was extracted from the formulation andlOixL of 
this extract was loaded on TLC plates and chromatography 
was performed. 
Effect of Different Modifiers in Solvent System 
To study the effect of change in microenvironment of 
solvent systems due to presence of alkanols, pH buffers, 
electrolytes (NaCl) and non electrolyte (urea) on the identifi-
cation and mobility of all the four herbal drugs, different 
alcohols (methanol, ethanol, propanol and butanol) and 5% 
aqueous SDS solution prepared in 1% and 5% aqueous 
solution of NaCI and urea were used as solvent systems. 
After that the chromatography was performed on silica gel 
layers with these solvent systems (M20- M42) and Rj values 
are calculated and compared 
Interference 
For investigating the interference of various organic and 
inorganic metabolites like sodium and potassium salts, urea, 
liquor ammonia, nitrate and glucose as an sample impurity, 
on the identification and mobility of herbal drugs (Bhanga, 
Jataiphala, Pippali and Vidanga), an aliquot (lOpL) of all 
herbal drugs were spotted separately on silica gel TLC plate 
followed by spotting of lO\iL of the interfering species 
(1 mg/mL) on the same spot The chromatography was 
performed with solvent system M12. The spots were detected 
and the Rp values of drugs were calculated and compared. 
Detection Limits with Different Detectors 
The detection limits of jatiphala, bhanga, pippali and 
vidanga were determined by spotting different amounts of all 
the four compounds on silica gel stationary phase, developed 
with solvent system (M12) and the spots were detected with 
various detectors such as -
(a) Iodine vapors 
(b) 1% solution of vanillin in methanolic sulfuric acid 
(c) Sulfuric acid anisaldhyde. 
The method was repeated with successive lowering of the 
amount of drugs. The lowest amount that could be detected 
was taken as the limit of detection for each detector. 
RESULTS 
The four main constituents (Bhanga, Jatiphala, Pippali 
and Vidanga) of an aurvedic herbal formulation Jatiphaladya 
have been separated by using micellar thin layer chromata-
tography. These four constituents of Jatiphaladya were first 
extracted from their natural sources using aqueous organic 
solvent and then chromtographed on silica gel layers with 
various surfactant mediated solvent systems (M2- M19). The 
surfactants used in this study differ mainly on the basis of 
the charge present on their hydrophilic groups. The results 
of the present study are reported in Table 2. In addition 
to the effect of nature of charge of various surfactants, the 
additive effect of various organic and inorganic modifiers, 
electrolytes and non-electrolytes, as well as the pH of the 
solvent system were utilized to examine the chromatographic 
behavior of these herbal drugs. 
The following conclusions are drawn from the results 
reported in Table 2 for the effect of nature of different 
surfactants on the chromatography of these herbal drugs. 
4 The Open Nulraceullcals Journal, 2009, yotume 2 Mohammad et aL 
Table 2. R^ values (mobility) of Cannabis saliva (Bhanga), Emblda rtbes (Vidanga), Myrisllca fragrans (Jathiphala) and Piper 
longum (Pippall) on Silica Gel 'G* Layen with DifTerent (M1-M41) Mobile Phases 
Mobile Pluses 
M, 
Mj 
M3 
M4 
Ms 
M. 
M7 
M, 
M, 
M,o 
M„ 
M,: 
M„ 
Mu 
M,5 
M,6 
M„ 
M„ 
. M„ 
MM 
Mj, 
Ma 
Mu 
M„ 
M2, 
M» 
Mn 
MM 
M» 
Mjo 
M„ 
M,2 
Mj, 
MM 
M,i 
M« 
M„ 
M„ 
M„ 
M« 
M,, 
M^a 
Cannabis satlva (Bhangi) 
0.72 (T) 
0.70 
0.67 
0.64 
0.62 
0.60 
0.60 
0.86 
0.88 
0.91 
0.93 
0.95 
0.97 
0.90 
0.88 
0.87 
0.85 
0.83(T) 
0.83(T) 
0.98 
0.98 
0.95 
0.91 
N.D 
N.D 
0.94 
0.90 
N.D 
0.93 
0.90 
0.89 
0.91 
0.89 
N.D 
0.92(T) 
0.90(T) 
N.D. 
N.D. 
N.D. 
0.93 
0.91 
N.D. 
Emblela tibe% (Vidanga) 
0.60 (T) 
0.64 
0.61 
0.57 
0.48 
0.50 
0.51 
0.56 
0.58 
0.59 
0.61 
0.64 
0.65 
0.69 
0.67 
0.66 
0.63 
0.61 
0.60 
0.70 
0.71 
0.69 
0.67 
0.64 
0.64 
0.68 
0.66 
0.62 
0.67 
0.66 
N.D 
0.65 
0.63(T) 
0.63(T) , 
0.71 
0.69 
N.D. 
N.D. 
0.61(T) 
0.60 
0.58 
0.65 
AfyHslkafragrans (Jatiphala) 
N.D. 
0.22 
0.18 
0.15 
0.13 
0.11(T) 
0.10(7) 
0.32 
0.35 
0.39 
0.39 
0.41 
0.43 
0.61 
0.59 
0.55 
0.52 
0.50 
0.50 
0.49 
0.49 
0.47 
0.45 
0.42 
0.40 
0.47 
0.47 
0.44 
0.45 
0.43 
0.40 
0.45 
0.42 
0.43 
0.42(T) 
0.39(T) 
0.37 
0.39 
N.D 
0.40 
0.37 
0.44 
Piper longum (Pippali) 
0.14 (T) 
0.20 
0.18 
0.15 
0.12 
O.IOCT) 
0.10(T) 
0.20 
0.22 
0.23 
0.25 
0.26 
0.27 
0.00 
0.00 
0.14 
0.17 
0.18 
0.19 
0.36 
0.30 
0.29 
0.27 
0.25 
0.26 
0.30 
0.28 
0.25 
0.27 
0,24 
0.21 
0.24 
0.20 
0.20(T) 
0.23(T) 
0.27(T) 
0.21 
0.23 
N.D 
0.24 
0.25 
0.26 
N.D - Not delected T - Trailing. 
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(1) In double distilled water (zero concentration of surfac-
tants), Jatiphala was not detected while the other com-
pounds appeared as tailed spots with different mobility. 
(2) In case of CTAB and TX-lOO, the mobility of Bhanga, 
Vidanga and Jatiphala decreases with the increase in 
concentration of surfactant in the solvent system while in 
case of Pippali mobility increases with the increase in 
concentration of TX-lOO in solvent system and decreases 
in case of CTAB. 
(3) The SDS containing solvent systems have shown 
appreciable increase in the mobility of all the four herbal 
drugs with the increase in the concentration of surfactant 
in the solvent system. 
EfTectof Alkanols 
The results of the additive effects of various organic 
modifiers such as alcohols in the micellar mobile phase Mu 
on the mobility of all the four drugs studied are presented in 
Table 2. It is clear from the results that the presence of traces 
of alcohols in solvent system increases the mobility of all the 
four drugs but further increase in concentration of various 
alcohols viz. methanol, ethanol, propanol and butanol in the 
micellar mobile phase (M12) decreases the mobility of all the 
four drugs. 
Effect of Electrolyte and Non Electrolyte 
It has been reported [26] that the microenvironment of 
micellar system is greatly influenced by the presence of 
added organic substance or inorganic electrolytes. Thus the 
effect of addition of urea (organic non electrolyte) and NaCl 
(inorganic electrolyte) at two different concentration levels 
in the solvent system M u (5% SDS) on mobility of all the 
four herbal drugs were examined. The results presented in 
Table 2 shows following noticable trend -
( l ) I n urea containing solvent systems (M37- M3») both 
Bhanga and Vidanga are not detected while in case of 
Pippali and Jatiphala the mobility decreases. 
(2) In case o f NaCl containing solvent systems (M35-M36), all 
the three drugs (Jatiphala, Pippali and Bhanga) produced 
tailed spots except Vidanga. 
Effect of pH 
The results showing effect o f pH (2 .3 ,4 .2 ,5 .7 and 9.0) of 
the solvent systems (M39-M42) on the mobility of all the four 
herbal drugs are presented in Table 2. It is clear from the 
results that in strongly acidic pH none of the drugs except 
Vidanga was detected on TLC plates. In the pH range 4.2 -
5.7 no significant change in mobility was observed for all 
drugs. At pH 9.1 Bhanga could not be detected. 
Limits of Detection 
The lowest possible amount of all the drugs detected 
using various detection reagents on silica gel surfaces 
with solvent system M ^ are presented in Table 3 . The results 
obtained indicate that vanillin sulfuric acid is most suitable 
for sensitive and efficient detection of drugs under study. 
Interference Studies 
It is clear from Table 4 that the presence of various 
organic and inorganic metabolites like sodium and potassium 
salts, urea, liquor ammonia, nitrate and glucose in the herbal 
Table 3. Limit ofDetection (pg/mL) Achieved Using Different Detection Reagents on Silica Gel 'G' Layers with Solvent System Mu 
Uerbal Drug 
Embleia ribes 
Sifyrislica fragrans 
Piper longum 
Cannabis saliva 
Iodine 
0.20 ^g/mL (light brown) 
0.40 |jg/mL (brown) 
0.70 pg/mL (brown) 
0.90 pg/mL (black brown) 
Detection Rtagenti 
Vanillin Sulfuric Acid 
0.50 pg/mL (bluish grey) 
0.20 Mg/mL (light pink) 
0.30 pg/mL (light yellow) 
0.40 pg/mL (violet) 
Sulfuric Acid Anisaldehyde 
0.90 pg/mL (blue) 
0.70 pg/mL (orange) 
1.0 pg/mL (green) 
0.80 pg/mL (black) 
Table4. Effect of Various Organic and Inorganic Impurities (interference) on the Identification and Mobility (Rf) of Cannabis 
saliva, Embleia ribes, Myrlsticafragrans and Plpper longum on Silica Gel 'G' Layers Developed with Solvent System M12 
Impurity 
NaCl 
KCI 
Urea 
Ammonia 
NOj-
Glucose 
Cannabis sa^a 
0.91 T 
0.86 
h4D 
ND 
0.97 
0.94 T 
Emblela ribes 
0.58 T 
0.55 T 
0.71 
N.D. 
ND 
0.38 T 
Myrlstka/ragrana 
0.44 T 
0.43 T 
0.41 
0.00 
ND 
0.47 T 
lipper longum 
0.32 T 
0.30 T 
ND 
0.13 T 
ND 
ND 
ND = Not detected. 
T = Trailing. 
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drug sample as impurities influences the mobility of all the 
four herbal drugs. In case of NaCl, KCI and glucose as an 
interfering species all the three drugs produced tailed spots 
except Pippali which was not detected in glucose. Only 
Bhanga was detected when N03' was used as an interfering 
species. No spot was detected for Bhanga and Vidanga in 
presence of ammonia. In case urea as an interfering species 
Bhanga and Pippali were not detected. 
DISCUSSION AND CONCLUSION 
It may be concluded from the results that in case of 
CTAB and TX-lOO, all the four drugs (Jatiphala, Pippali, 
Vidanga and Bhanga) are expelled or excluded from the 
micelle due to some sort of repulsion. This repulsion causes 
the increase in the retention of these compounds with the 
stationary phase with the increase in concentration of surfac-
tants in die solvent system. While in case of SDS all the four 
drugs associate or bind with the micelle. This association 
with drugs causes a decrease in the retention of all the four 
drugs with stationary phase. This may also be concluded that 
these drugs behave as binding solutes for the SDS and the 
antibinding solutes for both CTAB and TX-IOO. From the 
chromatographic point of view, solvent system (M^) was 
found to be best solvent system for the resolution of all 
the four herbal drugs due to higher A RF values [(RF Bhwgt -
RF v.dMp) and (RF j.dphj. - RF Pippdi)! which was 0.31 and 0.15 
respectively in solvent system M12 as compared to Mjo (ARF 
values, 0.28 and 0.13 respectively) and also all the 
four drugs studied produced compact spots with high color 
intensity in 5% aqueous SDS containing solvent system 
(M12). Therefore, solvent system M^ is selected for the 
further study. 
The mobility (Rp) of all the four drugs is greatly affected 
by the presence of alcohols in the miceller solvent system. 
The addition of alcohols in the micellar solvent systems may 
result in the less population of surfactants molecules on the 
adsorbent and this may provide some free silanol groups on 
the silica surface for the adsorption of analyte [27] and also 
the addition of short-chain alcohols to the micellar mobile 
phase increases the polarity of solvent system and reduces 
the thickness of the film of surfactant molecules covering 
the stationary phase which results in increase of mobility 
of drugs. It is also reported that the addition of short-chain 
alcohols at lower concentrations also affects the micelle 
formation [28- 29]. From all the alcohols used butanol con-
taining solvent system (M32) provides highly compact spots 
for all the four drugs. This may be due io decrease in the 
polarity of the solvent system which in turn improves the 
efficiency and this could be related to improvement brought 
about by wetting the stationary phase with organic modifier. 
The actual polarity decreases in the order methanol> 
ethanol>propanol>butanol and hence efficiency follows the 
reverse trend as butanol<propanol<ethanol < methanol. 
To widen the applicability of developed thin layer 
chromatographic method in the field of herbal drugs all 
the four constituents was identified and separated from 
ayurvedic formulation Jatiphaladya. Simultaneous use of 
other sensitive analytical methods such as HPLC and 
GC-MS may further provide the evidence about accuracy 
of our developed TLC system and data for estimation of 
biochemical structural composition of these herbals for 
future research. All the four important herbal drugs 
were identified and separated fi-om an ayurvedic herbal 
formulation Jatiphaladya. The identification and resolution 
of Cannabis saliva (Bhanga), Embleia ribes (Vidanga), 
Myristica fragrans (Jatiphala) and Piper longum (Pippali) 
from Jatiphaladya ayurvedic formulation on silica gel layers 
with solvent system M12 is shown in Fig. (1). The charac-
terization and comparative studies of these identified 
and separated herbals with their standards may be more 
informative and useful for the proposed chromatographic 
system during future analytical studies of these herbals 
drugs. 
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Abstract 
Thin layer chromatography (TLC) has been used as an analytical technique for the 
identification and separation of two different drugs (paracetamol and diclofenac sodium) on 
silica gel H layers under optimized experimental conditions using surfactant mediated mobile 
phase systems. Cationic, non-ionic and anionic surfactants at different concentration levels 
have been used as mobile phases. Among the TLC systems studied, silica gel H used as 
stationary phase and methanol + 1% aqueous N-cetyl-N,N,N-trimethylammonium bromide 
(CTAB) + acetic acid (4:5:1 v/v/v) used as mobile phase were most favorable for achieving 
mutual separation of paracetamol and diclofenac sodium. The effect of forced degradation 
parameters such as sunlight, pH variation and storage temperature on the mobility (Rp) of 
drugs have been studied using 1% aqueous N-cetyl-N,N,N-trimethylammonium bromide 
(CTAB) and sodium dodecyl sulfate (SDS) as eluents. This chromatographic system [silica 
gel H (stationary phase) and methanol + 1% aqueous CTAB+ glacial acetic acid (mobile 
phase)] is also used in order to identify diclofenac sodium from human urine. 
Rezumat 
Pentru identificarea §i separarea paracetamolului §i diclofenacului sodic a fost 
utilizata ca tehnica de analiza cromatografia in strat subfire (CSS) pe straturi de silicagel H, in 
condifii experimentale imbunata^te, utilizand diverse faze mobile, optimizate prin surfactanti. S-au 
utilizat surfactanti cationici, non-ionici ji anlonici, la concentra i^i diferite. Dintre sistemele CSS 
studiate eel mai favorabil pentru separarea paracetamolului ji diclofenacului sodic a fost 
sistemul care utilizeaza silicagelul H ca fazS staponara ji amestecul: metanol + bromura de N-
cetil, N,N,N-trimetilamoniu (CTAB) solu i^e apoasa 1% + acid acetic (4:5:1 v/v/v), drept faza 
mobila. A fost studiat efectul unor factori de degradare cum ar fi: lamina, varia i^a de pH, 
temperatura, asupra factorului de retenfie (Rp) al medicamentelor, utilizand solufia apoasa 1% de 
bromura de N-cetil,N,N,N-trimetilamoniu (CTAB) ji dodecil sulfatul de sodiu ca eluen^. 
Sistemul cromatografic silicagel H (faza sta i^onara) ?i metanol + bromura de N-cetil, N,N,N-
trimetilamoniu (CTAB) solupe apoasa 1% + acid acetic (faza mobila) a fost utilizat, de 
asemenea, pentru identificarea diclofenacului sodic tn urina. 
Keywords: thin layer chromatography; surfactants; paracetamol; diclofenac 
sodium; human urine 
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Introduction 
Diclofenac sodium (DS) is sodium-[(2, 6- dicholorophenyl) amino]-
phenyl acetate. It is a sodium salt of an aryl acetic acid derivative [1,2]. It 
possesses analgesic, anti-inflammatory and antipyretic activity. It inhibits 
prostaglandins synthesis by interfering with the action of prostaglandin 
synthetase (Cyclooxygenase) [2]. Paracetamol (Para-acetyl amino phenol) is a 
widely used analgesic and antipyretic drug. It is the active metabolite of 
phenacetin, but unlike phenacetin, paracetamol has not been shown to be 
carcinogenic. Paracetamol reduces the production of prostaglandins [3]. The 
separation of drugs by thin layer cfiromatography (TLC) is generally 
governed by the physical interaction of the adsorbent and the coordinative 
properties of the mobile phase. As a general practice, the composition of 
mobile phases is usually modified in order to achieve the desired separation 
on a particular adsorbent [4-7]. An extensive survey of literature reveals that 
the single and multicomponent mobile phases belonging to the follovvdng 
main groups have been used for TLC analysis of drugs: 
(1) Organic solvents containing alcohols (methanol, ethanol, propanol or 
butanol), chloroform, acetone and acetonitrile as one of the 
components [5,6]. 
(2) Aqueous organic solvents containing chloroform, alcohol, ethyl 
acetate and pyridine as one of the components [8,9]. 
(3) Mixed aqueous organic acidic or alkaline solvents containing 
ammonia, hydrochloric acid and acetic acid as one of the components 
[8,9]. 
In most cases, a mixture of three or four solvents, in various 
proportions, has been used as mobile phase. These systems have one major 
drawback of compositional nonuniformity during the development of tfiin layer 
chromatographic plates due to differences in evaporation tendencies of each 
component. Thus, the need of a simple mobile phase system for the analysis of 
pharmaceutical products is always felt by the chromatographers. The systematic 
studies in our laboratory on TLC analysis of heavy metals [10,11], amines [12], 
anions [13], and amino acids [14] showed that toxic organic solvents can be 
easily replaced by aqueous surfactant mediated systems. Keeping this in mind we 
decided to develop a simple mobile phase system, containing a surfactant as one 
of the component for separation and identification, of coexisting paracetamol and 
diclofenac sodium on silica gel H layers. 
Surfactant modified mobile phases have received considerable 
attention in liquid chromatography since first report by Armstrong and 
Fender in 1977 [15] who exploited the advantageous features of micellar 
system in chromatography. The use of surfactant ions as mobile phase 
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components below their critical micelle concentration (CMC), in ion-pair 
chromatography (IPC), or above their CMC in micellar liquid 
chromatography (MLC), has been the focus of numerous studies [16,17]. 
This report is an attempt in the direction of developing a simple and reliable 
method for on plate identification and separation of paracetamol and 
diclofenac sodium using silica gel H layers developed with a new mobile 
phase comprising of 0.0001% - 1.0% aqueous N-cetyl-N, N, N-
trimethylammonium bromide (CTAB), sodium dodecyl sulphate (SDS) or t-
octyl phenoxydecaethoxy ethanol (TX-lOO) in combination with methanol 
and glacial acetic acid in 5:4:1 v/v/v ratio. Paracetamol and diclofenac 
sodium have been previously separated by TLC on silica coated glass plates 
using several mixed aqueous organic mobile phases involving mainly 
methanol, water and acetic acid [18-20]. Silica gel stationary phase have 
been successfiilly used for identification of second series of drugs [21], 
densitometric determination of certain antidiabetic drugs [22] and detection 
of tuberculosis drugs [23] in dosage form. 
Urine biological samples are often preferred for drug analysis due 
to the ease of collection, the presence of high concentrations of drugs and 
metabolites, and their stability in urine for up to two or three days after 
consumption. In case of forensic drug analysis TLC enables the simple, fast, 
cheap and effective extraction, identification and separation of the complex 
mixtures of drugs and other metabolites from human urine samples [24,25]. 
Therefore TLC is considered as one of the best known and thoroughly tested 
methods of analysis of substances such as biologically active amines [26], 
carbohydrates [27], enzymes [28], porphyrins and their precursors [29], 
alkaloids [30], banned drugs [30] from human urine samples. 
As far as we are aware, TLC with surfactant modified mobile 
phases has not been used for identification and mutual separation of 
paracetamol and diclofenac sodium. This study thus bears practical as well 
as theoretical importance. 
Materials and methods 
Apparatus 
A TLC applicator, pH meter (Elico model L 1 0 T), Electronic 
heating dry box (T S I India). 
Reagents 
Silica gel H, iodine crystals, N-cetyl-N, N, N-trimethylammonium 
bromide (CTAB), sodium dodecyl sulfate (SDS) and t-octyl 
phenoxydecaethoxy ethanol (TX-lOO) were purchased from CDH, Delhi, 
India. Methanol, isoamyl alcohol, ethylene-dichloride, ethanol, propanol. 
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butanol and glacial acetic acid were from Qualigen Chemicals, Mumbai, 
India. Buffer capsules for pH 2.4, 4.0 and 9.2 (on dilution with 100 mL 
distilled water) were obtained from Merck Reagents, Mumbai, India. 
Paracetamol (Paracip®) of Cipla Labs, India and diclofenac sodium 
(Voveran®) of Emcure Pharma, India were used. All reagents were of 
Analar grade. 
Detection 
Iodine vapors were used for detection of all drugs. 
Chromatography 
a. Preparation of Test Solutions 
Analyte solutions of the drugs were prepared by dissolving 25 mg 
of pure active powder ingredients of paracetamol and diclofenac sodium in 
5.0 mL of methanol. For the solution preparation of formulated drugs, the 
five tablets of each drug were taken and weighed. The tablets were finely 
grounded into a homogenous powder form. The powder equivalent to 250 
mg active substance was weighed, transferred into a 50 mL standard 
volumetric flask, mixed with 25 mL methanol and sonicated for 40 min. The 
solution was filtered through Whatman filter paper (No.41) and the residue 
was washed twice with methanol. The filtrate and washings were combined 
in a 50 mL standard volumetric flask and diluted to the mark with methanol. 
This solution contains 5 mg/mL of drug. 
b. Mobile Phase 
Following mobile phases were used. 
Code Constituents Ratio 
Mo 
M, 
M2 
M3 
M4 
M5 
M6 
M7 
Ms 
M9 
M,o 
Mu 
M,2 
M,3 
Mu 
M,5 
methanol: double distilled water: glacial acetic acid 
methanol: 0.0001% aqueous CTAB : glacial acetic acid 
methanol: 0.01% aqueous CTAB : glacial acetic acid 
methanol: 0.1 % aqueous CTAB : glacial acetic acid 
methanol: 1.0% aqueous CTAB : glacial acetic acid 
methanol: 0,0001% aqueous SDS : glacial acetic acid 
methanol: 0.01 % aqueous SDS : glacial acetic acid 
methanol: 0.1 % aqueous SDS : glacial acetic acid 
methanol: 1.0 % aqueous SDS : glacial acetic acid 
methanol: 0.0001% aqueous TX-lOO : glacial acetic acid 
methanol: 0.01 % aqueous TX-lOO : glacial acetic acid 
methanol: 0.1% aqueous TX-lOO : glacial acetic acid 
methanol: 1.0% aqueous TX-lOO : glacial acetic acid 
ethanol: 1.0% aqueous CTAB : glacial acetic acid 
propanol: 1.0% aqueous CTAB : glacial acetic acid 
butanol: 1.0% aqueous CTAB : glacial acetic acid 
c. Stationary Phase 
Silica gel H was used as the stationary phase. 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
(4:5:1) 
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d. Preparation of TLC Plates 
The plates were prepared by mixing silica gel H with double 
distilled water in 1 -.3 ratios by weight. The resultant slurry was mechanically 
shaken for 10 min after which it was applied on well cleaned glass plates to 
give a layer of 0.25 mm thickness. The plates were air dried at room 
temperature and then heated at 100 ± 5 °C for one hour. After the activation, 
the plates were kept in an airtight chamber. 
e. Procedure 
0.01 mL of the solutions of pure and formulated drugs were spotted 
separately on TLC plates with the help of a micropipette at a distance of 2.0 
cm above the lower edge of the plate. The spots were allowed to dry at room 
temperature and the plates were then developed with the chosen mobile 
phase in a 24 cm X 6 cm glass jar by ascending technique. The development 
distance was kept 10 cm in all cases. After development, the plates were 
dried again and placed in a sealed iodine chamber. The spots of both 
formulated and pure drugs were visualized and compared. The RF values for 
both pure and formulated drug spots were calculated. 
The RF value can be calculated as: 
RF = 0.5 X (RL+RT) 
RL= RF of leading front. 
RT =RF of trailing fix)nt. 
In order to study the effect of concentration and type of surfactants 
on the RF values of drugs, the double distilled water in the mobile phase (Mo) 
was substituted by 0.0001-1.0% aqueous (cationic, anionic and nonionic) 
surfactants (M1-M12) for performing the chromatography of drugs. The 
variation in RF values, spot color and the intensity of spots were examined 
using the resultant mobile phases (M1-M12). For separating the mixture of 
drugs, equal volumes of all the drugs were mixed and then 0.01 mL of the 
resultant drug solution was applied on TLC plates. The plates were developed 
with the most suitable mobile phase M4 and the RF values of separated drugs 
[paracetamol (Pa) and diclofenac sodium (Ds)] were calculated. 
For examining the effect of the pH value of drug solutions (i.e. 
analyte) on the mobility (RF values) of drugs, the different pH values (2.4, 
4.0 and 9.2) of drug solutions were adjusted using buffer solutions. The 
chromatography of these resultant drug solutions was performed on silica 
gel H plates with M4 and Mg mobile phases. The RF values of the spots were 
calculated and compared. 
For examining the effect of sunlight on the mobility of drug 
solutions, paracetamol and diclofenac sodium, they were exposed to direct 
sunlight for 48 hours under normal room temperature conditions, in sealed 
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transparent glass vials. The exposed drug solutions (0.01 mL) were spotted 
on the silica gel H TLC plates and developed with solvent system M4 and 
Mg.The variation in Rp values of detected spots were investigated. 
In order to study the effect of the storage temperature on the 
mobility of the drugs, the drug solutions were kept for 48 hours at four 
different temperatures (°C ± 2) as follows: 
(a) 10°C (b)20°C 
(c) 30°C (d) 40°C 
After this, chromatography was performed for these drug samples 
on silica H plates with solvent system M4 and Mg.The variation in RF values 
were reported and compared. 
/ Extraction of diclofenac sodium from urine samples 
A sample of urine is taken from a patient after 4-6 hours from the 
intake of the diclofenac sodium. 100 mL of urine sample was adjusted to pH 
7-8 with 1 M NaOH solution. Then, the urine sample was mixed with 400 
mL of ethylene dichloride containing 10% of isoamyl alcohol and shaken 
for 15 min. After this, the organic layer was separated and evaporated in 
order to obtain diclofenac sodium as residue. The residue was diluted with 5 
mL of methanol. The chromatography of the extracted drug (diclofenac 
sodium) was performed on silica gel H layers with surfactant modified 
solvent system (M4). 
Results and discussion 
1. Effect of the type and concentration of surfactants 
The chromatography of the studied drugs (paracetamol and 
diclofenac sodium) was performed on silica gel H plates using thirteen 
solvent systems (Mo -Mi2). The results were presented in Table L In the 
solvent system Mo (methanol: water: glacial acetic acid, 4:5:1 v/v/v) the two 
drugs show marginall differential migration in the order paracetamol > 
diclofenac sodium as seen in Table I. In the hope of achieving better 
separation possibilities of the drugs, water from the solvent system MQ was 
replaced by aqueous solutions of surfactants (cationic, anionic or nonionic). 
The results obtained with these mobile phases (M1-M12) are recorded in 
Table I. In these solvent systems, the concentration of surfactants was 
maintained in the range of 0.0001 - 1.0 % in order to understand the effect 
of surfactants as an electrolyte (surfactant concentration below CMC) and 
micelles (surfactant concentration above CMC). The value of CMC (in 
water at 25 °C) of CTAB, TX-lOO and SDS are 9.2x lO^^ , 2.05x 10"^  and 
8.1x lO"'' M respectively. 
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Table I 
The mobility of drugs on silica gel H layers developed with water 
:ontaining (Mo) and surfactant mediated mobile phase systems (M1-M15) 
Mobile 
phase (M) 
Mo 
M, 
M2 
M3 
M4 
M5 
M<i 
M7 
Mg 
M9 
M,o 
M„ 
M,2 
M,3 
M,4 
M,5 
RF values 
Paracetamol 
0.56 
0.68 
0.70 
0.77 
0.81 
0.52 
0.46 
0.39 
0.33 
0.60 
0.68 
0.71 
0.76 
0.72 
0.68 
0.59 
Diclofenac sodium 
0.13 
0.19 
0.24 
0.27 
0.32 
0.12 
0.07 
0.05 
0.00 
0.15 
0.17 
0.22 
0.23 
0.24 
0.18 
0.15 
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From the results shown in Table I, it is clear that the mobility (RF 
value) of the two drugs increases with the increase in the concentration of 
cationic (CTAB) as well as nonionic (TX-lOO) surfactants. Conversely, with 
anionic (SDS) surfactant, the mobility of drugs was found to decrease with 
the increase in the concentration of the surfactant. Thus, the mobility of 
drugs is influenced by the nature of charge of surfactant irrespective of its 
presence in the form of electrolyte or micelles. Among these, M4 (methanol: 
0.0001% aqueous CTAB: glacial acetic acid, 4:5:1 v/v/v) was found most 
favorable from the separation point of view. This may be due to the 
presence of strong hydrophobic and electrostatic interactions of cationic 
surfactants with dissociated silanol groups of silica gel layers [31]. Thus it is 
selected for further studies of these drugs because of the following 
advantages: spot compactness, high color intensity of the spots, and better 
separation of the drugs. This method successfully resolved the co-existing 
mixture of diclofenac sodium and paracetamol from the mixture containing 
formulated drugs of two different tablets (diclofenac sodium and 
paracetamol) and also from a formulated tablet containing mixture of both 
diclofenac sodium and paracetamol. 
2. Effectofalkanols 
To investigate the retention behavior of paracetamol and diclofenac 
sodium on silica gel H layers and hybrid-mobile phase systems comprising of 
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micelle (1% aqueous CTAB)- glacial acetic acid- alcohol (ethanol, propahol 
or butanol) were also used and better chromatographic performance in terms 
of promotion of differential migration of drugs (paracetamol and diclofenac 
sodium) by these mobile phases was observed. The RF values shown m Table 
I, clearly indicate a general trend of decreasing Rp value with the increase in 
carbon chain length of alcohol. This retention mechanism is connected with 
the adsorption of surfactant on the surface of the stationary phase. The nature 
and polarity of alcohol lead to the reduction in the adsorbed amount of 
surfactant on the stationary phase which causes an increase in retention of 
solutes and a change in selectivity [32]. 
Table II. 
3. Effect of variation of pH in the drug solution 
The effect of pH on the mobility (RF value) of drugs is shown in 
pH of drug 
solutions 
9.2 
4.0 
2.4 
Table II 
Effect of change of drug pH on their mobility (Rp) 
through silica gel H layers deve oped with mobile phase M4 and Mg 
Paracetamol 
M4 
Rf values 
0.80 
0.76 
n.d. 
Mg 
RF values 
0.35 
0.31 
n.d. 
Diclofenac sodium 
M4 
Rf values 
0.30 
0.33 
n.d. 
Mg 
RF values 
0.00 
0.03 
n.d. 
n.d. = not determined 
It is evident from Table II that at a higher pH, none of the drugs 
was detected on TLC plate. In case of paracetamol and diclofenac sodium, a 
minor variation in RF values was observed for pH change from 4.0 to 9.2. 
4. Effect of sunlight 
The effect of sunlight or the photosensitivity of drugs (paracetamol 
and diclofenac sodium) on their mobility was examined and the obtained 
results are presented in Table III. It was clearly observed that in solvent 
systems M4 and Mg, the RF values of the drugs were significantly affected. 
Table III 
Effect of sunlight on the mobility (Rp value) of drugs 
on silica gel H layers developed with mobile phase M4 and Mg 
Exposure 
time (hours) 
00 
24 
48 
Paracetamol 
M4 
RF values 
0.79 
0.76 
0.72 
Mg 
RF values 
0.33 
0.28 
0.24 
Diclofenac sodium 
M4 
RF values 
0.32 
0.29 
0.26 
Mg 
RF values 
0.04 
0.00 
0.00 
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5. Effect of storage temperature 
The results obtained when investigating the effect of storage 
temperature on the mobility of drugs are presented in Table IV. A gradual 
increase in Rp values was observed for the two drugs with the increase of 
temperature. 
Table IV 
Effect of storage temperature on the mobility (Rp value) 
of drug solution 
Temperature 
("Ci 2) 
10 
20 
30 
40 
s through silica ge 1 H layers develo 
Paracetamol 
M4 
Rp values 
0.79 
0.81 
0.83 
n.d 
Ms 
Rf values 
0.30 
0.34 
0.37 
n.d. 
ped with mobile phase M4 and Mg 
Diclofenac sodium 
M4 
RF values 
0.30 
0.32 
0.39 
n.d. 
Mg 
RF values 
0.00 
0.04 
0.05 
n.d. 
6. Identification of diclofenac sodium from human urine samples 
The proposed chromatographic method (silica gel H layers with 
MeOH+ 1% aq CTAB+ glacial acetic acid, 4:5:1) successfully identified the 
diclofenac sodium extracted from the human urine samples on the basis of 
the RF values. Chromatogram shows the resolution of diclofenac sodium 
from formulated drug and from human urine sample on silica gel H layers 
using M4 solvent system. Thus the proposed method is very sensitive for the 
identification of drugs from urine samples. 
Conclusions 
Thin layer chromatography of two drugs paracetamol and 
diclofenac sodium, was performed on silica gel H layers using cationic, 
anionic and nonionic surfactant modified mobile phases. From the results, it 
has been clearly and conclusively demonstrated that, the mobility of 
paracetamol and diclofenac depends on the nature and concentration of 
surfactants used in the mobile phase. Among mobile phase studied, the 
mobile phase consisting of methanol + 1% aq. CTAB + glacial acetic acid 
was found most suitable from the separation point of view. This mobile 
phase also proved to be sensitive for the identification of diclofenac sodium 
extracted from human urine samples. 
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Abstract: Various siu-factant modified silica layers were used for the chromatography of five different Cephalosporins. The 
4% methanolic CTAB impregnated silica layer was useful for the chromatography of Cephalosporins. The acidic buffer 
solvent systems were used with the 4% methanolic CTAB impregnated silica layers for the separation of different mixtures [A 
(Cefaclor, Ceftriaxone and Cefadroxil), B (Ceftriaxone, Cefoprazone and Cephalexin) and C (Cefaclor, Ceftriaxone and 
Cephalexin)] of Cephalosporins. The interference due to the presence of sodium and potassium salts, glucose and urea on the 
identification and mobility of all the five Cephalosporins were also examined. 
Keywords:Cephalosporins,Thin Layer Chromatography,Surfactants,BuflFer solvent systems. 
Introduction 
Cephalosporins (fig:l) structurally differ from 
pemcillin's by the heterocyclic ring system. 
Cephalosporins are pencillinase resistance antibiotics 
with significant activity against both gram-positive and 
gram-negative bacteria. They are among the safest and 
the most effective broad spectrum bactericidal 
antimicrobial agents, therefore they are the most 
prescribed of all the available antibiotics ' l Because of aliphatic and aromatic mono- and polyamines ^"", amino 
acids '^  peptides and dipeptides . The introduction of 
In this report we have utilized the versatile 
amphiphotheric nature of surfactants in the impregnation 
of silica layers. It is reported that the preliminary 
impregnation of the adsorbent with surfactant solutions 
leads to the change in elution order and their behavior 
was observed in the impregnation of both normal and 
reversed stationary phase. The separation of primary 
9-11 
the high therapeutic importance of cephalosporins several 
analytical techniques have been used for their analysis 
such as, titrimetric^"*, High performance liquid 
chromatography ', Voltametric *, Spectrophotometry 
Mass-spectrophotomtery .^ The most of these analytical 
methods required expensive and sophisticated 
instruments. This report is an attempt in the direction of 
developing a simple and reliable method for on plate 
identification and separation of cephalosporins in 
pharmaceutical formulations. Amongst all 
chromatographic techniques, thin layer chromatography 
(TLC) has been the most popular for routine analysis due 
to its simplicity of use, simultaneous analysis of large 
number of samples, use of specific and colorful reactions, 
the possibility of two-dimensional separation and easier 
manipulation of stationary and mobile phases. The aim of 
this study was to develop a new chromatographic system 
by impregnating silica gel with solutions of surfactants. 
surfactant into the stationary phase leads to dynamic 
modifications in the stationary phase. According to the 
literature survey, previously Cephalosporins were 
analyzed by various TLC methods on silica gel layers '^' 
' but the use of methanolic surfactant modified 
stationary phase is lacking. 
Experimental: 
Instrumentation and reagents 
A TLC applicator (Toshiwal India) and pH meter Elico 
India Ltd was used. Chemical required like silica Gel 'H', 
Sodium dodecyl sulfate (SDS), N-cetyl-N, N, N-
trimethylammonium bromide (CTAB), Methanol, were 
purchased fi-om Merck India, Iodine crystals, Glacial 
acetic acid. Boric acid, Phosphoric acid and Sodium 
hydroxide were obtained from CDH India, 
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Samples 
Cefaclor, Ceftriaxone, Cefaperozone, Cefadroxil and 
Cephalexin (pure & formulated) were from Lupin labs, 
Mandideep, M.P., India as a gift samples. 
General procedure 
Preparation of Test Solution 
The drug powder (250 mg) was transferred into a 50 mL 
standard volumetric flask and then 25 mL metlmnol was 
added and the resulting mixture was sonicated for 40 
mins. The solution was filtered through Whatman filter 
paper (No.41) and the residue obtained was washed again 
with methanol. The total filtrate was transferred in a 50 
mL standard volumetric flask and made-up to the mark 
with methanol. This solution contains 5 mg/mL (w/v) of 
drug. 
Detector Iodine Vapors were used as detector 
.Stationary Phase: The following (Table 1) stationary 
phases were used for the chromatography 
Mobile phase: The solvent systems were used (Table 2) 
as mobile phases for chromatography of all the drugs. 
Chromatography 
(a) Preparation of TLC plates 
The TLC plates were prepared by mixing silica gel G 
with double distilled water in 1:3 ratios by weight with 
constant shaking to obtain homogeneous slurry. The 
resultant slurry was applied on the glass plates with the 
help of a manual applicator to give a 0.25 mm-thick 
layer. The plates were dried at room temperature and then 
activated at 100 ± 2 "C by heating in an electrically 
controlled oven for one hr. The activated plates were 
stored in a close chamber at room temperature until used. 
(b) Chromatographic procedure 
Test solutions (lO^L) were applied on (15 x 3 cm) 
silica gel thin layer plates with the help of micropipette at 
about 2 cm above the lower edge of the plates. The 
solvent ascent was fixed to 10 cm in all cases for the 
determination of Rp values of all individual drugs. Linear 
ascending development was carried out in a vapor 
equilibrated TLC twin trough chamber. The optimized 
chamber saturation time for the mobile phase was 15 min 
at room temperature (25 ± 1 "C). Subsequent to the 
development, TLC plates were dried at room 
temperature. The plates were then detected by usbg 
iodine vapors and all the drugs are visualized as colored 
spots. The RF values of drug were determined by the 
following relation -
RF = 0 .5(RL + RT) 
where RL = RF of leading front. 
RT = RF of frailing front. 
Separation 
For the separation, equal amount of drugs to be separated 
were mixed [A (Cefaclor, Ceftriaxone and Cefadroxil), B 
(Ceftriaxone, Cefoprazone and Cephalexin) and C 
(Cefaclor, Ceftriaxone and Cephalexin)] and 10|iL of the 
analyte from the resultant mixtures were loaded on 
CTAB impregnated TLC plates (Sio). The plates were 
developed with different solvent systems (Mi, M2 and M3 
for A, B and C mixtures respectively) and the spots were 
detected and the RF values of the separated drugs were 
determined. 
Interference 
For investigating the interference of various organic and 
inorganic compounds like sodium and potassium salts, 
urea and glucose on the identification and mobility of all 
the five cephalosporins smdied, an aliquot (lOpL) of all 
drugs were spotted on CTAB impregnated TLC plates 
(Sio) followed by spotting of lOuL of the interfering 
species (1 mg/mL) on the same spot. The chromatography 
was performed with solvent system Mi on CTAB 
impregnated silica layers (Sio). The spots were detected 
and the RF values of drugs were calculated and conpared. 
Results and discussion: 
The chromatography of cephalosporin was performed on 
various stationary phases impregnated with cationic and 
anionic surfactants at different concentrations. The 
various buffer systems were also used as solvent systems. 
The buffer system having pH 3.15 (Mi) was first used 
with all the stationary phases in order to select the most 
useful chromatographic system for the identification and 
separation of Cephalosporin. The results of the present 
study are presented in Table 3. The following conclusions 
are dravra from the results. 
1. On silica surface (unimpregnated) the Cefaclor 
and Cefaprozone are not detected while 
Ceffriaxone and Cefadroxil show tailed spots and 
Cephalexin remains at the point of application. 
2. In case of SDS impregnated silica layers (S2 _ 
Sa), the mobility of Cefaclor, Cefadroxil and 
Cephalexin increases with the increase in 
concentration of SDS as an impregnant, while 
the mobility of Cefatiiaxone decreases and also 
Cefoperazone remains at the point of application. 
3. On CTAB impregnated silica layers (S7-S] 1), the 
mobility of all the Cephalosporins increases witii 
the increase in the concenfration of CTAB as an 
impregnant. 
It is clear from the results that the lower Rp 
values are observed for all the Cephalosporins on SDS 
impregnated silica layers as compared to CTAB 
impregnated layers except Ceftriaxone where the reverse 
trend was observed. This may be due to the electrostatic 
interactions between the SDS and the Cephalosporins. 
This situation is caused because SDS is impregnated on 
negatively charged silica via the hydrophobic group and 
its negatively charged hydrophilic group is oriented away 
from the surface. As compared to SDS, CTAB is 
impregnated on negatively charged silica via positively 
charged head group and its hydrophobic group is oriented 
away from the surface. On the other hand, the acidic 
buffer solvent systems show significant interactions with 
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all the drugs on CTAB impregnated layers as compared 
to SDS impregnated layers. The significant influence of 
solvent system M| on the stationary phase Sio (Si 
Impregnated with 4 % MeOH solution of CTAB) 
results in the beneficial mobilitys of all the 
cephalosporins and high compactness and high visibility 
of spots. The mutual separation possibility of 
Cephalosporins also increases on the stationary phase Sio. 
The stationary phase Sio (Si Impregnated with 4 % 
MeOH solution of CTAB) was used for the further 
study. Different buffer systems were used as eluents for 
the chromatography of Cephalosporins on the stationary 
phase Sio. The results are presented in Table 4. From the 
point of chromatographic conditions all the 
Cephalosporins provide efficient results in the acidic 
buffer solvent systems as compared to the alkaline buffer 
solvent systems. This might be due to the presence of Na 
^ ion in Cephalosporins which facilitates the release of an 
electron, leading to the formation of a polar compound. 
In acidic medium it was possible to resolve three 
combinations of Cephalosporins (Table 5) such as: (a) 
Cefaclor, Ceftriaxone and Cefadroxil, (b) Cefaclor, 
Ceftriaxone and Cephalexin (c) Ceftriaxone, Cefaprozone 
and Cephalexin in the solvent systems Mj, M2 and M3 
respectively. These separations are not possible in the 
alkaline buffer solvent systems. The results of the 
influence of interfacing species on the chromatography of 
Cephalosporins on stationary phase Sio developed with 
solvent system Mi are presented in Table 6. It is clear 
from the results that in NaCl as KCl as interfering 
species, ceftriaxone and cefadroxil show tailed spots 
while all other three drugs are not greatly influenced by 
their presence. In urea, all the cephalosporins are not 
detected. In case of glucose as an interfering species 
cefaclore and cefadroxil show tailed spots while all other 
three drugs are not detected. Therefore, it is concluded 
that the presence of these interfering species greatly 
influence the chromatography of Cephalosporins. 
Table 1; Stationary Phase. 
Code 
s, 
S2 
S3 
S4 
S5 
S6 
S7 
Ss 
S9 
Sio 
S I , 
Composition 
Silica gel G 
S, Impregnated with 0.1% MeOH solution of SDS 
Si Impregnated with 1% MeOH solution of SDS 
Si Impregnated with 2 % MeOH solution of SDS 
Si Impregnated with 4 % MeOH solution of SDS 
S, Impregnated with 7 % MeOH solution of SDS 
Si Impregnated with 0.1% MeOH solution of CTAB 
S, Impregnated with 1 % MeOH solution of CTAB 
Si Impregnated with 2 % MeOH solution of CTAB 
S, Impregnated with 4 % MeOH solution of CTAB 
Si Impregnated with 7 % MeOH solution of CTAB 
COOH 
Fig: 1 Structure of Cephalosporin 
A. Mohammad e/fl//Int.J. ChemTech Res.2009,l(3) 594 
Table 2: Mobile Phases. 
Code Composition 
Ml Citrate buffer (0.2M citric acid + 0.2 M NaOH) pH 3.15 
M, Citrate buffer (0.2M citric acid + 0.2 M NaOH) pH 4.05 
Ml Citrate buffer (0.2M citric acid + 0.2 M NaOH) pH 5.05 
M4 Borate buffer (0.2M boric acid + 0.2 M NaOH) pH 9.10 
M, Borate buffer (0.2M boric acid + 0.2 M NaOH) pH 10.03 
Table 3: RF values of Cephalosporins developed on unimpregnated and 
impregnated silica layers with solvent system Mi. 
Drugs 
Cefaclor 
Ceftriaxone 
Cefadroxil 
Cefaprozone 
Cephalexin 
Stationary Phases 
s, 
ND 
0.91 
(T) 
0.98 
(T) 
ND 
0.00 
S2 
0.54 
0.87 
(T) 
0.47 
(T) 
ND 
0.00 
S3 
0.57 
0.83 
(T) 
0.48 
(T) 
0.00 
0.28 
S4 
0.57 
0.82 
(T) 
0.48 
0.00 
0.31 
S5 
0.59 
0.80 
(T) 
0.51 
0.00 
0.31 
S6 
0.61 
0.80 
(T) 
0.57 
0.00 
0.38 
S7 
0.81 
0.00 
0.61 
0.00 
0.57 
S8 
0.81 
0.07 
0.61 
0.00 
0.58 
s. 
0.82 
0.10 
0.68 
0.00 
0.61 
Sio 
0.86 
0.14 
0.71 
0.04 
0.67 
S,i 
0.88 
0.13 
0.71 
0.04 
0.68 
Table 4: Rp value of Cephalosporin's developed with CTAB impregnated silica 
layers 
Drugs 
Cefaclor 
Ceftriaxone 
Cefadroxil 
Cefaprozone 
Cephalexin 
Sio) using differe nt buffer 
Solvent Systems 
Ml 
0.86 
0.14 
0.71 
0.04 
0.67 
M2 
0.76 
0.00 
0.00 
0.00 
0.11 
M3 
0.81 
0.00 
0.76 
0.31 
0.70 
solvent 
M4 
0.92 
0.14 
0.41 
0.43 
0.91 
systems. 
Ms 
0.97 
0.36 
0.36 
0.43 
0.43 
Table 5: Separations (RF values) of different Cephalosporins achieved from their 
mixtures on CTAB impregnated silica layers (Sio) using with different solvent systems. 
Mobile Phase 
M, 
M3 
M2 
Drug Mixture 
A 
B 
C 
Cefaclor (0.91) 
Ceftriaxone(O.OO) 
Cefaclor (0.79) 
Ceftriaxone (0.09) 
Cefeprozone (0.37) 
Ceftriaxone(O.OO) 
Cefadroxil (0.66) 
Cephalexin (0.81) 
Cephalexin (0.17) 
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Table 6: 
different 
Impurity 
NaCl 
KCl 
Urea 
Glucose 
Effect of Various 
Cephalosporins on 
Cefaclor 
0.84 
0.81 
ND 
T 
Organic and Inorganic Impurities on the IdentiflcationMobility (Rp) 
Silica gei layers (Sio) developed with Solvent System Mi 
Drugs 
Ceftriaxone 
0.1 IT 
0,09 T 
ND 
ND 
Cefadroxil 
0.72 T 
0.74 T 
ND 
T 
Cefaprozone 
0.00 
0.14 
ND 
ND 
Cephalexin 
0.66 
0.67 
ND 
ND 
of 
ND = Not detected ,T = Trailing 
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